Clinical Trials
Aspirin® Plus Rivaroxaban Versus Rivaroxaban Alone for the Prevention of Venous Stent Thrombosis in Patients With PTSConditions: Venous Thromboses; Stent StenosisIntervention: Drug: Aspirin 100mg Sponsors: University of Zurich; University Hospital Heidelberg; Medical University of Vienna; RWTH Aachen University; Klinikum Arnsberg Recruiting Wed, 16 Oct 2019 12:00:00 EDT Serum Thromboxane B2 Assay as a Measure of Platelet Production in Healthy Volunteers Taking AspirinCondition: AspirinIntervention: Drug: Aspirin 81 mg Sponsor: Hamilton Health Sciences Corporation Completed Wed, 07 Feb 2018 12:00:00 EST TIME ASPIRIN: Chronotherapy With Aspirin for Reduction of Cardiovascular DiseaseCondition: Cardiovascular DiseasesInterventions: Other: placebo after awakening + aspirin before bedtime; Other: aspirin after awakening + placebo before bedtime Sponsors: Leiden University Medical Center; ZonMw: The Netherlands Organisation for Health Research and Development Recruiting Mon, 21 Oct 2019 12:00:00 EDT The Effectiveness of Aspirin on Preventing Pre-eclampsiaCondition: Pre-EclampsiaIntervention: Drug: Aspirin Sponsor: The Third Affiliated Hospital of Guangzhou Medical University Not yet recruiting Mon, 07 Dec 2020 12:00:00 EST Mobilization of Endothelial Progenitor Cells and AspirinCondition: Hypertrophic Obstructive CardiomyopathyIntervention: Drug: Aspirin Sponsor: Ottawa Heart Institute Research Corporation Recruiting Fri, 05 Feb 2016 12:00:00 EST Unruptured Intracranial Aneurysm Aspirin Trial (UIAAT).Conditions: Intracranial Aneurysm; InflammationIntervention: Drug: Aspirin Sponsor: University Hospital Southampton NHS Foundation Trust Unknown status Fri, 07 Sep 2018 12:00:00 EDT Effects of Low Dose Aspirin Pre-treatment on Platelet Activation Undergoing Off-pump Coronary Artery Bypass SurgeryCondition: Coronary Artery DiseaseInterventions: Drug: aspirin continuation; Drug: aspirin discontinuation Sponsor: Seoul National University Hospital Completed Wed, 06 Aug 2014 12:00:00 EDT Aspirin for Uncontrolled AsthmaCondition: Uncontrolled AsthmaInterventions: Drug: Aspirin; Drug: Placebo Sponsor: Assistance Publique - Hôpitaux de Paris Recruiting Tue, 20 Sep 2016 12:00:00 EDT Prospective Study Investigating Aspirin and Intraoperative Blood Loss and Complications Following Inguinal Hernia RepairConditions: Hernia, Inguinal; Postoperative Complications; Postoperative HemorrhageIntervention: Drug: Aspirin Sponsor: Jesse Brown VA Medical Center Unknown status Wed, 12 Mar 2014 12:00:00 EDT A Comparison of Two Therapeutic Strategies for the Treatment of Aspirin-associated Peptic UlcersCondition: Peptic UlcerIntervention: Drug: aspirin Sponsor: Kaohsiung Veterans General Hospital. Completed Thu, 12 May 2011 12:00:00 EDT 
Aspirin in the Prevention of Collapse in Osteonecrosis of the HipConditions: Osteonecrosis of Femoral Head; Osteonecrosis; Aseptic, IdiopathicInterventions: Drug: Aspirin; Drug: Placebo Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre Recruiting Tue, 23 Jan 2018 12:00:00 EST Aspirin in the Treatment of Pregnant Women With Adenomyosis on Reducing Preterm DeliveryCondition: Adenomyosis of UterusIntervention: Drug: Aspirin/placebo Sponsor: Shanghai First Maternity and Infant Hospital Not yet recruiting Wed, 02 Sep 2020 12:00:00 EDT Peri-operative Aspirin Continuation Versus DiscontinuationConditions: Hematuria; Urinary Bladder NeoplasmsIntervention: Drug: Aspirin Sponsor: Rabin Medical Center Terminated Thu, 29 Jan 2015 12:00:00 EST Perioperative Bleeding and Aspirin Use in Spine SurgeryConditions: Hemorrhage; ThrombosisIntervention: Drug: Acetylsalicylic acid Sponsor: University Hospitals Cleveland Medical Center Unknown status Tue, 21 Jun 2016 12:00:00 EDT The Effect Of Aspirin On Survival in in Patients Undergoing Chronic HemodialysisCondition: HemodialysisIntervention: Drug: acetylsalicylic acid Sponsor: Shanghai Jiao Tong University School of Medicine Completed Thu, 09 Oct 2014 12:00:00 EDT Multi-center Prospective Randomized Control Trail of High Dose Aspirin in Acute Stage of Kawasaki DiseaseCondition: Kawasaki DiseaseIntervention: Drug: Aspirin Sponsor: Chang Gung Memorial Hospital Unknown status Tue, 10 Feb 2015 12:00:00 EST Pharmacodynamics and Pharmacokinetics of Aspirin Inhalation Powder With Non-Enteric-Coated Chewable AspirinCondition: Platelet Aggregation InhibitorsIntervention: Drug: Aspirin Sponsor: Inova Health Care Services Completed Wed, 01 Apr 2020 12:00:00 EDT Aspirin and a PoTent P2Y12 Inhibitor Versus Aspirin and Clopidogrel in Patients Undergoing PCI for Complex LesionCondition: Coronary Artery DiseaseIntervention: Drug: Dual antiplatelet therapy with a P2Y12 inhibitor plus aspirin Sponsors: Samsung Medical Center; Inje University; Seoul St. Mary's Hospital; Mediplex Sejong Hospital; Chonnam National University Hospital; Sejong General Hospital; Wonkwang University Hospital; Gachon University Gil Medical Center; Keimyung University Dongsan Medical Center; Chungbuk National University Hospital; Yeungnam University Hospital; Chungnam National University Hospital; Wonju Severance Christian Hospital; Konkuk University Chungju Hospital; Chung-Ang University Hosptial, Chung-Ang University College of Medicine; Dankook University; Incheon St.Mary's Hospital; Gyeongsang National University Hospital; Soonchunhyang University Hospital; Ewha Womans University Not yet recruiting Wed, 10 Jul 2019 12:00:00 EDT Aspirin for the Prevention of Preeclampsia in Women With Stage 1 HypertensionCondition: Pre-EclampsiaIntervention: Drug: Aspirin 81mg Sponsors: Eastern Virginia Medical School; AMAG Pharmaceuticals, Inc. Recruiting Tue, 01 Jun 2021 12:00:00 EDT Aspirin on CTCs of Advanced Breast and Colorectal CancerConditions: Epithelial-Mesenchymal Transition; Circulating Tumor CellsIntervention: Drug: Aspirin Sponsor: Zhejiang Provincial People's Hospital Unknown status Wed, 11 Nov 2015 12:00:00 EST
ASPIrin in Reducing Events in Dialysis ( ASPIRED )Condition: CKD (Chronic Kidney Disease) Stage 5DIntervention: Drug: Aspirin 100 mg Oral Tablet Sponsors: Guangdong Provincial People's Hospital; George Clinical Pty Ltd Recruiting Fri, 08 May 2020 12:00:00 EDT Aspirin for Prevention of Venous Thromboembolism Among Ovarian Cancer Patients Receiving Neoadjuvant ChemotherapyConditions: Venous Thromboembolism; Ovarian CancerIntervention: Drug: Aspirin Sponsor: Duke University Recruiting Mon, 20 Apr 2020 12:00:00 EDT COMT on Aspirin Platelets Effects (CAPE)Condition: Cardiovascular DiseasesInterventions: Drug: Aspirin 81 mg; Drug: Placebo Sponsors: Brigham and Women's Hospital; National Heart, Lung, and Blood Institute (NHLBI) Recruiting Wed, 14 Feb 2018 12:00:00 EST Protective Effect of Aspirin on COVID-19 PatientsConditions: Novel Coronavirus Pneumonia; Aspirin; TreatmentIntervention: Drug: Aspirin 100mg Sponsor: Xijing Hospital Enrolling by invitation Tue, 28 Apr 2020 12:00:00 EDT Body Weight, Aspirin Dose and Pro-resolving MediatorsCondition: Body WeightInterventions: Drug: Aspirin 81mg; Drug: Aspirin 325mg Sponsor: NYU Langone Health Recruiting Wed, 06 Jan 2021 12:00:00 EST Low-dose Aspirin Therapy in Patients With Ischemic Stroke and MicrobleedsCondition: Ischemic StrokeInterventions: Drug: low-dose aspirin; Drug: conventional-does aspirin Sponsors: Xijing Hospital; Shaanxi Provincial People's Hospital; The First Affiliated Hospital of Jiaotong University; Tang-Du Hospital; The First Affiliated Hospital of Xi'an Medical University; Xi'an Central Hospital; Xiangyang Central Hospital; Baoji Central Hospital Not yet recruiting Fri, 07 Aug 2020 12:00:00 EDT Effect of Preoperative Aspirin in Patients Undergoing Off-pump Coronary Artery Bypass GraftingConditions: Coronary Artery Disease; AspirinInterventions: Drug: Aspirin; Drug: vitamin C Sponsor: Medinet Heart Centre Unknown status Thu, 09 Feb 2017 12:00:00 EST Effect of Aspirin on Gut MicrobiomeCondition: HealthyInterventions: Drug: Aspirin; Drug: Placebo Sponsor: University of Minnesota Completed Wed, 04 May 2016 12:00:00 EDT EffectiveNess of Low Dose Aspirin in GastrointEstinal Cancer Prevention - TaiwanCondition: Colorectal NeoplasmsInterventions: Drug: Aspirin (Acetylsalicylic Acid, BAYE4465); Other: No drug Sponsor: Bayer Completed Mon, 09 Jul 2018 12:00:00 EDT Length of Effect of Extended Release Aspirin on Platelets in Patients With Diabetes and Heart DiseaseCondition: Cardiovascular DiseaseInterventions: Drug: Aspirin; Drug: Durlaza™ Sponsor: New Haven Pharmaceuticals, Inc. Completed Wed, 25 Feb 2015 12:00:00 EST
Platelet Hyperreactivity to Aspirin and StrokeConditions: Stroke; Cerebral Infarction; Cardiovascular Diseases; Vascular Diseases; Atherosclerosis; Ischemia; Thrombosis; Acute Coronary SyndromeIntervention: Drug: Aspirin (platelet sensitive versus platelet hyperreactivity) Sponsors: University of Sao Paulo; Fundação de Amparo à Pesquisa do Estado de São Paulo; Accumetrics, Inc.; Helena Laboratories Point of Care; Chrono-Log Corporation Completed Mon, 06 Oct 2008 12:00:00 EDT Aspirin Resistance in Coronary Artery DiseaseCondition: Coronary Artery DiseaseInterventions: Drug: enteric-coated aspirin; Drug: Chewable aspirin Sponsors: Vanderbilt University; National Heart, Lung, and Blood Institute (NHLBI) Completed Wed, 17 Sep 2008 12:00:00 EDT Low-dose Aspirin Therapy for Esophageal CancerCondition: Esophageal CancerIntervention: Drug: Acetylsalicylic acid Sponsor: Zhejiang University Withdrawn Mon, 29 Dec 2014 12:00:00 EST Aspirin to Prevent Preeclampsia in Women With Elevated Blood Pressure and Stage 1 Hypertension (ASPPIRE)Conditions: Pre-Eclampsia; Stage 1 Hypertension; Elevated Blood PressureInterventions: Drug: Aspirin 81 mg; Drug: Placebo Sponsor: Yale University Recruiting Tue, 26 May 2020 12:00:00 EDT Transplacental Aspirin Therapy for Early Onset Fetal Growth RestrictionConditions: Fetal Growth Restriction; Fetal Growth Retardation; Intrauterine Growth Restriction; Intrauterine Growth RetardationIntervention: Drug: Aspirin Sponsor: Johns Hopkins University Withdrawn Mon, 21 Sep 2020 12:00:00 EDT Genotypic and Phenotypic Correlates of Resistance to AspirinCondition: Platelet Dysfunction Due to AspirinIntervention: Drug: aspirin Sponsor: George Washington University Completed Fri, 27 May 2011 12:00:00 EDT Adherence to Universal Aspirin Compared to Screening Indicated Aspirin for Prevention of PreeclampsiaConditions: Medication Adherence; PreeclampsiaIntervention: Drug: Low-dose aspirin Sponsor: Women and Infants Hospital of Rhode Island Recruiting Mon, 15 Mar 2021 12:00:00 EDT Safety and Efficacy of Aspirin in Stroke Patients With Glucose-6-phosphate Dehydrogenase Deficiency (SAST)Conditions: G6PD Deficiency; StrokeInterventions: Drug: Aspirin; Drug: Clopidogrel Sponsor: First Affiliated Hospital, Sun Yat-Sen University Recruiting Thu, 12 Sep 2019 12:00:00 EDT Finding the Best Dose of Aspirin to Prevent Lynch Syndrome CancersCondition: Lynch Syndrome I (Site-specific Colonic Cancer)Intervention: Drug: Aspirin Sponsors: Tel-Aviv Sourasky Medical Center; Rambam Health Care Campus; Rabin Medical Center; Soroka University Medical Center; Sheba Academic Medical Center Hospital Not yet recruiting Wed, 15 Jul 2015 12:00:00 EDT Antenatal Platelet Response On Aspirin and Correlation With HDP (Hypertensive Disorders of Pregnancy)Condition: PreeclampsiaIntervention: Drug: Aspirin 81 mg Sponsor: Thomas Jefferson University Recruiting Thu, 05 Mar 2020 12:00:00 EST
Postoperative Aspirin and Ankle Fracture HealingCondition: Ankle FracturesIntervention: Drug: Aspirin Sponsor: University of Alabama at Birmingham Recruiting Wed, 05 Dec 2018 12:00:00 EST Postpartum Low-Dose Aspirin and PreeclampsiaCondition: Preeclampsia PostpartumInterventions: Drug: Aspirin; Drug: Placebo oral capsule Sponsor: Columbia University Recruiting Wed, 12 Sep 2018 12:00:00 EDT Early Prediction and Randomised Prevention of Preeclampsia With Low Dose Aspirin in Chinese CohortCondition: PreeclampsiaIntervention: Drug: Aspirin Sponsor: Peking Union Medical College Hospital Not yet recruiting Tue, 17 Nov 2020 12:00:00 EST Short Term Aspirin on the Biologic and Immunologic Changes of the Fallopian TubeConditions: Fallopian Tube Cancer; Fallopian Tube InfectionIntervention: Drug: Aspirin 81 mg Sponsor: University of Oklahoma Recruiting Tue, 11 Dec 2018 12:00:00 EST Study to Evaluate How Patients Regard the Benefits and Risks of Low-dose Aspirin for the Prevention of Heart and Blood Vessels Disease and for the Prevention of Cancer of the Colon and RectumConditions: Cardiovascular Disease; Colorectal CancerIntervention: Drug: Acetylsalicylic acid (Aspirin, BAYE4465) Sponsor: Bayer Completed Fri, 27 Jul 2018 12:00:00 EDT Aspirin Versus Aspirin+Clopidogrel as Antithrombotic Treatment Following TAVIConditions: Aortic Valve Disease; Myocardial Infarction; Stroke; BleedingInterventions: Drug: Clopidogrel; Drug: Aspirin Sponsor: Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec Completed Tue, 29 Dec 2015 12:00:00 EST Pilot PARTUM Trial: Postpartum Aspirin to Reduce Thromboembolism Undue MorbidityConditions: Venous Thromboembolism; Postpartum Period; AspirinInterventions: Drug: Aspirin 81 mg; Drug: Placebo Sponsors: University of Calgary; Canadian Institutes of Health Research (CIHR); Canadian Venous Thromboembolism Clinical Trials and Outcomes Research (CanVECTOR) Network Recruiting Wed, 06 Nov 2019 12:00:00 EST Low Dose Aspirin in the Prevention of Preeclampsia in ChinaCondition: PreeclampsiaInterventions: Drug: Aspirin; Other: Blank Sponsor: Peking University First Hospital Completed Mon, 13 Jun 2016 12:00:00 EDT Fish Oil and Aspirin With Type 2 DiabetesCondition: Cardiovascular DiseaseIntervention: Dietary Supplement: Fish Oil and Aspirin Sponsors: University of Rochester; Cornell University; Albany College of Pharmacy and Health Sciences Completed Fri, 13 Aug 2010 12:00:00 EDT Role of ASpirin in Placental and Maternal Endothelial Cell Regulation IN Pre-eclampsiaCondition: Pre-EclampsiaInterventions: Drug: Acetylsalicylic Acid 81 mg; Drug: Acetylsalicylic Acid 162 mg; Other: Control Sponsor: John O'Brien, MD Recruiting Thu, 28 Mar 2019 12:00:00 EDT
Effect of Aspirin on Hemostatic and Vascular Function After Live Fire FightingConditions: Cardiovascular Risk Factor; C.Medical Procedure; Vascular, Functional or Late; Electrolyte and Fluid Balance ConditionsIntervention: Drug: 81 mg enteric coated aspirin Sponsors: University of Illinois at Urbana-Champaign; Federal Emergency Management Agency Completed Thu, 13 Jan 2011 12:00:00 EST Aspirin Use for Gastric Cancer Prevention in the Early Gastric Cancer PatientsConditions: Aspirin; Gastric CancerInterventions: Drug: Aspirin 100mg; Drug: Placebo oral tablet Sponsors: National Cancer Center, Korea; Incheon St.Mary's Hospital/The Catholic University; Kosin University Gospel Hospital; Pusan National University Hospital; SMG-SNU Boramae Medical Center; Chonnam National University Hospital; Chung-Ang University Hosptial, Chung-Ang University College of Medicine; Chilgok Kyungpook National University; Hallym University Medical Center; Seoul National University Hospital; Asan Medical Center Recruiting Thu, 02 Jan 2020 12:00:00 EST Aspirin and Renal Disease Progression in Patients With Type 2 DiabetesCondition: DiabetesInterventions: Drug: Aspirin; Other: Placebo Sponsor: University of Roma La Sapienza Unknown status Fri, 09 Sep 2016 12:00:00 EDT Effect of Aspirin on Abacavir-induced Platelet Reactivity in HIV-infected PatientsCondition: HIV-infected PatientsIntervention: Drug: Aspirin Sponsor: Azienda Ospedaliera di Perugia Completed Fri, 20 Oct 2017 12:00:00 EDT ASPirin in Immune thRombocytopenia Patients With Cardiovascular disEaseConditions: Purpura, Thrombocytopenic; Idiopath Thrombocytopenic Purp; AspirinIntervention: Drug: Aspirin Sponsor: University Hospital, Toulouse Not yet recruiting Thu, 03 Jun 2021 12:00:00 EDT ASpirin for Patients With SEPsis and SeptIc ShockCondition: SepsisIntervention: Drug: Aspirin Sponsor: Federal University of São Paulo Recruiting Tue, 05 Feb 2013 12:00:00 EST Aspirin Withdrawal and Clinical Outcome in Patients With Moderate to High Cardiovascular Risk But Without Cardiovascular DiseaseCondition: Healthy Participants With Moderate and High Cardiovascular RiskIntervention: Other: Withdrawal of aspirin Sponsor: Yonsei University Not yet recruiting Wed, 28 Nov 2018 12:00:00 EST Combined Multi-marker Screening and Treatment With Aspirin for Pre-eclampsia PreventionCondition: PreeclampsiaInterventions: Drug: Aspirin; Drug: Placebo Sponsors: Rabin Medical Center; University College, London Completed Wed, 26 Nov 2014 12:00:00 EST Aspirin Impact on Platelet Reactivity in Acute Coronary Syndrome Patients on Novel P2Y12 Inhibitors TherapyConditions: Acute Coronary Syndrome; Platelet Function and Reactivity Tests; Novel P2Y12 InhibitorsIntervention: Drug: Aspirin Sponsor: Sheba Medical Center Completed Thu, 30 Jan 2014 12:00:00 EST Low Doses of Aspirin in the Prevention of PreeclampsiaCondition: PreeclampsiaIntervention: Drug: acetylsalicylic acid Sponsor: Weill Medical College of Cornell University Recruiting Wed, 28 Aug 2019 12:00:00 EDT
The Long Term Effect of Low Dose Aspirin on Uric Acid in Chinese Patients With Coronary Artery Disease（AURORA）Conditions: Coronary Artery Disease; HyperuricemiaInterventions: Drug: Aspirin 100 mg; Drug: Clopidogrel 75mg Sponsor: Shanghai Zhongshan Hospital Recruiting Tue, 02 Oct 2018 12:00:00 EDT An Investigation Into The Impact Of Enteric Coated Of Aspirin In Patients With Newly Diagnosed Ischemic Stroke.Condition: Stroke, IschemicInterventions: Drug: Enteric Coated Aspirin Tablet; Drug: Plain Aspirin Sponsor: Hamad Medical Corporation Completed Thu, 02 Apr 2020 12:00:00 EDT Aspirin Dosing in Diabetic PatientsConditions: Type 2 Diabetes Mellitus; Coronary Artery DiseaseIntervention: Drug: Aspirin Sponsor: University of Florida Completed Wed, 15 Sep 2010 12:00:00 EDT WilL LOWer Dose Aspirin be More Effective Following ACS? (WILLOW-ACS)Condition: Acute Coronary SyndromeIntervention: Drug: Aspirin Sponsor: Sheffield Teaching Hospitals NHS Foundation Trust Completed Mon, 18 Apr 2016 12:00:00 EDT Aspirin Dosing: A Patient-Centric Trial Assessing Benefits and Long-termCondition: Atherosclerotic Cardiovascular DiseaseIntervention: Drug: aspirin Sponsors: Duke University; Patient-Centered Outcomes Research Institute; Mytrus; Chicago Area Patient-Centered Outcomes Research Network (CAPriCORN); Greater Plains Collaborative Clinical Data Research Network; Mid-South Clinical Data Research Network; Research Action for Health Network (REACHnet); Patient-Centered Scalable National Network for Effectiveness Research; PaTH Clinical Data Research Network; New York City Clinical Data Research Network; Health eHeart Patient Powered Network; OneFlorida Clinical Data Research Network; HealthCore-Anthem Research Network; Humana-HUMnet; The Patient-Centered Network of Learning Health Systems Completed Thu, 03 Mar 2016 12:00:00 EST Aspirin for the Treatment of Nonalcoholic Fatty Liver DiseaseConditions: Nonalcoholic Fatty Liver; Nonalcoholic SteatohepatitisInterventions: Drug: Aspirin 81 mg; Drug: Placebo oral tablet Sponsor: Massachusetts General Hospital Recruiting Wed, 24 Jul 2019 12:00:00 EDT The Effect of Aspirin on Patency of Metal Stent in Malignant Distal Bile Duct ObstructionCondition: Biliary Stasis, ExtrahepaticInterventions: Drug: Aspirin; Drug: Placebo Sponsor: Woo Hyun Paik Terminated Tue, 12 Sep 2017 12:00:00 EDT Aspirin and PreeclampsiaCondition: Preeclampsia PostpartumInterventions: Drug: Aspirin 81 mg; Drug: Placebo Sponsor: University of Chicago Recruiting Tue, 21 Jul 2020 12:00:00 EDT PPARGC1β and CNTN4 Genotype Aspirin StudyCondition: Cardiovascular DiseasesIntervention: Drug: Aspirin Sponsor: Royal College of Surgeons, Ireland Unknown status Tue, 22 Nov 2016 12:00:00 EST Study of Aspirin in Patients With Vestibular SchwannomaConditions: Vestibular Schwannoma; Acoustic Neuroma; Neurofibromatosis 2Interventions: Drug: Aspirin; Drug: Placebo Sponsors: Massachusetts Eye and Ear Infirmary; United States Department of Defense; Massachusetts General Hospital Recruiting Wed, 15 Mar 2017 12:00:00 EDT
Effects of Aspirin on Uterine Endometrial Repair Severe Intrauterine AdhesionCondition: Intrauterine AdhesionInterventions: Drug: Aspirin; Device: intrauterine balloon Sponsor: First Affiliated Hospital, Sun Yat-Sen University Completed Wed, 20 Apr 2016 12:00:00 EDT Aspirin for Prevention of PreeclampsiaCondition: PreeclampsiaInterventions: Drug: aspirin 162 mg; Drug: aspirin 81 mg; Drug: placebo Sponsor: Aswan University Hospital Unknown status Wed, 31 Oct 2018 12:00:00 EDT Adjuvant Aspirin Treatment for Colon Cancer PatientsCondition: Colon CancerInterventions: Drug: Aspirin; Drug: Placebo Sponsors: Swiss Group for Clinical Cancer Research; European Organisation for Research and Treatment of Cancer - EORTC; Central European Society for Anticancer Drug Research Active, not recruiting Wed, 10 Jun 2015 12:00:00 EDT Resistance to Aspirin and/or Clopidogrel Among Patients With PAD.Condition: Intermittent ClaudicationIntervention: Drug: Aspirin Sponsors: Aalborg University Hospital; Danish Heart Foundation Completed Wed, 07 Dec 2005 12:00:00 EST Optimal Dose of Acetylsalicylic Acid After Coronary Artery Bypass GraftingConditions: Coronary Artery Bypass Surgery; Stable AnginaIntervention: Drug: Acetylsalicylic acid Sponsors: Karolinska University Hospital; Karolinska Institutet Completed Fri, 26 Jun 2015 12:00:00 EDT Early Administration of Aspirin in Patients With Acute Ischemic Stroke Treated With Systemic ThrombolysisConditions: Stroke; Brain IschemiaIntervention: Drug: acetylsalicylic acid Sponsor: City Clinical Hospital No. 67, Moscow, Russia Unknown status Mon, 03 Oct 2016 12:00:00 EDT A Trial of Aspirin on Recurrence and Survival in Colon Cancer PatientsConditions: Colon Cancer; Adjuvant TherapyInterventions: Drug: Acetylsalicylic acid; Drug: Placebo Acetylsalicylic acid Sponsors: Leiden University; Stichting voor Patienten met Kanker aan het Spijsverteringskanaal (SPKS); Dutch Colorectal Cancer Group; Stichting Geriatrische Oncologie Nederland (GeriOnNe); Fonds NutsOhra; Innovatiefonds Zorgverzekeraars Recruiting Tue, 25 Nov 2014 12:00:00 EST Aspirin Resistance in OSA PatientsCondition: Obstructive Sleep ApneaIntervention: Other: Aspirin Resistance testing Sponsors: Danbury Hospital; Accriva Diagnostics Completed Mon, 29 Apr 2019 12:00:00 EDT Aspirin Supplementation for Pregnancy Indicated Risk Reduction In Nulliparas (ASPIRIN)Condition: Premature BirthInterventions: Drug: Low dose aspirin; Drug: Placebo Sponsors: NICHD Global Network for Women's and Children's Health; Thomas Jefferson University; Jawaharlal Nehru Medical College Completed Tue, 07 Apr 2015 12:00:00 EDT Aspirin for Venous Ulcers: Randomised Trial (AVURT)Condition: Venous Leg UlcerInterventions: Drug: Aspirin; Drug: Placebo (for Aspirin) Sponsors: St George's, University of London; University of York; University of Manchester; Bradford Teaching Hospitals NHS Foundation Trust; Harrogate & District NHS Foundation Trust; Hull University Teaching Hospitals NHS Trust; University of Nottingham; Cardiff University; University of Newcastle Upon-Tyne Terminated Wed, 07 Jan 2015 12:00:00 EST
Chronic Subdural Hematoma and AspirinCondition: Chronic Subdural HematomaInterventions: Drug: Acetylsalicylic acid; Drug: Placebo Oral Tablet Sponsor: University Hospital, Basel, Switzerland Recruiting Wed, 19 Apr 2017 12:00:00 EDT Preventive Effects of Aspirin as Adjuvant Therapy in Patients With Locally Advanced Renal Cell CarcinomaCondition: Aspirin as Adjuvant Therapy in Patients With Surgically Treated High Risk Renal Cell CarcinomaIntervention: Drug: Low dose of aspirin Sponsor: RenJi Hospital Recruiting Thu, 08 Nov 2018 12:00:00 EST Ticagrelol Versus Aspirin in Ischemic StrokeConditions: Acute Stroke; Ischemic StrokeInterventions: Drug: Ticagrelor (Brilique) 90; Drug: Aspirin 75mg Sponsors: Kafrelsheikh University; Ain Shams University Completed Thu, 21 Mar 2019 12:00:00 EDT Aspirin Discontinuation After Left Atrial Appendage Occlusion in Atrial FibrillationConditions: Atrial Fibrillation; Stroke; BleedingInterventions: Drug: Aspirin Tablet; Drug: Placebo Sponsor: Xinhua Hospital, Shanghai Jiao Tong University School of Medicine Recruiting Wed, 30 Jan 2019 12:00:00 EST Aspirin for Prevention of Preeclampsia in Healthy, Nulliparous Obese and Overweight Pregnant WomenCondition: PreeclampsiaInterventions: Drug: Aspirin 162 mg; Drug: Aspirin 81 mg; Drug: placebo Sponsor: Aswan University Hospital Recruiting Wed, 31 Oct 2018 12:00:00 EDT INVestIgation of rheumatiC AF Treatment Using Vitamin K Antagonists, Rivaroxaban or Aspirin Studies, SuperiorityCondition: Rheumatic Heart DiseaseInterventions: Drug: Rivaroxaban (15 mg); Drug: Aspirin Sponsors: Population Health Research Institute; University of Cape Town Not yet recruiting Thu, 14 Jul 2016 12:00:00 EDT Does Discontinuation of Aspirin Treatment Following Head Trauma Decrease the Incidence of Chronic Subdural Hematoma?Conditions: Head Trauma; Traumatic Brain Injury; Chronic Subdural HematomaInterventions: Drug: discontinuation of aspirin therapy; Drug: continuation of aspirin therapy Sponsor: Hadassah Medical Organization Unknown status Fri, 11 Nov 2011 12:00:00 EST ASPIRIN: Neurodevelopmental Follow-up TrialCondition: Neurodevelopmental AbnormalityInterventions: Drug: Aspirin; Drug: Placebo Sponsors: NICHD Global Network for Women's and Children's Health; Thomas Jefferson University; RTI International; Thrasher Research Fund Not yet recruiting Mon, 17 May 2021 12:00:00 EDT Effect of Aspirin on Mammogram Density in Healthy Postmenopausal Women With a Moderate or High Level of Breast DensityCondition: Mammographic Breast DensityInterventions: Drug: Aspirin; Drug: Placebo Sponsors: Fred Hutchinson Cancer Research Center; National Cancer Institute (NCI) Completed Mon, 07 May 2007 12:00:00 EDT Ticagrelor With Low-dose Versus Regular Aspirin in Patients With Acute Coronary Syndrome (ACS) at High-Risk for Ischemia After Percutaneous Coronary InterventionConditions: Acute Coronary Syndrome; Interventional CardiologyInterventions: Drug: Aspirin; Drug: Ticagrelor Sponsor: Fu Wai Hospital, Beijing, China Not yet recruiting Mon, 27 Jan 2020 12:00:00 EST
Trial of Aspirin and Arginine Restriction in Colorectal CancerCondition: Colorectal CancerIntervention: Drug: Aspirin Sponsor: University of California, Irvine Active, not recruiting Fri, 21 Dec 2007 12:00:00 EST Primary Cardiovascular Risk Prevention With Aspirin in Chronic Kidney Disease PatientsConditions: Chronic Kidney Disease Stage 4; Chronic Kidney Disease Stage 3Intervention: Drug: Aspirin Sponsor: Fundación de Ayuda a la Investigación sobre la Hipertensión, Riesgo Cardiovascular y Enfermedades Renales Unknown status Thu, 18 Oct 2012 12:00:00 EDT Antenatal Platelet Response on Aspirin and Correlation With Hypertensive Disorders of Pregnancy: a Pharmacokinetic Study Through PregnancyCondition: PreeclampsiaIntervention: Drug: Aspirin 81Mg Ec Tab Sponsors: Thomas Jefferson University; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); March of Dimes Recruiting Wed, 25 Nov 2020 12:00:00 EST Effect of Daily Low Dose Aspirin on Exhaled Inflammatory Mediators in Normal SubjectsCondition: HealthyIntervention: Drug: aspirin Sponsor: Brigham and Women's Hospital Completed Tue, 12 May 2009 12:00:00 EDT An Investigational Study to Assess the Effect of BMS-986177 on Aspirin in Healthy ParticipantsCondition: Healthy VolunteersInterventions: Drug: Aspirin; Drug: BMS-986177; Drug: Placebo Sponsor: Bristol-Myers Squibb Completed Tue, 14 Nov 2017 12:00:00 EST Mechanism Based Resistance to AspirinConditions: Aspirin Resistance; Pharmacological Aspirin Non-responsivenessIntervention: Drug: Aspirin Sponsors: University of Pennsylvania; National Institutes of Health (NIH); Bayer Completed Thu, 30 Jul 2009 12:00:00 EDT The Effects of Aspirin in Gestation and ReproductionConditions: Birth; Spontaneous AbortionInterventions: Drug: acetylsalicylic-acid (aspirin); Dietary Supplement: Folic acid Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Completed Mon, 30 Apr 2007 12:00:00 EDT Induction Chemotherapy Plus Chemoradiotherapy With or Without Aspirin in High Risk Rectal CancerConditions: Rectal Cancer, Adenocarcinoma; Locally Advanced Malignant Neoplasm; ChemoradiationInterventions: Drug: Aspirin; Drug: Placebo Oral Tablet Sponsor: Instituto Nacional de Cancer, Brazil Terminated Tue, 30 May 2017 12:00:00 EDT Aspirin Effects on Emotional ReactionsCondition: Healthy AdultsInterventions: Drug: Aspirin 500 MG; Drug: Placebo Sponsor: Ohio State University Enrolling by invitation Thu, 31 Oct 2019 12:00:00 EDT Aspirin to Target Arterial Events in Chronic Kidney DiseaseConditions: Chronic Kidney Diseases; Cardiovascular Diseases; BleedingIntervention: Drug: Aspirin Sponsors: University of Southampton; University of Nottingham; University of Warwick; Nottingham University Hospitals NHS Trust; East Kent Hospitals University NHS Foundation Trust; University of Durham; Epsom and St Helier University Hospitals NHS Trust Recruiting Tue, 08 Jan 2019 12:00:00 EST
Aspirin Versus Aspirin + ClopidogRel Following Transcatheter Aortic Valve Implantation: the ARTE TrialConditions: Aortic Valve Disease; Myocardial Infarction; StrokeInterventions: Drug: Aspirin (80 mg/d) + clopidogrel (75 mg/d); Drug: Aspirin Sponsors: Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec; Edwards Lifesciences Completed Wed, 21 Mar 2012 12:00:00 EDT Pharmacodynamic Evaluation of PL2200 Versus Enteric-Coated Aspirin in Diabetic PatientsCondition: Diabetes Mellitus, Type 2Interventions: Drug: PL2200 Aspirin Capsules; Drug: Enteric-coated aspirin caplets Sponsor: PLx Pharma Completed Wed, 11 Dec 2013 12:00:00 EST Comparative Pharmacokinetics Study of Clopidogrel and Aspirin Fixed-dose Combination Versus Separate Combination-2nd TrialCondition: Coronary Artery DiseaseInterventions: Drug: Clopidogrel and Aspirin; Drug: Fixed dose combination of clopidogrel/aspirin Sponsors: Chong Kun Dang Pharmaceutical; Inje University Completed Wed, 21 Dec 2011 12:00:00 EST Aspirin Versus Clopidogrel Effect on Uterine Blood Flow in Women With Unexplained Recurrent MiscarriagesCondition: Recurrent Pregnancy LossInterventions: Drug: Aspirin; Drug: Clopidogrel Sponsor: Ain Shams University Unknown status Mon, 09 Jul 2012 12:00:00 EDT Aspirin in Asymmetrically Intrauterine GrowthCondition: Intrauterine Growth Restriction AsymmetricalIntervention: Drug: Aspirin Sponsor: Assiut University Completed Tue, 31 Jan 2017 12:00:00 EST Aspirin Attenuates Inflammation in Human Cerebral AneurysmsCondition: The Focus of the Study is to Monitor MRI Signal Changes and Inflammatory Biomarkers With Use of Aspirin in Patients With Unruptured Cerebral AneurysmIntervention: Drug: aspirin Sponsor: University of Iowa Completed Thu, 18 Oct 2012 12:00:00 EDT Effect of aSpirin Versus CilOstazol for Inhibition of Antiplatelet aggRegaTion in Type 2 DM PatientsCondition: Type 2 Diabetes MellitusInterventions: Drug: Cilostazol; Drug: Acetylsalicylic acid Sponsors: Kangbuk Samsung Hospital; Asan Medical Center Unknown status Fri, 14 Oct 2016 12:00:00 EDT Low Dose Aspirin for Venous Leg UlcersCondition: Venous Leg UlcerInterventions: Drug: Aspirin; Drug: Placebo Sponsors: University of Auckland, New Zealand; Health Research Council, New Zealand Completed Mon, 09 Jun 2014 12:00:00 EDT Clopidogrel With Aspirin in High-risk Patients With Acute Non-disabling Cerebrovascular Events IIConditions: Stroke; Transient Ischemic AttackInterventions: Drug: Ticagrelor and Aspirin; Drug: Clopidogrel and Aspirin Sponsors: Beijing Tiantan Hospital; Ministry of Science and Technology of the People´s Republic of China Active, not recruiting Fri, 06 Sep 2019 12:00:00 EDT ASPIRED-XT: ASPirin Intervention for the REDuction of Colorectal Cancer Risk -EXTensionCondition: Colorectal CancerInterventions: Drug: Aspirin; Other: Placebo Sponsors: Massachusetts General Hospital; National Cancer Institute/NIH/DHHS (NCI); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National Institutes of Health (NIH) Not yet recruiting Mon, 27 Sep 2021 12:00:00 EDT
Multiple Daily Doses of Aspirin to Overcome Hyporesponsiveness Post Cardiac Bypass Surgery (ASACABG)- Part BCondition: Postoperative Dysfunction Following Cardiac SurgeryIntervention: Drug: Aspirin Sponsor: Hamilton Health Sciences Corporation Completed Thu, 18 Jul 2013 12:00:00 EDT Aspirin in the Prevention of Cardiovascular Events in Hemodialysis PatientsCondition: End-Stage Renal DiseaseInterventions: Drug: aspirin; Drug: Placebo Sponsors: Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation; Taipei Veterans General Hospital, Taiwan Withdrawn Fri, 10 Sep 2010 12:00:00 EDT Aspirin Withdrawal in Non-ischaemic Cardiomyopathy StudyCondition: Heart FailureInterventions: Drug: Aspirin; Other: withdrawal of aspirin Sponsor: The Alfred Completed Thu, 16 Feb 2012 12:00:00 EST Optimal Dosing For Low-Dose Aspirin Chemoprophylaxis For VTE Following Total Joint ArthroplastyCondition: Venous ThromboembolismIntervention: Drug: Aspirin Sponsors: University of Miami; Sagie Haziza Recruiting Wed, 04 Mar 2020 12:00:00 EST Effectiveness of Higher Aspirin Dosing for Prevention of Preeclampsia in High Risk Obese GravidaConditions: Pre-Eclampsia; Hypertension in Pregnancy; ObesityInterventions: Drug: Aspirin 81 mg; Drug: Aspirin 162 mg Sponsor: The University of Texas Health Science Center, Houston Recruiting Thu, 23 May 2019 12:00:00 EDT Adjuvant Low Dose Aspirin in Colorectal CancerCondition: Colorectal CancerInterventions: Drug: Acetylsalicylic acid; Drug: Placebo Sponsors: Anna Martling; Uppsala University Hospital; Skane University Hospital Recruiting Wed, 06 Jan 2016 12:00:00 EST Aspirin as a Pre-Treatment for Exercise in Multiple SclerosisConditions: Fatigue; OverheatingInterventions: Drug: Acetylsalicylic acid at 1st visit, then Placebo at 2nd visit; Drug: Placebo at 1st visit, then Acetylsalicylic acid at 2nd visit Sponsors: Columbia University; National Multiple Sclerosis Society Completed Tue, 14 Feb 2017 12:00:00 EST ASPirin Intervention for the REDuction of Colorectal Cancer RiskCondition: Colorectal CancerInterventions: Drug: Aspirin; Drug: Placebo for Aspirin Sponsors: Massachusetts General Hospital; National Cancer Institute (NCI) Active, not recruiting Fri, 20 Mar 2015 12:00:00 EDT The Effect Of Aspirin On Survival in Lung CancerConditions: Non Small Cell Lung Cancer; Survival; AspirinInterventions: Drug: Aspirin 75 mg; Other: no aspirin Sponsor: Liverpool Heart and Chest Hospital NHS Foundation Trust Withdrawn Fri, 29 Jan 2010 12:00:00 EST The Effect of Aspirin Desensitization on Patients With Aspirin-exacerbated Respiratory DiseasesCondition: Asthma, Aspirin-InducedIntervention: Drug: aspirin Sponsors: Tehran University of Medical Sciences; Rassoul Akram Hospital Completed Mon, 03 Jun 2013 12:00:00 EDT
A Study to Evaluate the Incidence of Gastric Ulcers Following Administration of Either PA32540 or Enteric Coated Aspirin 325 mg in Subjects Who Are at Risk for Developing Aspirin-Associated UlcersCondition: Gastric UlcerInterventions: Drug: PA32540; Drug: EC Aspirin 325 Sponsor: POZEN Completed Tue, 18 Aug 2009 12:00:00 EDT GaStroEsophageal effeCt of indobUfen Versus aspiRin in Patients Undergoing Dual antiplatElet TherapyConditions: Coronary Artery Disease; Gastroesophageal Reflux DiseaseInterventions: Drug: Indobufen and aspirin mimetic; Drug: Aspirin and indobufen mimetic Sponsor: Beijing Anzhen Hospital Unknown status Wed, 16 Oct 2019 12:00:00 EDT ASpirin as a Treatment for ARDS (STAR): a Phase 2 Randomised Control TrialCondition: Acute Respiratory Distress SyndromeInterventions: Drug: Aspirin 75mg; Drug: Lactose powder Sponsors: Belfast Health and Social Care Trust; Queen's University, Belfast; Northern Ireland Clinical Trials Unit Terminated Mon, 29 Dec 2014 12:00:00 EST Atorvastatin ± Aspirin in Lynch Syndrome SyndromeCondition: Lynch SyndromeInterventions: Drug: Atorvastatin 20mg; Drug: Atorvastatin 20mg AND Aspirin 325 mg Sponsor: Fox Chase Cancer Center Recruiting Fri, 08 May 2020 12:00:00 EDT Study to Evaluate the Incidence of Gastric Ulcers Following Administration of Either PA32540 or Enteric Coated Aspirin 325 mg in Subjects Who Are at Risk for Developing Aspirin-Associated UlcersCondition: Gastric UlcerInterventions: Drug: PA32540; Drug: EC-Aspirin 325 mg Sponsor: POZEN Completed Tue, 18 Aug 2009 12:00:00 EDT Clinical Trial to Evaluate the Influence of Genotype and DDIs of Aspirin on the PK/PD of Clopidogrel and PK of DigoxinCondition: DRUG REACTIONSInterventions: Drug: Aspirin+Clopidogrel/Digoxin(oral); Drug: Aspirin+Clopidogrel/Digoxin(IV) Sponsor: Seoul National University Hospital Completed Fri, 25 Jan 2013 12:00:00 EST Influence of Aspirin on Human Gut Microbiota Composition and MetabolomeConditions: Aspirin; MicrobiotaIntervention: Drug: Aspirin 80mg Sponsor: Chinese University of Hong Kong Recruiting Thu, 01 Mar 2018 12:00:00 EST Aspirin Reload Before Percutaneous Coronary Intervention: Reperfusion Indexes Evaluation.Condition: Coronary ArteriosclerosisIntervention: Drug: Aspirin Sponsor: University of Roma La Sapienza Completed Thu, 16 Jun 2011 12:00:00 EDT Pharmacokinetic and Pharmacodynamic Assessment of a Novel, Pharmaceutical Lipid-Aspirin ComplexCondition: BioequivalenceIntervention: Drug: Aspirin Sponsor: PLx Pharma Completed Fri, 05 Jul 2019 12:00:00 EDT INdobufen Versus aSpirin in acUte Ischemic stRokE,INSUREConditions: Ischemic Stroke; Indobufen; AspirinInterventions: Drug: Indobufen; Drug: Aspirin Sponsor: Ministry of Science and Technology of the People´s Republic of China Not yet recruiting Tue, 12 Mar 2019 12:00:00 EDT
Low Dose Aspirin for the Prevention of PreeclampsiaCondition: PreeclampsiaInterventions: Drug: Aspirin; Drug: Placebo Sponsor: Saint Thomas Hospital, Panama Unknown status Mon, 01 Jul 2013 12:00:00 EDT Aspirin for Treatment of Multiple Sclerosis-Related FatigueConditions: Multiple Sclerosis; FatigueInterventions: Drug: High Dose Aspirin (1300 mg/day); Drug: Low Dose Aspirin (162 mg/day); Drug: Placebo Sponsors: Mayo Clinic; National Multiple Sclerosis Society Terminated Mon, 30 Apr 2007 12:00:00 EDT Randomized, Crossover Bioequivalence Study of PL-ASA vs Immediate-release Aspirin in Healthy Volunteers.Condition: To Establish Bioequivalence of a Novel Formulation PL-ASA to Immediate Release AspirinIntervention: Drug: Pharmaceutical-lipid aspirin (PL-ASA) Sponsor: PLx Pharma Completed Fri, 24 Sep 2021 12:00:00 EDT Ticagrelor With Aspirin or Alone in High-Risk Patients After Coronary InterventionConditions: Cardiovascular Disease; Interventional CardiologyInterventions: Drug: Aspirin; Drug: Placebo; Drug: ticagrelor Sponsors: Icahn School of Medicine at Mount Sinai; AstraZeneca Completed Tue, 21 Oct 2014 12:00:00 EDT Aspirin Prophylaxis in Sickle Cell DiseaseCondition: Sickle Cell DiseaseIntervention: Drug: aspirin Sponsors: University of Rochester; University of Miami; Bayer; National Institute of Neurological Disorders and Stroke (NINDS) Completed Thu, 15 Sep 2005 12:00:00 EDT Aspirin Responsiveness in Women at Risk for Cardiac EventsCondition: Heart DiseaseIntervention: Drug: Aspirin Sponsor: Creighton University Completed Wed, 07 Jan 2009 12:00:00 EST Pharmacokinetic and Pharmacodynamic Study of a Novel Sublingual Aspirin TabletCondition: Cardiovascular DiseasesInterventions: Drug: Sublingual aspirin; Drug: Oral aspirin Sponsor: Vita Green Health Products Co. Ltd Not yet recruiting Thu, 11 Mar 2021 12:00:00 EST Combination of Osimertinib and Aspirin to Treat Osimertinib Resistance Non-small Cell Lung Cancer ( NSCLC)Conditions: Non-Small Cell Lung Cancer Stage IIIB; Non-small Cell Lung Cancer Stage IV; EGFR T790MInterventions: Drug: Aspirin; Drug: Osimertinib Sponsor: Daping Hospital and the Research Institute of Surgery of the Third Military Medical University Not yet recruiting Tue, 22 May 2018 12:00:00 EDT Outcome Analysis of Aspirin in Liver TransplantationCondition: Liver Transplant; ComplicationsIntervention: Other: Aspirin Sponsor: University of Zurich Recruiting Tue, 31 Mar 2020 12:00:00 EDT Aspirin (ASA) Therapy and Preeclampsia PreventionCondition: PreeclampsiaInterventions: Drug: Aspirin 81 mg Enteric Coated Tab - 1 tablet; Drug: Aspirin 81 mg Enteric Coated Tab - 2 tablets Sponsor: University of Tennessee Withdrawn Tue, 12 Nov 2019 12:00:00 EST
Effects of Aspirin Treatment on Fibrin Network Formation in Patients With Type 1 DiabetesCondition: Diabetes Mellitus, Type 1Intervention: Drug: Aspirin Sponsor: Karolinska Institutet Completed Tue, 19 Jul 2011 12:00:00 EDT The Effect of Two Aspirin Dosing Strategies for Obese Women at High Risk for PreeclampsiaCondition: PreeclampsiaIntervention: Drug: 162mg aspirin dose Sponsor: Ohio State University Recruiting Thu, 08 Nov 2018 12:00:00 EST Combination of Osimertinib and Aspirin to Treat 1st Generation EGFR-TKI Resistance in NSCLCConditions: Non-Small Cell Lung Cancer Stage IIIB; Non-small Cell Lung Cancer Stage IV; EGFR T790MInterventions: Drug: Osimertinib; Drug: Aspirin Sponsor: Daping Hospital and the Research Institute of Surgery of the Third Military Medical University Not yet recruiting Fri, 01 Jun 2018 12:00:00 EDT When Should Low-dose Aspirin be Resumed After Peptic Ulcer Bleeding?Conditions: Aspirin; GastroIntestinal BleedingInterventions: Other: Resume Aspirin within 12 hours; Other: Resume Aspirin 72 - 84 hours Sponsors: Chinese University of Hong Kong; Beijing Friendship Hospital; National Taiwan University Hospital Recruiting Mon, 24 Dec 2018 12:00:00 EST Study to Gather Information to What Extent Patients Follow the Treatment Regimen of Low-dose Aspirin for Primary and Secondary Prevention of Diseases of the Heart and Blood VesselsConditions: Myocardial Infarction; Stroke (Including Ischaemic Stroke and Transient Ischaemic Attack); Unstable Angina; Angina; Ischaemic Heart DiseaseIntervention: Drug: Acetylsalicylic Acid (Aspirin, BAYE4465) Sponsor: Bayer Completed Fri, 20 Sep 2019 12:00:00 EDT Modulation of Immune Activation by AspirinCondition: HIV-1 InfectionInterventions: Drug: Aspirin; Drug: Placebo Sponsors: AIDS Clinical Trials Group; National Institute of Allergy and Infectious Diseases (NIAID) Completed Wed, 04 Jun 2014 12:00:00 EDT Aspirin Twice a Day in Patients With Diabetes and Acute Coronary SyndromeConditions: Diabetes Mellitus; Acute Coronary Syndrome; Coronary Artery Disease; ObesityInterventions: Drug: Novel strategy Aspirin; Drug: Conventional strategy Aspirin Sponsors: Assistance Publique - Hôpitaux de Paris; Bayer Recruiting Thu, 13 Aug 2015 12:00:00 EDT Chronotherapy With Low-dose Aspirin for Primary PreventionCondition: Type 2 DiabetesIntervention: Drug: aspirin Sponsor: University of Vigo Recruiting Wed, 30 Jul 2008 12:00:00 EDT Enoxaparin Versus Aspirin in Patients With Cancer and StrokeCondition: Cancer Patients First-ever Acute Ischemic StrokeInterventions: Drug: Enoxaparin; Drug: Aspirin Sponsors: Memorial Sloan Kettering Cancer Center; New York Presbyterian Hospital; Weill Medical College of Cornell University Completed Wed, 09 Jan 2013 12:00:00 EST Aspirin in Young Psychotic PatientsConditions: Psychosis; Acute Psychosis; SchizophreniaInterventions: Drug: Aspirin; Drug: Placebo; Drug: Pantoprazole Sponsors: Clinic for Psychiatric Disorders, Dr Laza Lazarevic; Stanley Medical Research Institute Completed Fri, 19 Feb 2016 12:00:00 EST
Comparative Pharmacokinetics Study of Clopidogrel and Aspirin Fixed-dose Combination Versus Separate CombinationCondition: Coronary Artery DiseaseInterventions: Drug: Clopidogrel; Drug: Fixed dose combination of clopidogrel/Aspirin; Drug: Aspirin Sponsors: Chong Kun Dang Pharmaceutical; Inje University Completed Mon, 13 Aug 2012 12:00:00 EDT Aspirin as a Novel Anti-Inflammatory Modality in the Fontan PatientsCondition: Fontan ProcedureIntervention: Drug: Aspirin Sponsor: University of Michigan Terminated Thu, 17 Nov 2016 12:00:00 EST Effect of Indobufen and Aspirin on Platelet Aggregation and Long Term Prognosis in Patients With Coronary Heart DiseaseCondition: Stable Coronary Heart DiseaseInterventions: Drug: Indobufen; Drug: Aspirin Sponsor: Henan Institute of Cardiovascular Epidemiology Not yet recruiting Mon, 16 Mar 2020 12:00:00 EDT Prevention of Pre-eclampsia and SGA by Low-Dose Aspirin in Nulliparous Women With Abnormal First-trimester Uterine Artery DopplersConditions: Pre-eclampsia; Intra-uterine Growth RestrictionInterventions: Drug: Aspirin; Drug: Placebo Sponsor: University Hospital, Tours Completed Tue, 20 Nov 2012 12:00:00 EST Acetylsalicylic Acid and Type 2 Diabetes MellitusConditions: Diabetes Mellitus, Type 2; Antioxidant Enzyme SystemInterventions: Drug: Acetylsalicylic acid; Drug: Calcined magnesia Sponsor: Centro Universitario de Ciencias de la Salud, Mexico Completed Tue, 14 Nov 2017 12:00:00 EST Aspirin Resistance in Women With MigraineConditions: Episodic Migraine; Chronic MigraineInterventions: Drug: Aspirin (acetylsalicylic acid); Drug: Placebo Sponsors: Swedish Medical Center; University of Washington; National Headache Foundation; Wadsworth Foundation; Accumetrics, Inc. Withdrawn Fri, 10 Dec 2010 12:00:00 EST Efficacy and Safety of Acetaminophen and Aspirin Versus Placebo in the Acute Treatment of MigraineCondition: Acute MigraineInterventions: Drug: Acetaminophen 250 mg and Aspirin 250 mg; Drug: Placebo Sponsor: Novartis Completed Thu, 31 Oct 2013 12:00:00 EDT The Effects of Omega-3 Fatty Acids on Aspirin ResistanceCondition: Increased Drug ResistanceInterventions: Drug: Aspirin; Drug: Lovaza; Drug: Both Aspirin and Lovaza; Other: Placebo Sponsors: University of Rochester; GlaxoSmithKline; American College of Clinical Pharmacy; Cornell University Completed Wed, 15 Oct 2008 12:00:00 EDT Randomized Controlled Trial of Aspirin vs Placebo in the Treatment of Pre-psychosisCondition: Clinical High Risk for PsychosisInterventions: Drug: Aspirin; Drug: Placebo Sponsor: Yale University Terminated Tue, 28 Jan 2014 12:00:00 EST Effects of Low Dose Aspirin in Bipolar Disorder (The A-Bipolar RCT)Condition: Bipolar DisorderInterventions: Drug: acetylsalicylic acid; Drug: Calcium Sponsor: Lars Vedel Kessing Not yet recruiting Sun, 05 Sep 2021 12:00:00 EDT
Trial of Early Screening Test for Pre-eclampsia and Growth RestrictionConditions: Pre-Eclampsia; Placenta Diseases; Eclampsia Preeclampsia; Fetal Growth Retardation; Foetal Growth RestrictionIntervention: Drug: Low dose aspirin Sponsors: University College Dublin; Perinatal Ireland; National Maternity Hospital, Ireland; Royal College of Surgeons, Ireland Completed Mon, 17 Sep 2018 12:00:00 EDT Enteric Coating as a Factor in Aspirin ResistanceCondition: Cardiovascular DiseaseIntervention: Drug: Plain aspirin Sponsors: Royal College of Surgeons, Ireland; Irish Heart Foundation Completed Tue, 18 Sep 2007 12:00:00 EDT Aspirin AM or PM: Effect on Circadian Rhythm of Platelet ReactivityConditions: Aspirin; Circadian Rhythm; Platelet Activation; Cardiovascular DiseasesIntervention: Behavioral: change time of intake of aspirin Sponsor: Leiden University Medical Center Completed Tue, 16 Jul 2013 12:00:00 EDT The LEAD COVID-19 Trial: Low-risk, Early Aspirin and Vitamin D to Reduce COVID-19 HospitalizationsConditions: COVID; Vitamin D Deficiency; Coagulopathy; Disseminated Intravascular CoagulationInterventions: Drug: Aspirin 81 mg; Dietary Supplement: Vitamin D Sponsor: Louisiana State University Health Sciences Center in New Orleans Not yet recruiting Mon, 27 Apr 2020 12:00:00 EDT Sorafenib Combined With Aspirin to Prevent the Recurrence in High-risk Patients With Hepatocellular CarcinomaCondition: Hepatocellular CarcinomaInterventions: Other: control; Drug: sorafenib; Drug: aspirin Sponsor: Fudan University Terminated Fri, 22 Apr 2016 12:00:00 EDT WILL lOWer Dose Aspirin be Better With Rivaroxaban in Patients With Chronic Coronary Syndromes?Condition: Coronary SyndromeInterventions: Drug: Aspirin 75mg; Drug: Aspirin 20mg; Drug: Rivaroxaban 2.5 mg Sponsor: Sheffield Teaching Hospitals NHS Foundation Trust Recruiting Wed, 04 Aug 2021 12:00:00 EDT The Risk of Bleeding After Removal of Large Colorectal Polyps in Patients Taking AspirinCondition: Gastrointestinal HemorrhageInterventions: Drug: Aspirin (ASA); Drug: Placebo Sponsors: Maria Sklodowska-Curie Institute - Oncology Center; Centre of Postgraduate Medical Education Unknown status Fri, 09 Mar 2012 12:00:00 EST Ginkgo Diterpene Lactone Meglumine Injection on Platelet Reactivity in Acute Ischemic StrokeCondition: Ischemic StrokeInterventions: Drug: Ginkgo Diterpene Lactone Meglumine Injection; Drug: Acetylsalicylic acid Sponsors: RenJi Hospital; Jiangsu Kanion Pharmaceutical Co., Ltd Unknown status Mon, 17 Jul 2017 12:00:00 EDT The Effect of Aspirin on REducing iNflammation in Human in Vivo Model of Acute Lung InjuryCondition: Acute Lung InjuryInterventions: Drug: Aspirin 75mg; Drug: Lactose powder; Drug: Aspirin 1200mg Sponsors: Belfast Health and Social Care Trust; The Intensive Care Society United Kingdom; Northern Ireland Clinical Trials Unit; Queen's University, Belfast Unknown status Tue, 07 Aug 2012 12:00:00 EDT Timed Aspirin Chronobiome StudyCondition: HealthyInterventions: Drug: Aspirin 81 mg; Drug: Celecoxib 200mg capsule Sponsor: University of Pennsylvania Not yet recruiting Wed, 18 Jul 2018 12:00:00 EDT
Aspirin for Prevention of Postsurgical Recurrence and Metastasis in Asian Colorectal Cancer Patients: a Multi-center Randomized TrialCondition: Colorectal CancerInterventions: Drug: Acetylsalicylic acid (ASA)/aspirin 200 mg daily; Drug: Acetylsalicylic acid (ASA)/aspirin 100 mg daily; Drug: Placebo Sponsors: The Fourth Affiliated Hospital of Anhui Medical University; The First Affiliated Hospital of Anhui Medical University; Anhui Provincial Hospital Recruiting Tue, 17 Nov 2015 12:00:00 EST Effects of Omega-3 Plus Low-dose Aspirin as Adjunct to Periodontal Debridement for Chronic Periodontitis in DiabeticsConditions: Diabetes Mellitus; Chronic PeriodontitisInterventions: Drug: Placebo; Drug: 3g omega-3 plus 100mg aspirin daily for 60 days; Drug: omega-3 plus aspirin before periodontal therapy Sponsors: Universidade Estadual Paulista Júlio de Mesquita Filho; Fundação de Amparo à Pesquisa do Estado de São Paulo Unknown status Wed, 15 Jun 2016 12:00:00 EDT Aspirin, Heparin and MiscarriageConditions: Pregnancy; MiscarriageInterventions: Drug: Aspirin; Drug: Heparin Sponsor: University of Khartoum Unknown status Wed, 07 Aug 2013 12:00:00 EDT Rivaroxaban or Aspirin for Biological Aortic ProsthesisConditions: Aortic Stenosis; Aortic Regurgitation; ThrombosisInterventions: Drug: Rivaroxaban 10 MG; Drug: Aspirin Sponsors: Christian Torp-Pedersen; Aalborg University Hospital; Aarhus University Hospital; Odense University Hospital; Rigshospitalet, Denmark Recruiting Tue, 29 Nov 2016 12:00:00 EST The Effect of Aspirin on Angiogenesis Proteins in Women on Tamoxifen TherapyConditions: Breast Cancer; AngiogenesisIntervention: Drug: Aspirin Sponsor: University of Vermont Completed Mon, 04 Aug 2008 12:00:00 EDT Personalizing Aspirin Therapy in Peripheral Arterial Disease PatientsCondition: Peripheral Arterial DiseaseIntervention: Drug: Aspirin Sponsors: Unity Health Toronto; University of Toronto Not yet recruiting Mon, 17 Feb 2020 12:00:00 EST Effectiveness of Low Dose Aspirin in Decreasing the Chance Getting Stomach and Intestine CancerCondition: Gastrointestinal CancerIntervention: Drug: Acetylsalicylic Acid (Aspirin, BAYE4465) Sponsor: Bayer Completed Mon, 09 Sep 2019 12:00:00 EDT A Pilot Study of Adjunctive Aspirin for the Treatment of HIV Negative Adults With Tuberculous MeningitisCondition: Tuberculous MeningitisInterventions: Drug: 81mg aspirin; Drug: 1000mg aspirin; Drug: Placebo Sponsors: Oxford University Clinical Research Unit, Vietnam; Hospital for Tropical Diseases, Ho Chi Minh City, Vietnam Completed Thu, 11 Sep 2014 12:00:00 EDT Aspirin in Colorectal Cancer Liver MetastasesConditions: Colorectal Cancer Liver Metastases; Colorectal Cancer; Liver MetastasesInterventions: Drug: Acetylsalicylic acid; Drug: Placebo Oral Tablet Sponsors: Oslo University Hospital; Norwegian Cancer Society; The Research Council of Norway; Klinbeforsk Recruiting Tue, 31 Oct 2017 12:00:00 EDT Aspirin in Reducing Events in the ElderlyConditions: Functional Disability; Dementia; Heart Disease; Stroke; Cancer; Bleeding; DepressionInterventions: Drug: 100 mg enteric-coated aspirin; Drug: Placebo Sponsors: Hennepin Healthcare Research Institute; National Health and Medical Research Council, Australia; Bayer; Monash University; Berman Center for Outcomes and Clinical Research; National Institute on Aging (NIA); National Cancer Institute (NCI) Active, not recruiting Thu, 24 Dec 2009 12:00:00 EST
Combination of Osimertinib and Aspirin to Treat EGFR Mutation NSCLC PatientsCondition: Lung Cancer Non-small Cell Stage IVInterventions: Drug: Aspirin 100mg; Drug: Osimertinib 80 MG Sponsor: Daping Hospital and the Research Institute of Surgery of the Third Military Medical University Not yet recruiting Wed, 04 Dec 2019 12:00:00 EST Low Dose Aspirin Inhibition of COX-2 Derived PGE2 in Male SmokersConditions: Tobacco Use Disorder; SmokingInterventions: Drug: Aspirin 325 mg daily; Drug: Celecoxib 200 mg BID Sponsor: Vanderbilt University Completed Fri, 22 Feb 2013 12:00:00 EST Evaluation of Upper GI Ulceration Induced by PL2200 Versus Aspirin in At-Risk SubjectsCondition: Gastroduodenal UlcerationInterventions: Drug: PL2200; Drug: Aspirin tablets Sponsor: PLx Pharma Completed Fri, 20 Jul 2012 12:00:00 EDT Japanese Primary Prevention of Atherosclerosis With Aspirin for Diabetes (JPAD) TrialConditions: Coronary Disease; Arteriosclerosis; Diabetes Mellitus, Type 2Interventions: Drug: Aspirin; Drug: No aspirin Sponsor: Kumamoto University Completed Tue, 10 May 2005 12:00:00 EDT Anticoagulant After Implantation of Biological Aortic Valve Comparing With AspirinConditions: Thromboembolism; BleedingInterventions: Drug: Aspirin; Drug: Warfarin Sponsor: Rigshospitalet, Denmark Completed Mon, 17 Oct 2011 12:00:00 EDT Clopidogrel and Aspirin Interaction Study-2Condition: Drug Action IncreasedInterventions: Drug: Clopidogrel; Drug: Aspirin Sponsor: Population Health Research Institute Completed Tue, 26 Apr 2011 12:00:00 EDT Aspirin Desensitization Registry in Patients With Aspirin HypersensitivityCondition: Aspirin HypersensitivityIntervention: Drug: aspirin Sponsor: Italian Society of Cardiology Completed Thu, 28 Jul 2016 12:00:00 EDT Prospective Double-blind Study for the Use of Aspirin During Transurethral Surgery of the Bladder or the ProstateConditions: Blood Loss, Surgical; Intraoperative Complications; Re-operation Rates in Patients With Aspirin TreatmentIntervention: Drug: transurethral surgery with or without aspirin Sponsor: University Hospital, Basel, Switzerland Withdrawn Fri, 13 Mar 2009 12:00:00 EDT Aspirin in Patients With Myocardial Infarction and ThrombocytopeniaConditions: Thrombocytopenia; Myocardial InfarctionIntervention: Drug: Aspirin Sponsor: M.D. Anderson Cancer Center Terminated Mon, 16 Jul 2007 12:00:00 EDT Study of Ticagrelor Versus Aspirin Treatment in Patients With Myocardial Injury Post Major Non-cardiac SurgeryCondition: Myocardial InjuryInterventions: Drug: ticagrelor; Drug: aspirin Sponsors: The Cleveland Clinic; AstraZeneca Terminated Fri, 14 Nov 2014 12:00:00 EST
Study of Aspirin and Exemestane as Adjuvant Treatment in Breast CancerCondition: Breast NeoplasmsInterventions: Drug: aspirin; Drug: Exemestane Sponsor: Chinese Academy of Medical Sciences Unknown status Fri, 09 Sep 2011 12:00:00 EDT The Effects of Preoperative Aspirin on Graft Patency and Cardiac Events in Off-pump Coronary Artery BypassConditions: Coronary Artery Disease; Off-pump Coronary Artery Bypass; AspirinIntervention: Drug: aspirin Sponsor: Chinese Academy of Medical Sciences, Fuwai Hospital Unknown status Fri, 31 Dec 2010 12:00:00 EST Aspirin Non-responsiveness and Clopidogrel Endpoint Trial.Conditions: Coronary Heart Disease; Angina Pectoris; AtherosclerosisInterventions: Drug: aspirin; Drug: clopidogrel Sponsors: Ullevaal University Hospital; The Norwegian Council for Cardiovascular Diseases.; Ada and Hagbart Waages Humanitarian and Charity Foundation; Alf and Aagot Helgesens Research Foundation. Completed Thu, 22 Sep 2005 12:00:00 EDT Low-Dose Aspirin in in Vitro Fertilization (IVF) and Intracytoplasmic Sperm Injection (ICSI) TreatmentsConditions: Pregnancy; Miscarriage Less Than 12 Gestational Weeks; Extrauterine Pregnancy; Preeclampsia; Intrauterine Fetal Growth RestrictionInterventions: Drug: Acetylsalicylic acid; Drug: Placebo Sponsors: University of Oulu; Bayer; Kuopio University Hospital; Tampere University Completed Fri, 23 May 2008 12:00:00 EDT Aspirin for Dukes C and High Risk Dukes B Colorectal CancersCondition: Colorectal CancerInterventions: Other: placebo; Drug: Acetylsalicylic acid Sponsors: National Cancer Centre, Singapore; University of Oxford; Australasian Gastro-Intestinal Trials Group; INDOX Cancer Research Network Active, not recruiting Fri, 30 Nov 2007 12:00:00 EST Clopidogrel Use and Long-term Safety After Drug-Eluting Stents ImplantationCondition: Coronary Artery DiseaseInterventions: Drug: Aspirin; Drug: Aspirin,Clopidogrel Sponsors: Seung-Jung Park; CardioVascular Research Foundation, Korea Completed Thu, 10 Jan 2008 12:00:00 EST Duration of Clopidogrel Therapy After Drug-Eluting Stent (DES-LATE)Condition: Coronary Artery DiseaseInterventions: Drug: Aspirin monotherapy; Drug: Aspirin,Clopidogrel Sponsors: Seung-Jung Park; CardioVascular Research Foundation, Korea Completed Mon, 23 Aug 2010 12:00:00 EDT ASPIRIN Trial BelgiumCondition: Colon CancerInterventions: Drug: acetylsalicylic acid; Drug: Placebo Sponsors: University Hospital, Antwerp; Kom Op Tegen Kanker; Anticancerfund Recruiting Wed, 14 Mar 2018 12:00:00 EDT Treatment of Rivaroxaban Versus Aspirin for Non-disabling Cerebrovascular EventsConditions: Ischemic Stroke; TIAInterventions: Drug: rivaroxaban; Drug: Aspirin; Drug: placebo Sponsor: Xijing Hospital Unknown status Fri, 16 Aug 2013 12:00:00 EDT Mono Antiplatelet and Colchicine TherapyConditions: Acute Coronary Syndrome; Drug-Eluting StentsInterventions: Drug: Aspirin; Drug: Colchicine Sponsor: Wonkwang University Hospital Recruiting Fri, 02 Jul 2021 12:00:00 EDT
Efficacy of BNG-1 to Treat Acute Ischemic StrokeCondition: Ischemic StrokeInterventions: Drug: BNG-1; Drug: Aspirin Sponsor: Chang Gung Memorial Hospital Completed Wed, 29 Aug 2012 12:00:00 EDT Continuing Low Dose Aspirin Before Prostate BiopsyCondition: ComplicationIntervention: Drug: Aspirin Sponsor: National Taiwan University Hospital Unknown status Wed, 20 Apr 2016 12:00:00 EDT Oxidative Stress and Oxysterols Profiling in Patients With Carotid RevascularizationConditions: Carotid Stenosis; Cardiovascular Disease; Atherosclerosis; StrokeInterventions: Drug: Aspirin; Drug: aspirin plus dipyridamole Sponsors: University of Roma La Sapienza; Civic Hospital, Italy Completed Tue, 15 Dec 2015 12:00:00 EST Synergistic Influence of Rivaroxaban on Inflammation and Coagulation Biomarkers in Patients With CAD and PAD on Aspirin TherapyConditions: Coronary Artery Disease; Peripheral Artery DiseaseInterventions: Drug: Rivaroxaban 2.5 Mg Oral Tablet; Drug: Aspirin 81 mg Sponsors: LifeBridge Health; Janssen Scientific Affairs, LLC Recruiting Fri, 16 Aug 2019 12:00:00 EDT Low-dose Aspirin for Prevention of Adverse Pregnancy Outcomes in Twin PregnanciesConditions: Twin Pregnancy; Preeclampsia; Preterm Birth; Fetal Growth RestrictionIntervention: Drug: Aspirin 100mg Sponsors: Ministry of Science and Technology of the People´s Republic of China; Peking University Third Hospital; Chongqing Health Center for Women and Children Unknown status Fri, 09 Aug 2019 12:00:00 EDT Effect of Aspirin, Hemodilution and Desmopressin on Platelet DysfunctionConditions: Platelet Dysfunction; Hemodilution; Mild Hypothermia; NSAID; DesmopressinInterventions: Drug: Aspirin, desmopressin; Drug: Placebo, desmopressin Sponsor: The University of Hong Kong Completed Mon, 27 Jun 2011 12:00:00 EDT RECAB-ASA; Treatment of Recurrent Abortion With AspirinCondition: Abortion, HabitualInterventions: Drug: Aspirin; Drug: Placebo Sponsors: Göteborg University; Vastra Gotaland Region Completed Wed, 06 Jul 2016 12:00:00 EDT In-Vivo Bleeding Volume Test for Platelet-Aspirin InteractionCondition: HealthyInterventions: Drug: Aspirin ingestion followed by doing a Bleeding Volume Test; Procedure: Gatorade Placebo followed by Bleeding Volume Test. Sponsor: Klein, Jeffrey A., M.D. Unknown status Wed, 13 Jan 2010 12:00:00 EST Effects of Different Doses of Aspirin on Pathophysiological Markers in Type 2 DiabetesCondition: Diabetes Type 2Interventions: Drug: Aspirin; Other: placebo tablet Sponsor: University of Portsmouth Completed Tue, 12 May 2009 12:00:00 EDT An Assessment of Aspirin Plus Prednisone Treatment for Euthyroid Women With Thyroid AutoimmunityCondition: Thyroid DiseasesIntervention: Drug: Prednisone 10 MG+aspirin 100MG Sponsors: Second Affiliated Hospital, School of Medicine, Zhejiang University; Ningbo Women and Children's Hospital; People's Hospital of Jinhua Recruiting Tue, 29 Jun 2021 12:00:00 EDT
Bioequivalence of Single Dose Fast Release Aspirin (1000 mg) Tablet Versus Single Dose of Two 500 mg Fast Release Aspirin TabletsCondition: PainIntervention: Drug: Acetylsalicylic acid (Aspirin, BAY1019036) Sponsor: Bayer Completed Fri, 17 Feb 2017 12:00:00 EST Pharmacokinetics & Safety Study of Clopidogrel 75mg and Aspirin 100mg CoadministrationCondition: AtherosclerosisInterventions: Drug: G0041(75/100mg); Drug: Clopidogrel & Aspirin Sponsor: Dong-A ST Co., Ltd. Completed Fri, 03 Feb 2012 12:00:00 EST Aspirin and Enoxaparin for VTE in TraumaConditions: Venous Thromboembolism; Thromboprophylaxis; TraumaInterventions: Drug: Aspirin; Drug: Enoxaparin Sponsor: University of Miami Terminated Tue, 24 Mar 2015 12:00:00 EDT Hirudin Plus Aspirin in the Secondary Prevention of Cardioembolic Stroke Due to Nonvalvular Atrial FibrillationConditions: Cardioembolic Stroke; Atrial FibrillationInterventions: Drug: hirudin plus aspirin; Drug: Warfarin Sponsors: Xijing Hospital; Xi'an Central Hospital; Shaanxi people's Hospital; The Third Hospital of PLA; Hanzhong Central Hospital; Xianyang 215 hospital; Yulin Second Hospital; Yan'an University Affiliated Hospital; Baoji Central Hospital; Ankang Central Hospital; Baoji People's Hospital; Yan'an people's Hospital; 451 Hospital; Shangluo Central Hospital; Central Hospital of China Railway 20th Bureau; Xiangyang Central Hospital; Xi'an Ninth Hospital; Shangluo Second People's Hospital Completed Thu, 03 Jul 2014 12:00:00 EDT Aspirin as an add-on Treatment of Refractory Epilepsy in Tuberous Sclerosis ComplexConditions: Tuberous Sclerosis Complex; Aspirin; Epilepsy; Cognitive Decline; Skin LesionsInterventions: Drug: Aspirin; Drug: AED; Drug: Placebo Sponsors: Peking Union Medical College Hospital; Shijiazhuang Yiling Pharmaceutical Co. Ltd Recruiting Wed, 29 Nov 2017 12:00:00 EST Association of Clopidogrel Therapy and Stent ThrombosisCondition: Coronary Artery DiseaseInterventions: Drug: Aspirin monotherapy; Drug: Aspirin,Clopidogrel Sponsors: Seung-Jung Park; CardioVascular Research Foundation, Korea Completed Tue, 12 Jun 2007 12:00:00 EDT Warfarin Versus Aspirin in Patients With Atrial Fibrillation and Chronic Kidney DiseaseConditions: Atrial Fibrillation; Chronic Kidney DiseaseInterventions: Drug: warfarin; Drug: Aspirin Sponsor: Seoul National University Hospital Withdrawn Mon, 20 Aug 2012 12:00:00 EDT Effect of Steady State Meloxicam on Low Dose Aspirin Induced Inhibition of Platelet Aggregation and Thromboxane Synthesis in Healthy Males and FemalesCondition: HealthyInterventions: Drug: Meloxicam; Drug: Aspirin Sponsor: Boehringer Ingelheim Completed Fri, 11 Jul 2014 12:00:00 EDT Study of Platelet Function After Administration of Aspirin Versus Lysine Acetylsalicylate in STEMI PatientsCondition: Acute Myocardial InfarctionInterventions: Drug: Lysine Acetilsalicilate; Drug: Aspirin Sponsor: Fundacion Investigacion Interhospitalaria Cardiovascular Unknown status Tue, 11 Oct 2016 12:00:00 EDT Comparative Efficacy of Ticagrelor Versus Aspirin on Blood Viscosity in Peripheral Artery Disease Patients With Type 2 DiabetesConditions: Peripheral Artery Disease; Type 2 DiabetesInterventions: Drug: Aspirin; Drug: Ticagrelor; Drug: Aspirin Placebo; Drug: Ticagrelor Placebo Sponsor: Icahn School of Medicine at Mount Sinai Completed Thu, 25 Dec 2014 12:00:00 EST
LIPS-A: Lung Injury Prevention Study With AspirinCondition: Acute Respiratory Distress SyndromeInterventions: Drug: Aspirin; Drug: Lactose powder Sponsors: Mayo Clinic; Beth Israel Deaconess Medical Center; Montefiore Medical Center; Vanderbilt University Medical Center; National Heart, Lung, and Blood Institute (NHLBI); National Center for Research Resources (NCRR) Completed Fri, 06 Jan 2012 12:00:00 EST Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation TherapyCondition: Node Positive HER2 Negative Breast CancerInterventions: Other: Placebo; Drug: Aspirin Sponsors: Alliance for Clinical Trials in Oncology; National Cancer Institute (NCI); United States Department of Defense; Bayer; Canadian Cancer Trials Group Active, not recruiting Fri, 07 Oct 2016 12:00:00 EDT Postpartum Low-Dose Aspirin After Preeclampsia for Optimization of Cardiovascular Risk (PAPVASC)Conditions: Preeclampsia Severe; Cardiovascular Diseases; Primary PreventionInterventions: Drug: Low-dose aspirin; Drug: Placebo oral tablet Sponsor: Dr. Graeme Smith Recruiting Tue, 28 Jan 2020 12:00:00 EST Rivaroxaban 2.5 mg BID and Aspirin for Intermittent Claudication in PAD PatientsConditions: Peripheral Artery Disease; Intermittent ClaudicationIntervention: Drug: Rivaroxaban 2.5 Mg Oral Tablet Sponsors: Science Valley Research Institute; Bayer Recruiting Wed, 21 Apr 2021 12:00:00 EDT STAT-STatin and Aspirin in TraumaConditions: Wounds and Injuries; Venous ThromboembolismInterventions: Drug: Aspirin and Rosuvastatin; Drug: Placebo (for Aspirin and Rosuvastatin) Sponsor: Denver Health and Hospital Authority Active, not recruiting Thu, 15 Sep 2016 12:00:00 EDT Pharmacogenomics of Antiplatelet ResponseCondition: AtherosclerosisIntervention: Drug: Aspirin Sponsor: Johns Hopkins University Completed Tue, 09 Sep 2014 12:00:00 EDT The Effect of Cilostazol Compared to Aspirin on Endothelial Function in Acute Cerebral Ischemia PatientsConditions: Ischemic Stroke; Endothelial DysfunctionInterventions: Drug: Cilostazol 100mg; Drug: Aspirin Sponsor: Ajou University School of Medicine Completed Mon, 17 Apr 2017 12:00:00 EDT Whole Blood Platelet Aggregation in Chronic Kidney Disease Patients on Aspirin StudyCondition: Chronic Kidney DiseaseInterventions: Drug: Aspirin; Drug: Clopidogrel Sponsors: University of Texas Southwestern Medical Center; American Heart Association Completed Tue, 15 Jan 2013 12:00:00 EST Study on Aspirin Versus Placebo in Resected Colon Cancer With PI3K Mutation Stage III or II High RiskCondition: Colorectal CancerInterventions: Drug: aspirin intake; Drug: placebo intake; Procedure: Surgical resection of colonic adenocarcinoma stage III or II high risk; Biological: Molecular analysis of exon 9 and 20 of PI3K; Biological: blood intake Sponsors: University Hospital, Rouen; Federation Francophone de Cancerologie Digestive Recruiting Wed, 26 Oct 2016 12:00:00 EDT Validation of an Assay to Measure Cyclooxygenase-1 ActivityCondition: HealthyIntervention: Other: Chewable aspirin Sponsor: Vanderbilt University Completed Tue, 30 Sep 2008 12:00:00 EDT
Prevention of Preeclampsia With Aspirin in Recipients of Donated Oocytes.Condition: Pre-EclampsiaInterventions: Drug: Acetylsalicylic acid; Drug: Placebo Sponsor: Instituto de Investigacion Sanitaria La Fe Terminated Wed, 25 Jun 2014 12:00:00 EDT Effect of Aspirin at the Acute Phase of Cerebral Ischemic Event.Condition: Ischemic StrokeInterventions: Drug: Aspirin; Biological: blood sample Sponsor: Central Hospital, Nancy, France Unknown status Fri, 17 Jun 2011 12:00:00 EDT EffectiveNess of Low-dose Aspirin in Prevention of Cancer in the Stomach and Oesophagus (GastrointEstinal Cancer Prevention) - United Kingdom ("ENgAGE - UK"): Study to Evaluate the Risk of Cancer in the Stomach and Oesophagus Among New Users of Low-dose Aspirin Using the THIN Database in the UKCondition: Prevention of Oesophagus Cancer and Stomach CancerIntervention: Drug: Acetylsalicylic Acid(BAYE4465, Aspirin ) Sponsor: Bayer Completed Fri, 16 Nov 2018 12:00:00 EST Postpolypectomy Bleeding in Patients With Antiplatelet TherapyCondition: Bleeding Complication During Colon PolypectomyIntervention: Drug: Aspirin Sponsor: Soonchunhyang University Hospital Unknown status Fri, 04 Nov 2011 12:00:00 EDT Mechanism of Drug-drug Interaction Between Salvianolate Injection and AspirinCondition: Angina, StableInterventions: Drug: salvianolate injection; Drug: Aspirin Tablet Sponsor: Xiyuan Hospital of China Academy of Chinese Medical Sciences Unknown status Wed, 11 Oct 2017 12:00:00 EDT Hydroxyurea Versus Aspirin and Hydroxyurea in Essential ThrombocythemiaConditions: MPN; Essential ThrombocythemiaInterventions: Other: Aspirin therapy interruption; Other: Usual treatment by aspirin 100 mg/d in the active comparator arm; Other: No interruption of aspirin in the Observational arm; Drug: Hydroxyurea treatment (HU) Sponsor: Assistance Publique - Hôpitaux de Paris Recruiting Mon, 23 Nov 2015 12:00:00 EST Anticoagulation Alone Versus Anticoagulation and Aspirin Following Transcatheter Aortic Valve Interventions (1:1)Condition: Transcatheter Aortic Valve ReplacementInterventions: Drug: Vitamin K antagonist or direct oral anticoagulant treatment; Drug: Aspirin Sponsors: Centre Hospitalier Universitaire de Nīmes; Medtronic Recruiting Wed, 13 Apr 2016 12:00:00 EDT Aspirin Resistance in Systemic Lupus Erythematosus (SLE)Condition: Systemic Lupus ErythematosusIntervention: Drug: aspirin and meloxicam Sponsors: Vanderbilt University; National Heart, Lung, and Blood Institute (NHLBI) Completed Fri, 08 Aug 2008 12:00:00 EDT Aspirin Prophylaxis for Venous Thromboembolism in GlioblastomaCondition: GlioblastomaInterventions: Drug: Aspirin; Drug: Placebo Sponsor: M.D. Anderson Cancer Center Terminated Thu, 13 Nov 2008 12:00:00 EST Ticagrelor With and Without Aspirin in Patients With Diabetes MellitusConditions: Diabetes Mellitus, Type 2; Coronary Artery DiseaseInterventions: Drug: Ticagrelor monotherapy; Drug: Ticagrelor plus aspirin; Drug: Clopidogrel with aspirin Sponsors: University of Florida; AstraZeneca Recruiting Thu, 23 Jul 2020 12:00:00 EDT
Aspirin and Plavix Following Coronary Artery Bypass GraftingCondition: Coronary Graft PatencyInterventions: Drug: clopidogrel; Drug: sugar pill; Drug: Aspirin Sponsors: Ahmad Slim; Bristol-Myers Squibb Terminated Thu, 08 Jul 2010 12:00:00 EDT Multiple Daily Doses Of Aspirin To Overcome Aspirin Hyporesponsiveness Post Cardiac Bypass SurgeryCondition: Postoperative; Dysfunction Following Cardiac SurgeryIntervention: Drug: Aspirin Sponsor: Hamilton Health Sciences Corporation Completed Wed, 13 Jun 2012 12:00:00 EDT Efficacy and Safety of Dorner Tablets and Aspirin for Prevention of Arteriosclerosis Progress in Type 2 Diabetes Mellitus PatientsCondition: Type 2 Diabetes MellitusInterventions: Drug: Beraprost; Drug: Aspirin Sponsor: Astellas Pharma Inc Terminated Wed, 01 Jun 2016 12:00:00 EDT Aspirin for Exercise in Multiple Sclerosis (ASPIRE)Condition: Multiple SclerosisInterventions: Drug: Aspirin 650mg Oral Capsule; Drug: Acetaminophen Tab 650mg; Other: Placebo Sponsors: Columbia University; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Recruiting Thu, 31 Jan 2019 12:00:00 EST Clinical Study of Combination Therapy for Angina of Coronary Heart Disease With Aspirin and Salvianolate InjectionCondition: AnginaInterventions: Drug: Salvianolate injection; Drug: Aspirin Sponsors: China Academy of Chinese Medical Sciences; Xiyuan Hospital of China Academy of Chinese Medical Sciences; Guang'anmen Hospital of China Academy of Chinese Medical Sciences; General Hospital of Beijing PLA Military Region; Guangdong Provincial Hospital of Traditional Chinese Medicine Unknown status Tue, 01 Mar 2016 12:00:00 EST To Evaluate the Bioavailability of a Single Oral Dose of the Acetylsalicylic Acid Containing Dry Powder 500 mg in Comparison to the Bioavailability of a Single Oral Dose of Aspirin Tablets and Aspirin Effervescent Tablets in Healthy Adults.Condition: Pharmacology, ClinicalIntervention: Drug: Aspirin (Acetylsalicylic acid, BAYe4465) Sponsor: Bayer Completed Fri, 20 Mar 2015 12:00:00 EDT Cilostazol Versus Aspirin for Primary Prevention of Atherosclerotic EventsCondition: Type 2 Diabetes MellitusInterventions: Drug: Cilostazol; Drug: Aspirin Sponsors: Hanyang University; Ajou University School of Medicine; Kyunghee University Medical Center; Korea University Guro Hospital; Inha University Hospital; Inje University; Hallym University Medical Center Unknown status Thu, 23 Apr 2009 12:00:00 EDT A Bioequivalence Study Comparing Clopidogrel/Aspirin Combination Tablet With Coadministration of Clopidogrel and AspirinCondition: HealthyIntervention: Drug: HCP0911 / clopidogrel, aspirin Sponsor: Hanmi Pharmaceutical Company Limited Completed Fri, 07 Oct 2011 12:00:00 EDT VTE Prevention Following Total Hip and Knee ArthroplastyCondition: Venous ThromboembolismInterventions: Drug: Rivaroxaban 10 MG and acetylsalicylic acid 81 mg; Drug: acetylsalicylic acid 81 mg Sponsors: Sudeep Shivakumar; Canadian Institutes of Health Research (CIHR); Nova Scotia Health Authority; Canadian Venous Thromboembolism Clinical Trials and Outcomes Research (CanVECTOR) Network Not yet recruiting Fri, 30 Aug 2019 12:00:00 EDT Effects of Omacor and Aspirin on Platelet FunctionCondition: HealthyInterventions: Drug: Aspirin; Drug: omega-3 acid ethyl esters Sponsor: Sanford Research Completed Tue, 03 Jun 2008 12:00:00 EDT
Evaluating the Need for Pneumatic Compression DevicesCondition: OsteoarthritisInterventions: Drug: Aspirin; Device: Portable Compression Device Sponsor: West Virginia University Completed Tue, 29 Dec 2015 12:00:00 EST Optimizing Aspirin and Clopidogrel Therapy (BOchum CLopidogrel and Aspirin Plan)Condition: Coronary Artery DiseaseIntervention: Drug: Optimizing ASA and clopidogrel treatment Sponsor: Ruhr University of Bochum Completed Thu, 30 Sep 2010 12:00:00 EDT Does Early Re-administration of Aspirin/Clopidogrel Increase the Risk of Bleeding From Artificial Ulcer After EMR or ESD?Conditions: Early Gastric Cancer; Gastric DysplasiaIntervention: Drug: aspirin and/or clopidogrel Sponsors: Asan Medical Center; Takeda Unknown status Mon, 18 Jun 2012 12:00:00 EDT Efficacy and Safety of Aspirin and Clopidogrel in the Atrial Fibrillation With Low or Moderate Stroke RiskCondition: Atrial FibrillationInterventions: Drug: Aspirin; Drug: Clopidogrel Sponsor: Chuncheon Sacred Heart Hospital Unknown status Wed, 09 Nov 2016 12:00:00 EST Chemoprevention of Esophageal Squamous Cell Carcinoma (ESCC) With Aspirin and Tea PolyphenolsCondition: Carcinoma, Squamous CellInterventions: Drug: Aspirin; Dietary Supplement: Tea Polyphenols Sponsor: Beijing Friendship Hospital Unknown status Wed, 21 Dec 2011 12:00:00 EST REsistance to Aspirin and Clopidogrel in acuTe Myocardial InfarctionCondition: Acute Myocardial InfarctionIntervention: Drug: Aspirin 200mg qd, Clopidogrel 2x75mg qd Sponsor: University Hospital Ostrava Completed Mon, 27 Jun 2011 12:00:00 EDT SMart Angioplasty Research Team: CHoice of Optimal Anti-Thrombotic Strategy in Patients Undergoing Implantation of Coronary Drug-Eluting Stents 3Condition: Coronary Artery DiseaseInterventions: Drug: Aspirin; Drug: Clopidogrel Sponsor: Samsung Medical Center Not yet recruiting Fri, 05 Jun 2020 12:00:00 EDT Oral Progesterone and Low Dose Aspirin in the Prevention of PreeclampsiaCondition: PreeclampsiaInterventions: Drug: Aspirin; Drug: Placebo Oral Tablet; Drug: Progesterone Sponsor: John Uckele Terminated Mon, 21 Jul 2008 12:00:00 EDT Efficacy Study of Cilostazol and Aspirin on Cerebral Small Vessel DiseaseCondition: Cerebral Small Vessel DiseaseInterventions: Drug: aspirin; Drug: cilostazol Sponsors: Inha University Hospital; Otsuka Pharmaceutical Development & Commercialization, Inc. Unknown status Fri, 30 Aug 2013 12:00:00 EDT Study to Develop a Prediction Model to Understand the Effect of Low-dose Aspirin on Cancer That Develops in the Colon and/or the Rectum, Diseases That Affects the Heart or Blood Vessels and Safety Outcomes in European Countries. The Study is Also Called PEACOS Model EUConditions: Colorectal Cancer; Cardiovascular Disease; BleedingIntervention: Drug: Acetylsalicylic Acid (Aspirin, BAYE4465) Sponsor: Bayer Completed Fri, 05 Apr 2019 12:00:00 EDT
Thromboelastography As An Assessment Tool for Possible Clopidogrel and Aspirin ResistanceCondition: Acute ST SEgment Elevation Myocardial InfarctionInterventions: Drug: Aspirin (200mg) and/or Plavix (150mg) dosage according to TEG; Drug: Aspirin 100mg and Plavix 75mg Sponsor: Assaf-Harofeh Medical Center Unknown status Fri, 13 Jun 2008 12:00:00 EDT Breast Cancer Active Surveillance, Alternative Option, Aspirin IncludedCondition: Breast CancerInterventions: Drug: Aspirin Low Dose; Drug: Placebo Oral Tablet Sponsor: Centro Hospitalar Lisboa Ocidental Not yet recruiting Mon, 09 Apr 2018 12:00:00 EDT Outcomes Study in Patients Receiving Aspirin With Mechanical Compression Devices Versus Aspirin Alone Following Knee and Hip ArthroplastyConditions: DVT - Deep Vein Thrombosis; PE - Pulmonary ThromboembolismInterventions: Drug: Aspirin; Device: (Post- discharge) Mechanical Compression Device Sponsors: Washington University School of Medicine; Medical Compression Systems Withdrawn Mon, 23 Jan 2017 12:00:00 EST Aspirin Dose and Atherosclerosis in Patients With Heart DiseaseConditions: Cardiovascular Diseases; Atherosclerosis; Myocardial InfarctionIntervention: Drug: Aspirin Sponsors: Florida Atlantic University; Bayer Completed Thu, 05 Jan 2006 12:00:00 EST The Impact of Aspirin Dose Modification on the Innate Immune Response - Will Lower Dose Aspirin Therapy Reduce the Response to EndotoxinCondition: Acute Coronary SyndromeInterventions: Drug: Aspirin; Drug: Ticagrelor Sponsor: Sheffield Teaching Hospitals NHS Foundation Trust Recruiting Mon, 11 Mar 2019 12:00:00 EDT Study Comparing Ticagrelor With Aspirin for Prevention of Vascular Events in Patients Undergoing CABGConditions: Coronary Artery Disease; Stable Angina; Acute Coronary SyndromeInterventions: Drug: Ticagrelor; Drug: Aspirin; Drug: Placebo - Ticagrelor; Drug: Placebo - Aspirin Sponsors: Deutsches Herzzentrum Muenchen; AstraZeneca Terminated Mon, 24 Dec 2012 12:00:00 EST Efficacy of Aspirin and L-arginine in High Risk PreeclampticCondition: High Risk PregnancyInterventions: Drug: L-arginine; Drug: Placebo (for L-arginine); Drug: acetylsalicylic acid Sponsors: University of Guadalajara; PhD Ernesto Javier Ramírez Lizardo; PhD Sylvia Elena Totsuka Sutto; PhD Fernando Grover Páez; MD Diego Hernández Molina Suspended Wed, 20 Jul 2016 12:00:00 EDT A Study of Aspirin and Simvastatin in Pulmonary Arterial HypertensionCondition: Hypertension, PulmonaryInterventions: Drug: Simvastatin; Drug: Aspirin; Drug: Placebo Sponsors: University of Pennsylvania; National Heart, Lung, and Blood Institute (NHLBI) Terminated Fri, 06 Oct 2006 12:00:00 EDT AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic StrokeCondition: StrokeInterventions: Drug: Apixaban; Drug: Aspirin Sponsors: Columbia University; National Institute of Neurological Disorders and Stroke (NINDS); University of Cincinnati; Medical University of South Carolina; Bristol-Myers Squibb; Pfizer; Roche Pharma AG; Weill Medical College of Cornell University; University of Washington Recruiting Tue, 20 Jun 2017 12:00:00 EDT Role of Inflammatory Mediators in AERDCondition: Asthma, Aspirin-InducedIntervention: Drug: aspirin Sponsor: Brigham and Women's Hospital Unknown status Wed, 06 Jul 2016 12:00:00 EDT
Effect of Chemoprevention by Low-dose Aspirin of New or Recurrent Colorectal Adenomas in Patients With Lynch SyndromeCondition: Lynch SyndromeInterventions: Drug: Acetylsalicylic acid lysinate 300 mg; Drug: Placebo (for Aspirin 300); Drug: Acetylsalicylic acid lysinate 100 mg; Drug: Placebo 100 (for Aspirin 100) Sponsor: Assistance Publique - Hôpitaux de Paris Recruiting Mon, 27 Jun 2016 12:00:00 EDT Effect of Low Dose Aspirin on Birthweight in Twins: The GAP Trial.Conditions: Small for Gestational Age; Infant, Very Low Birth Weight; Fetal Growth Retardation; Preeclampsia; Premature BirthInterventions: Drug: Acetylsalicylic Acid; Drug: Placebo Sponsor: CHU de Quebec-Universite Laval Completed Fri, 31 Oct 2014 12:00:00 EDT Evaluate Analgesic Efficacy of Fast Release AspirinCondition: Drugs, InvestigationalInterventions: Drug: Acetylsalicyclic acid (Fast acting Aspirin, BAY1019036); Drug: Acetylsalicyclic acid (Aspirin, BAYE4465); Drug: Placebo Sponsor: Bayer Completed Thu, 13 May 2010 12:00:00 EDT Ticagrelor Monotherapy Compared to Aspirin Monotherapy in Patients With History of ACSCondition: Acute Coronary SyndromeInterventions: Drug: Ticagrelor 60 mg; Drug: Aspirin 100 MG Oral Tablet, Enteric Coated Sponsor: The University of Hong Kong Completed Wed, 20 Mar 2019 12:00:00 EDT Assessment of Quitting Versus Using Aspirin Therapy In Patients Treated With Oral Anticoagulation for Atrial Fibrillation With Stabilized Coronary Artery DiseaseCondition: Coronary Artery DiseaseInterventions: Drug: OAC + Aspirin 100mg od; Drug: OAC + placebo of Aspirin 100mg od Sponsors: University Hospital, Brest; Bayer Not yet recruiting Fri, 03 Jan 2020 12:00:00 EST The Effect of Serum LDL Lowering on Aspirin ResistanceConditions: Aspirin Resistance; HypercholesterolemiaIntervention: Drug: Aspirin Sponsor: Ziv Hospital Completed Fri, 27 Apr 2007 12:00:00 EDT Early Prevention of Preeclampsia StudyCondition: PreeclampsiaInterventions: Drug: Aspirin; Drug: placebo Sponsor: Washington University School of Medicine Terminated Wed, 07 Mar 2012 12:00:00 EST ASpirin vs Triflusal for Event Reduction In Atherothrombosis Secondary Prevention (ASTERIAS)Condition: AtherothrombosisInterventions: Drug: Aspirin; Drug: Triflusal Sponsor: University of Ioannina Completed Mon, 30 Nov 2015 12:00:00 EST Omega-3 Plus Low-dose Aspirin Daily Supplementation in Non-surgical Therapy to Treat Aggressive PeriodontitisCondition: Aggressive PeriodontitisInterventions: Dietary Supplement: Omega-3 polyunsaturated fatty acids; Drug: Aspirin; Other: Placebo; Procedure: Full-mouth ultrasonic debridement Sponsor: Universidade Estadual Paulista Júlio de Mesquita Filho Completed Tue, 28 Mar 2017 12:00:00 EDT Evaluate Analgesic Efficacy of Fast Release AspirinCondition: Drugs, InvestigationalInterventions: Drug: Acetylsalicylic acid (Fast release Aspirin, BAY1019036); Drug: Acetylsalicylic Acid (Aspirin, BAYE4465); Drug: Placebo Sponsor: Bayer Completed Wed, 05 May 2010 12:00:00 EDT
Warfarin Versus Aspirin Recurrent Stroke StudyCondition: StrokeInterventions: Drug: Active Aspirin; Drug: Active Warfarin; Drug: Aspirin placebo; Drug: Warfarin placebo Sponsors: Columbia University; National Institute of Neurological Disorders and Stroke (NINDS) Completed Wed, 21 Nov 2001 12:00:00 EST Effect of Sarpogrelate, a Serotonin Receptor Antagonist, on Coronary Artery DiseaseCondition: Coronary Artery DiseaseInterventions: Drug: Sarpogrelate; Drug: Aspirin Sponsor: Seoul National University Bundang Hospital Completed Wed, 18 Nov 2015 12:00:00 EST Pharmacodynamic Evaluation of PL2200 Versus Enteric-Coated and Immediate Release Aspirin in Diabetic PatientsCondition: Diabetes Mellitus, Type 2Interventions: Drug: PL2200 Aspirin Capsules; Drug: Immediate-Release Aspirin Tablets; Drug: Enteric-coated aspirin caplets Sponsor: PLx Pharma Completed Tue, 24 Jan 2012 12:00:00 EST Add-Aspirin: A Trial Assessing the Effects of Aspirin on Disease Recurrence and Survival After Primary Therapy in Common Non Metastatic Solid TumoursConditions: Cancer; Breast Cancer; Prostate Cancer; Colorectal Cancer; Gastro-oesophageal CancerInterventions: Drug: Aspirin 100mg; Drug: Aspirin 300mg; Drug: Placebo 100mg; Drug: Placebo 300mg Sponsor: University College, London Recruiting Fri, 17 Jun 2016 12:00:00 EDT Endoscopic Evaluation of Upper Gastrointestinal (GI) Mucosal Damage Induced by PL-2200 Versus Aspirin in Healthy VolunteersCondition: Upper Gastrointestinal Mucosal DamageIntervention: Drug: acetylsalicylic acid Sponsor: PLx Pharma Completed Tue, 31 Mar 2009 12:00:00 EDT Aspirin Dose and Atherosclerosis in Patients With Metabolic SyndromeConditions: Cardiovascular Diseases; Metabolic Syndrome X; AtherosclerosisIntervention: Drug: Aspirin Sponsors: Florida Atlantic University; Bayer Completed Thu, 05 Jan 2006 12:00:00 EST Omega-3 Fatty Acids Plus Low-dose Aspirin Daily Supplementation in Surgical Therapy to Treat Aggressive PeriodontitisConditions: Residual Disease; Aggressive PeriodontitisInterventions: Procedure: Open flap debridement; Other: Placebo; Dietary Supplement: Omega-3 polyunsaturated fatty acids; Drug: Aspirin Sponsor: Universidade Estadual Paulista Júlio de Mesquita Filho Completed Tue, 28 Mar 2017 12:00:00 EDT Efficacy and Safety Study of Aspirin for the Prevention of Renal Artery Stenosis in Renal Transplantation RecipientsCondition: Renal TransplantInterventions: Drug: Aspirin 100mg; Other: Placebo Sponsor: Henan Provincial People's Hospital Recruiting Fri, 07 Feb 2020 12:00:00 EST Minocycline and Aspirin in the Treatment of Bipolar DepressionCondition: Bipolar Disorder DepressionInterventions: Drug: Minocycline; Drug: Aspirin; Drug: placebo Sponsors: Laureate Institute for Brain Research, Inc.; Stanley Medical Research Institute; University of Oklahoma Completed Wed, 07 Sep 2011 12:00:00 EDT Comparison of Doses of Acetylsalicylic Acid in Women With Previous History of PreeclampsiaConditions: Pre-Eclampsia; Fetal Growth Retardation; Premature Birth; Placental InsufficiencyInterventions: Drug: Acetylsalicylic Acid 160 mg; Drug: Acetylsalicylic Acid 80 mg Sponsor: CHU de Quebec-Universite Laval Completed Wed, 11 May 2011 12:00:00 EDT
Low-Dose Acetylsalicylic Acid in Treating Patients With Stage I-III Non-Small Cell Lung CancerConditions: Adenocarcinoma of the Lung; Recurrent Non-small Cell Lung Cancer; Stage IA Non-small Cell Lung Cancer; Stage IB Non-small Cell Lung Cancer; Stage IIA Non-small Cell Lung Cancer; Stage IIB Non-small Cell Lung Cancer; Stage IIIA Non-small Cell Lung Cancer; Stage IIIB Non-small Cell Lung CancerInterventions: Drug: acetylsalicylic acid; Other: laboratory biomarker analysis Sponsors: Vanderbilt-Ingram Cancer Center; National Cancer Institute (NCI) Terminated Tue, 16 Oct 2012 12:00:00 EDT Intermittent or Continuous Acetylsalicylic Acid and Gene Expression in the Nasal Tissue of Current SmokersConditions: Lung Carcinoma; Tobacco Use DisorderInterventions: Drug: Aspirin; Other: Laboratory Biomarker Analysis; Other: Placebo Sponsor: National Cancer Institute (NCI) Completed Mon, 28 Apr 2014 12:00:00 EDT N-Acetyl Cysteine and Aspirin as an Adjunctive Treatment for Bipolar DisorderCondition: Bipolar DisorderInterventions: Drug: Aspirin; Dietary Supplement: N-acetyl-cysteine (NAC); Drug: Sugar Pill Sponsors: The University of Texas Health Science Center, Houston; Stanley Medical Research Institute Completed Fri, 22 Feb 2013 12:00:00 EST Assessment of Low-dose ASA Discontinuation Risk Associated With Concomitant PPI Use During the First Year of ASA TherapyCondition: Cardiovascular PreventionIntervention: Drug: Risk of low dose aspirin discontinuation Sponsor: AstraZeneca Completed Fri, 28 Jun 2013 12:00:00 EDT NSAIDs vs. Coxibs in the Presence of AspirinConditions: Rheumatoid Arthritis; Cardiovascular DiseasesInterventions: Drug: celecoxib 200mg capsule; Drug: naproxen sodium 550mg tablet; Drug: Aspirin 81mg tablet Sponsor: Inova Health Care Services Unknown status Tue, 09 Oct 2018 12:00:00 EDT A Study to Assess the Efficacy and Safety of Enteric-Coated Acetylsalicylic Acid in Patients at Moderate Risk of Cardiovascular DiseaseCondition: Moderate Risk of CVDInterventions: Drug: Aspirin (Acetylsalicylic acid, BAYE4465); Drug: Placebo Sponsor: Bayer Completed Fri, 13 Jul 2007 12:00:00 EDT PACT (Platelet Activity After Clopidogrel Termination)Conditions: Blood Platelets; ClopidogrelInterventions: Drug: clopidogrel + aspirin; Drug: placebo; Drug: Aspirin Sponsors: University of Massachusetts, Worcester; Sanofi; Bristol-Myers Squibb Completed Wed, 20 Feb 2008 12:00:00 EST Evaluation of Antiplatelet Effects of Different Dosages of Aspirin in Type 2 Diabetic PatientsCondition: Type 2 Diabetes MellitusInterventions: Drug: Aspirin; Drug: aspirin Sponsor: Karolinska Institutet Completed Fri, 19 Dec 2008 12:00:00 EST Aspirin Resistance and Stroke Risk: Platelet Function Analysis in Patients With Ischemic EventsConditions: Stroke; Myocardial InfarctionsInterventions: Drug: Clopidogrel; Drug: Aspirin 81 mg; Drug: Aspirin >300 mg Sponsor: Northwestern University Completed Fri, 27 Apr 2012 12:00:00 EDT Comparative Study of Prophylactic Agent for Venous Thromboembolism After Total Knee ArthroplastyCondition: Venous ThromboembolismInterventions: Drug: acetylsalicylic acid; Drug: rivaroxaban Sponsor: Hanyang University Seoul Hospital Completed Wed, 22 Oct 2014 12:00:00 EDT
Antiaggregation in Primary Prevention of Vascular Access for HemodialysisCondition: ThrombosisIntervention: Drug: aspirin Sponsor: Tunis University Unknown status Tue, 04 Feb 2014 12:00:00 EST Aspirin in Reduction of Tension II StudyConditions: Hypertension; Cardiovascular DiseasesInterventions: Drug: Acetylsalicylic acid; Drug: Acetylsalicylic acid lysinate Sponsors: Leiden University Medical Center; Netherlands Heart Foundation Completed Thu, 23 Jun 2011 12:00:00 EDT Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis- EXtended Antiplatelet Monotherapy (HOST-EXAM)Condition: Coronary Heart DiseaseInterventions: Drug: Clopidogrel; Drug: Aspirin Sponsors: Seoul National University Hospital; Chong Kun Dang Pharmaceutical; Samjin Pharmaceutical Co., Ltd.; Daewoong Pharmaceutical Co. LTD.; Hanmi Pharmaceutical co., ltd. Completed Thu, 23 Jan 2014 12:00:00 EST Loss of Effect of Aspirin on Platelet Aggregation During Chronic AdministrationCondition: Platelet AggregationInterventions: Drug: aspirin; Drug: placebo Sponsor: Vanderbilt University Terminated Mon, 08 Sep 2008 12:00:00 EDT An Efficacy and Safety of Proprietary Formulations of Oral Ketamine + Aspirin in Treatment of AcuteCondition: PainInterventions: Drug: aspirin and ketamine; Drug: Nurtec (Rimegepant) Sponsor: Antonios Likourezos Recruiting Tue, 27 Apr 2021 12:00:00 EDT Warfarin Versus Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) TrialConditions: Heart Disease; Stroke; Ischemic Heart Disease; Myocardial InfarctionInterventions: Drug: aspirin; Drug: Warfarin Sponsors: Columbia University; National Institute of Neurological Disorders and Stroke (NINDS) Completed Mon, 22 Jul 2002 12:00:00 EDT A Comparison of Proprietary Formulations of Oral Ketamine + Aspirin and Oral Ketamine Alone for Musculoskeletal PainCondition: PainInterventions: Drug: Aspirin and Ketamine; Drug: Oral Ketamine Sponsor: Antonios Likourezos Recruiting Tue, 27 Apr 2021 12:00:00 EDT Aspirin for the Enhancement of Trophoblastic Invasion in Women With Abnormal Uterine Artery Doppler at 11-14 Weeks of GestationCondition: Placental InsufficiencyInterventions: Drug: Aspirin; Drug: placebo Sponsor: Sara Varea Completed Tue, 12 Jun 2012 12:00:00 EDT Aspirin Improve Survival of N2-3 Nasopharyngeal Carcinoma PatientsCondition: Nasopharyngeal CarcinomaInterventions: Radiation: Radiotherapy; Drug: Concurrent chemotherapy; Drug: Aspirin Sponsor: Sun Yat-sen University Not yet recruiting Mon, 25 Sep 2017 12:00:00 EDT DS1040b/Aspirin Drug/Drug Interaction StudyCondition: Acute Ischemic StrokeInterventions: Drug: DS-1040b; Drug: Aspirin Sponsor: Daiichi Sankyo, Inc. Completed Tue, 25 Feb 2014 12:00:00 EST
Chronic Hypertension and Acetyl Salicylic Acid in PregnancyConditions: Chronic Hypertension Complicating Pregnancy; Pre-Eclampsia; Intrauterine Growth Restriction; Aspirin; Perinatal Death; Placental AbruptionInterventions: Drug: Aspirin 150 mg; Drug: Placebo Sponsor: Centre Hospitalier Intercommunal Creteil Recruiting Wed, 22 Apr 2020 12:00:00 EDT Epidemiological Study on the Safety of Aspirin in The Health Improvement Network (THIN)Conditions: Secondary Prevention; Stroke; Ischemic Heart Disease; Coronary Heart DiseaseInterventions: Drug: Acetylsalicylic Acid (Aspirin, BAYE4465); Drug: Clopidogrel, Oral Anticoagulants, NSAIDs and SSRIs Sponsor: Bayer Completed Tue, 15 Sep 2015 12:00:00 EDT To Evaluate the Safety and Tolerability of Combined Administration of SHR2285 Tablets With Aspirin, Clopidogrel or Ticagrelor in Healthy SubjectsCondition: ThrombosisInterventions: Drug: Aspirin、clopidogrel、placebo or SHR2285; Drug: Aspirin、ticagrelor、placebo or SHR2285 Sponsor: Jiangsu HengRui Medicine Co., Ltd. Recruiting Wed, 30 Jun 2021 12:00:00 EDT Influence of Rivaroxaban for Intermittent Claudication and Exercise Tolerance in Patients With Symptomatic PADCondition: Peripheral Arterial DiseaseInterventions: Drug: Rivaroxaban; Drug: Aspirin Sponsors: Poznan University of Medical Sciences; Poznan University of Physical Education Not yet recruiting Thu, 12 Mar 2020 12:00:00 EDT Aspirin in Preventing Colorectal Cancer in Patients With Colorectal AdenomaCondition: Colorectal AdenomaInterventions: Drug: Aspirin; Other: Laboratory Biomarker Analysis; Other: Placebo Administration; Other: Questionnaire Administration Sponsor: National Cancer Institute (NCI) Active, not recruiting Thu, 17 Nov 2016 12:00:00 EST APACC Study:Prospective Study on Aspirin Efficacy in Reducing Colorectal Adenoma RecurrenceCondition: Colon AdenomasIntervention: Drug: Aspirin Sponsors: Assistance Publique - Hôpitaux de Paris; Société Nationale Française de Gastroentérologie; Ministry of Health, France; Sanofi-Synthelabo Terminated Fri, 23 Sep 2005 12:00:00 EDT Aspirin in Preventing Disease Recurrence in Patients With Barrett Esophagus After Successful Elimination by Radiofrequency AblationCondition: Barrett EsophagusInterventions: Drug: Aspirin; Other: Laboratory Biomarker Analysis; Other: Placebo Administration; Other: Questionnaire Administration Sponsor: National Cancer Institute (NCI) Active, not recruiting Thu, 13 Aug 2015 12:00:00 EDT IRELAnD: Investigating the Role of Early Low-dose Aspirin in DiabetesCondition: Pre-Gestational DiabetesInterventions: Drug: Aspirin; Drug: Placebos Sponsors: Royal College of Surgeons, Ireland; Health Research Board, Ireland Unknown status Mon, 02 Jul 2018 12:00:00 EDT Safety of "Ticagrelor+ Warfarin"in Comparison With "Clopidogrel+Aspirin+Warfarin"Conditions: Atrial Fibrillation; Coronary Artery DiseaseInterventions: Drug: Ticagrelor+Warfarin; Drug: Clopidogrel+Aspirin+Warfarin Sponsors: Genshan Ma; Zhongda Hospital Unknown status Fri, 01 Aug 2014 12:00:00 EDT Value of Cabergoline and Low Dose Aspirin in Poor Responders Undergoing ICSI-ET With GnRH Agonist Flare-Up-ProtocolCondition: Invitro FertilizationInterventions: Drug: cabergoline; Drug: Aspirin; Drug: GnRH agonist Sponsor: Cairo University Unknown status Mon, 28 Aug 2017 12:00:00 EDT
Does Low-Dose Aspirin Improve Outcome in In Vitro Fertilisation/Intra Cytoplasmatic Sperm Injection (IVF/ICSI)?Condition: InfertilityInterventions: Drug: aspirin; Drug: placebo Sponsor: University Hospital, Ghent Completed Wed, 26 Mar 2008 12:00:00 EDT Clinical Trial to Evaluate the Influence of Genotype on the Pharmacokinetics/Pharmacodynamics of ClopidogrelConditions: Influence of Genotype of Drug Metabolizing Enzyme or Transporter on the Pharmacokinetics/Pharmacodynamics of Clopidogrel; Influence of Aspirin on the Pharmacokinetics/Pharmacodynamics of ClopidogrelIntervention: Drug: Clopidogrel+Aspirin Sponsor: Seoul National University Hospital Completed Wed, 04 Jan 2012 12:00:00 EST Pharmacy Based Pharmacoepidemiological Observational Study With Aspirin Protect 100 mgConditions: Aspirin; Drug Safety; Effects, LongtermIntervention: Drug: Acetylsalicylic acid (Aspirin, BAYE4465) Sponsor: Bayer Completed Tue, 21 Aug 2012 12:00:00 EDT Comparison of Ulcer Healing in Patients Taking Rabeprazole With Different AntiplateletsConditions: Gastric Ulcer; Duodenal UlcerIntervention: Drug: rabeprazole plus aspirin versus rabeprazole plus clopidogrel Sponsor: Taipei Veterans General Hospital, Taiwan Unknown status Wed, 23 Dec 2009 12:00:00 EST Optimal Duration of Dual Antiplatelet Therapy After Drug-eluting Stent ImplantationConditions: Coronary Artery Disease; Stent Thrombosis; Myocardial IschemiaInterventions: Drug: Aspirin and Clopidogrel; Drug: Aspirin Sponsors: Assistance Publique - Hôpitaux de Paris; Fédération Française de Cardiologie Completed Wed, 14 Jan 2009 12:00:00 EST A Comparison of Safety and Treatment in Subjects With Osteoarthritis Taking Low Dose AspirinConditions: Osteoarthritis; Peptic UlcerInterventions: Drug: Lansoprazole and naproxen and aspirin; Drug: Celecoxib and aspirin Sponsor: Takeda Completed Thu, 15 Sep 2005 12:00:00 EDT Prochlorperazine Versus Acetaminophen, Aspirin, and Caffeine for the Treatment of Acute MigraineCondition: Migraine HeadachesInterventions: Drug: Aspirin, Acetaminophen, Caffeine pills; Drug: Prochlorperazine 10mg Sponsor: Albert Einstein Healthcare Network Terminated Wed, 27 Jun 2012 12:00:00 EDT The Effects of Acetylsalicylic Acid on Immunoparalysis Following Human EndotoxemiaCondition: EndotoxemiaInterventions: Drug: Aspirin; Drug: Placebo Sponsor: Radboud University Completed Tue, 04 Oct 2016 12:00:00 EDT Hormones Inflammation and ThrombosisConditions: Acute Coronary Syndrome; ThrombosisIntervention: Drug: Aspirin 81 mg Sponsor: Johns Hopkins University Terminated Tue, 11 Jun 2013 12:00:00 EDT Anti-Platelet Drugs and Brain-derived Neurotrophic Factor (BDNF) in Human Serum and PlasmaCondition: Healthy VolunteersIntervention: Drug: Aspirin and Clopidogrel Sponsor: University of Rostock Unknown status Wed, 22 Dec 2010 12:00:00 EST
Clinical Research on the Effect of Aspirin on the Disease Free Survival Rate of Esophageal CarcinomaCondition: Aspirin as an Adjuvant Therapy, to Observe Its Effect on the Disease Free Survival Rate of Patients With Esophageal Squamous Cell CarcinomaIntervention: Drug: Acetylsalicylic acid Sponsor: Hebei Medical University Fourth Hospital Not yet recruiting Wed, 03 Apr 2019 12:00:00 EDT Study of Aspirin and TPA in Acute Ischemic StrokeCondition: Acute Ischemic StrokeIntervention: Drug: Aspirin Sponsor: Hadassah Medical Organization Withdrawn Thu, 04 Jan 2007 12:00:00 EST Effects of Psyllium on Niacin TolerabilityConditions: Flushing; Hyperlipidemias; DyslipidemiasInterventions: Dietary Supplement: Psyllium; Drug: Aspirin Sponsor: VA Greater Los Angeles Healthcare System Completed Tue, 12 Dec 2017 12:00:00 EST Angioplasty and Stenting for Patients With Symptomatic Intracranial AtherosclerosisCondition: Intracranial AtherosclerosisInterventions: Procedure: Percutaneous transluminal angioplasty and stenting; Drug: Aspirin plus clopidogrel Sponsor: The 476th Hospital of People's Liberation Army Unknown status Tue, 23 Feb 2016 12:00:00 EST A Multi-center, Randomized to Compare the Efficacy of IVIG Alone and IVIG Plus High-dose Aspirin in Kawasaki DiseaseCondition: Kawasaki DiseaseInterventions: Other: IVIG only; Other: IVIG and Aspirin Sponsor: Chang Gung Memorial Hospital Unknown status Tue, 01 Nov 2016 12:00:00 EDT Pharmacokinetic Study Comparing Aspirin and Aspirin GranulesCondition: PharmacokineticsInterventions: Drug: Acetylsalicylic acid (Aspirin, BAY1019036); Drug: Acetylsalicylic acid (Aspirin, BAYE4465) Sponsor: Bayer Completed Mon, 22 Feb 2010 12:00:00 EST Metabolomic and Inflammatory Effects of Oral Aspirin (ASA) in Subjects at Risk for MelanomaCondition: Melanoma (Skin)Interventions: Drug: Aspirin 81 mg; Drug: Aspirin 325mg Sponsor: University of Utah Recruiting Tue, 20 Aug 2019 12:00:00 EDT Laboratory Aspirin Resistance in Diabetics and Non-DiabeticsCondition: Drug ResistanceIntervention: Drug: acetylsalicylic acid Sponsor: University of Aarhus Completed Mon, 26 Nov 2007 12:00:00 EST BAY81-8781, I.V. Aspirin in the Indication of Acute Coronary Syndrome (ACS)Condition: Acute Coronary SyndromeInterventions: Drug: D,L-lysine acetylsalicylate (Aspirin, BAY81-8781) 500 mg IV; Drug: D,L-lysine acetylsalicylate (Aspirin, BAY81-8781) 250 mg IV; Drug: Acetylsalicylic acid (Aspirin, BAYe4465) 300 mg Tablet Sponsor: Bayer Completed Fri, 29 May 2009 12:00:00 EDT Rivaroxaban Versus Aspirin in Secondary Prevention of Stroke and Prevention of Systemic Embolism in Patients With Recent Embolic Stroke of Undetermined Source (ESUS)Condition: StrokeInterventions: Drug: Rivaroxaban (Xarelto, BAY59-7939); Drug: Acetylsalicylic acid (Aspirin, BAY1019036); Other: Rivaroxaban-Placebo; Other: Aspirin-Placebo Sponsors: Bayer; Janssen Research & Development, LLC; Population Health Research Institute Terminated Wed, 10 Dec 2014 12:00:00 EST
Acetylsalicylic Acid Plus Intensive Blood Pressure Treatment in Patients With Unruptured Intracranial AneurysmsCondition: Unruptured Intracranial AneurysmsInterventions: Drug: Acetylsalicylic acid; Other: intensive blood pressure control Sponsors: Universitätsmedizin Mannheim; UMC Utrecht; Schwiete Stiftung, Mannheim, Germany; KKS Netzwerk; University of Hamburg-Eppendorf Recruiting Fri, 24 Feb 2017 12:00:00 EST Cilostazol Following Peripheral Endovascular ProceduresCondition: Peripheral Arterial DiseaseInterventions: Drug: Cilostazol; Drug: Aspirin Sponsors: Attikon Hospital; University Hospital of Patras Recruiting Thu, 12 May 2016 12:00:00 EDT Ticagrelor and Peripheral Arterial DiseaseCondition: Peripheral Arterial DiseaseInterventions: Procedure: Percutaneous Peripheral Intervention; Device: Optical Coherence Tomography; Other: Ankle Brachial Index; Other: Six minute walk distance; Drug: Aspirin; Drug: Aspirin + Ticagrelor Sponsors: Arkansas Heart Hospital; The University of Texas Health Science Center at San Antonio; University of Alabama at Birmingham Terminated Thu, 02 Apr 2015 12:00:00 EDT Pharmacokinetic Study Comparing Aspirin and Effervescent AspirinCondition: PharmacokineticsInterventions: Drug: Acetylsalicylic Acid (Aspirin BAY1019036); Drug: Alka Seltzer Extra Strength; Drug: Aspirin Migraine; Drug: Aspirin Aspro Sponsor: Bayer Completed Fri, 05 Mar 2010 12:00:00 EST Omega-3 and Aspirin in Periodontal RegenerationCondition: Periodontal DiseaseInterventions: Other: Regenerative therapy (omega 3 PUFA plus low dose aspirin); Drug: Sugar pill Sponsors: October 6 University; Cairo University Completed Fri, 30 Apr 2010 12:00:00 EDT Clopidogrel/Aspirin Interaction StudyCondition: Coronary Artery DiseaseInterventions: Drug: Clopidogrel; Drug: Aspirin Sponsor: Population Health Research Institute Completed Tue, 13 Apr 2010 12:00:00 EDT Effects of Aspirin and Low Molecular Weight Heparin in IVF Outcome.Condition: To Investigate the Effects of Low Dose Aspirin and Low Molecular Weight Heparin in IVF Out ComeInterventions: Drug: Low molecular weight heparin; Drug: Low dose aspirin; Drug: Heparin & aspirin; Other: NaCl Sponsor: Dr.Vandana Bansal Unknown status Fri, 16 Aug 2013 12:00:00 EDT Microvascular and Antiinflammatory Effects of Rivaroxaban Compared to Aspirin in Type-2 Diabetic Patients With Cardiovascular DiseaseCondition: Type 2 Diabetic PatientsInterventions: Drug: Rivaroxaban; Drug: Aspirin Sponsor: GWT-TUD GmbH Completed Mon, 16 Jun 2014 12:00:00 EDT Aspirin in Treating Patients With Colorectal Cancer That Has Been Surgically RemovedCondition: Colorectal CancerInterventions: Drug: aspirin; Other: placebo Sponsors: Alliance for Clinical Trials in Oncology; National Cancer Institute (NCI) Completed Tue, 31 Aug 2004 12:00:00 EDT A Study to Collect Data on the Treatment Pattern of Xarelto + Acetylsalicylic Acid in the Routine Clinical Practice in Patients Who Are Suffering From a Condition That Narrows the Blood Vessels Supplying the Heart and / or a Condition That Most Commonly Narrows the Blood Vessel in the LegsConditions: Coronary Artery Disease; Peripheral Artery DiseaseInterventions: Drug: Rivaroxaban (BAY59-7939, Xarelto); Drug: Acetylsalicylic acid Sponsor: Bayer Recruiting Tue, 26 May 2020 12:00:00 EDT
Platelet Reactivity in Acute Non-disabling Cerebrovascular EventsConditions: Stroke; Ischemic Attack, TransientInterventions: Drug: Ticagrelor and Acetylsalicylic acid; Drug: Clopidogrel and Acetylsalicylic acid Sponsors: Beijing Tiantan Hospital; Beijing Municipal Science & Technology Commission Completed Thu, 23 Jul 2015 12:00:00 EDT Impact of isoQUercetin and Aspirin on Platelet FunctionCondition: Cardiovascular DiseaseInterventions: Drug: Vehicle control; Drug: Isoquercetin; Drug: Aspirin; Drug: Isoquercetin plus Aspirin Sponsors: University of Reading; Biotechnology and Biological Sciences Research Council; Quercegen Pharmaceuticals Withdrawn Mon, 15 Aug 2016 12:00:00 EDT Low Molecular Weight Heparin (LMWH) vs Aspirin for Venous Thromboembolism (VTE) Prophylaxis in Orthopaedic OncologyConditions: Sarcoma; Soft Tissue Sarcoma; Bone Sarcoma; Bone Metastases; Venous Thromboembolism; Hematoma; Anticoagulant-induced BleedingInterventions: Drug: Aspirin 325mg; Drug: Enoxaparin 40Mg/0.4mL Prefilled Syringe Sponsors: Massachusetts General Hospital; Brigham and Women's Hospital; Beth Israel Deaconess Medical Center Enrolling by invitation Wed, 09 Aug 2017 12:00:00 EDT Optimal antiPlatelet Therapy for High Bleeding and Ischemic RISK Patients TrialCondition: Prolonged DAPT in ACS Patients With Hisk of Both Ischemic and HemorrhageInterventions: Drug: Clopidogrel; Drug: Clopidogrel+aspirin Sponsor: Shenyang Northern Hospital Recruiting Tue, 13 Feb 2018 12:00:00 EST Administration Time-dependent Antihypertensive Effects of Low Dose Aspirin in Well-controlled Hypertensive PatientsCondition: Well-controlled HypertensionIntervention: Drug: Aspirin enteric coated pellests 100mg Sponsors: Boryung Pharmaceutical Co., Ltd; Kyungpook National University Hospital; The Catholic University of Korea; Cheil General Hospital and Women's Healthcare Center; Inje University; Keimyung University; Seoul National University Bundang Hospital; Severance Hospital; Yeungnam University Hospital Completed Wed, 11 Oct 2006 12:00:00 EDT Aspirin and Zileuton and Biomarker Expression in Nasal Tissue of Current SmokersCondition: Tobacco Use DisorderInterventions: Drug: Aspirin; Other: Laboratory Biomarker Analysis; Other: Placebo Administration; Drug: Zileuton Sponsor: National Cancer Institute (NCI) Completed Wed, 28 Jan 2015 12:00:00 EST Low Molecular Weight Heparin and/or Aspirin in Prevention of Habitual AbortionCondition: Habitual AbortionInterventions: Drug: Aspirin; Drug: Klexane; Drug: Klexane and ASA Sponsors: University of Helsinki; Oulu University Hospital; Karolinska University Hospital; Leiden Hospital, Leiden, The Netherlands Completed Fri, 14 Aug 2009 12:00:00 EDT The Value of Prednisolone With Aspirin Before Embryo Transfer in Intracytoplasmic Sperm Injection (ICSI) CyclesCondition: InfertilityInterventions: Drug: prednisolone; Drug: Acetyl Salicylic acid Sponsor: Kasr El Aini Hospital Completed Thu, 19 Apr 2018 12:00:00 EDT Edoxaban for TIA and Acute Minor StrokeConditions: Ischemia; Stroke; Cerebral InfarctionInterventions: Drug: Aspirin; Drug: edoxaban; Drug: placebo Sponsor: Xijing Hospital Unknown status Wed, 20 Aug 2014 12:00:00 EDT Evaluate Relative Bioavailability of PA32540 (Asa/Omeprazole), Its Aspirin Component, and Ecotrin® in Healthy VolunteersCondition: HealthyInterventions: Drug: PA32540; Drug: aspirin component of PA32540; Drug: Ecotrin Sponsor: POZEN Completed Mon, 10 Mar 2008 12:00:00 EDT
Study to Gain Insights in Treatment Patterns and Outcomes in Patients With Atherosclerosis Prescribed to Xarelto in Combination With Acetylsalicylic AcidCondition: AtherosclerosisInterventions: Drug: Rivaroxaban (BAY59-7939, Xarelto); Drug: Acetylsalicylic acid Sponsors: Bayer; Janssen, LP Completed Mon, 19 Nov 2018 12:00:00 EST STOPping Versus Continuing Antiplatelet Therapy During Noncardiac Surgery and Procedures After Next Generation Drug-eluting Stent ImplantationCondition: Coronary Artery DiseaseInterventions: Drug: Continuing aspirin; Drug: Stopping aspirin Sponsor: Yonsei University Terminated Wed, 14 Jun 2017 12:00:00 EDT Cost Effectiveness Analysis In Patients With Heart Valve ProsthesisCondition: Complications Due to Heart Valve ProsthesisInterventions: Drug: Acetyl Salicylic Acid; Drug: Warfarin; Drug: Placebo (for Aspirin) Sponsor: Pharmacoeconomic Unit, Egypt Unknown status Fri, 27 Dec 2013 12:00:00 EST Study of Antiplatelet Therapy for Intracranial Aneurysm Stent-assisted CoilingCondition: Embolic StrokeIntervention: Drug: Aspirin and clopidogrel Sponsor: Beijing Tiantan Hospital Unknown status Mon, 25 Aug 2014 12:00:00 EDT Aspirin Statins Or Both For The Reduction Of Thrombin Generation In Diabetic PeopleCondition: Diabetes MellitusInterventions: Drug: Aspirin; Drug: Atorvastatin; Drug: Aspirin + Atorvastatin Sponsor: Fundacion GESICA Completed Wed, 19 Nov 2008 12:00:00 EST Mono- Versus Dual antiPlatelet Therapy During 6-12 Months After New Generation Drug Eluting Stent ImplantationConditions: Gastrointestinal Injury; Ischemic Heart DiseaseInterventions: Drug: Aspirin + clopidogrel; Drug: Clopidogrel monotherapy; Drug: Aspirin monotherapy Sponsors: Shenyang Northern Hospital; Changhai Hospital; ANKON medical technologies (Shanghai)Co.,LTD Recruiting Mon, 26 Jun 2017 12:00:00 EDT Aspirin for the Prevention of Recurrent Venous ThromboembolismConditions: Venous Thromboembolism; Deep Venous Thrombosis; Pulmonary Embolism; AtherosclerosisIntervention: Drug: aspirin Sponsor: University Of Perugia Unknown status Thu, 22 Sep 2005 12:00:00 EDT Metformin Hydrochloride and Aspirin in Treating Patients With Hormone-Dependent Prostate Cancer That Has Progressed After Surgery or Radiation TherapyConditions: Recurrent Prostate Carcinoma; Stage I Prostate Cancer; Stage IIA Prostate Cancer; Stage IIB Prostate Cancer; Stage III Prostate CancerInterventions: Drug: Aspirin; Other: Laboratory Biomarker Analysis; Drug: Metformin Hydrochloride; Other: Placebo Sponsors: Rutgers, The State University of New Jersey; National Cancer Institute (NCI); Rutgers Cancer Institute of New Jersey Terminated Mon, 20 Apr 2015 12:00:00 EDT Aspirin and Antiretroviral Therapy in HIV Infected PatientsCondition: HIV InfectionInterventions: Drug: Aspirin 325mg; Drug: Antiretroviral therapy (ART) Sponsor: Hennepin Healthcare Research Institute Terminated Sun, 02 Nov 2008 12:00:00 EDT Reversal of the Antiplatelet Effects of Ticagrelor in Combination With Aspirin, Using Normal PlateletsConditions: Ticagrelor; Aspirin; Platelet Dysfunction Due to Drugs; TransfusionIntervention: Drug: Antiplatelet treatment Sponsor: Hamilton Health Sciences Corporation Unknown status Thu, 29 Dec 2016 12:00:00 EST
Clinical Study of Antiviral and Aspirin Treatment in Liver Cancer After Radical SurgeryConditions: Hepatocellular Carcinoma; RecurrenceInterventions: Drug: Aspirin; Drug: Lamivudine Sponsor: Fudan University Recruiting Fri, 06 Sep 2013 12:00:00 EDT Salicylic Augmentation in DepressionConditions: Depression; Depressive Disorder; Major Depressive Disorder; Treatment Resistant DepressionInterventions: Drug: Aspirin 325mg; Drug: Placebo Oral Tablet Sponsors: Jessica Harder; Columbia University Recruiting Mon, 15 May 2017 12:00:00 EDT Dual Anti-Platelet Therapy in Patients With Coronary Multi-Vessel Disease (DAPT-MVD)Conditions: Coronary Artery Disease; Myocardial Ischemia; Acute Coronary Syndrome; Heart Diseases; Syndrome Heart Disease; Cardiovascular Diseases; Arteriosclerosis; Arterial Occlusive Diseases; Coronary Disease; Vascular DiseasesInterventions: Drug: Clopidogrel and Aspirin dual-antiplatelet therapy; Drug: Aspirin monotherapy Sponsors: Harbin Medical University; Chinese Society of Cardiology; Lepu Medical Technology (Beijing) Co., Ltd. Recruiting Thu, 12 Nov 2020 12:00:00 EST Study to Evaluate the Interaction Between Aspirin and NexiumCondition: Healthy VolunteersInterventions: Drug: Aspirin; Drug: Esomeprazole Sponsor: AstraZeneca Completed Fri, 10 Sep 2010 12:00:00 EDT A Study to Evaluate Platlet Aggregation of Clopidogrel, EC Aspirin 81 mg, EC Omeprazole 40 mg Compare to PA32540Condition: Platelet AggregationInterventions: Drug: Plavix® and PA32540; Drug: EC aspirin (Bayer®) ,EC omeprazole (Prilosec®) , Clopidogrel (Plavix®) Sponsor: POZEN Completed Mon, 19 Mar 2012 12:00:00 EDT Ivermectin, Aspirin, Dexamethasone and Enoxaparin as Treatment of Covid 19Conditions: Severe Acute Respiratory Syndrome; Ventilation PneumonitisInterventions: Drug: Ivermectin 5 MG/ML oral solution, Aspirin 250 mg tablets; Other: Ivermectin 5 mg/mL oral solution, Dexamethasone 4-mg injection, Aspirin 250 mg tablets; Other: Ivermectin 5 MG/ML oral solution, Dexamethasone 4-mg injection, Enoxaparin injection. Inpatient treatment with mechanical ventilation in ICU. Sponsor: Eurnekian Public Hospital Completed Thu, 11 Jun 2020 12:00:00 EDT Pilot Study of Aspirin Versus Warfarin for Cervicocephalic Arterial DissectionCondition: Ischemic StrokeInterventions: Drug: aspirin; Drug: warfarin Sponsor: University of California, San Diego Withdrawn Wed, 14 Dec 2005 12:00:00 EST Pilot Study of Continuing Aspirin Versus Switching to Clopidogrel After Stroke or Transient Ischemic AttackConditions: Transient Ischemic Attack; Stroke; Aspirin; ClopidogrelIntervention: Drug: aspirin versus clopidogrel Sponsor: University of California, San Diego Withdrawn Tue, 15 Aug 2006 12:00:00 EDT A Parallel Group Study to Compare the Gastroprotective Effects of PA 325 Versus 81 mg Enteric Coated AspirinCondition: HealthyInterventions: Drug: aspirin; Drug: omeprazole Sponsor: POZEN Completed Thu, 01 Mar 2007 12:00:00 EST Pharmacogenomics of Antiplatelet Response - II (PARes-II)Condition: AtherothrombosisIntervention: Drug: Aspirin Sponsor: Johns Hopkins University Completed Wed, 10 Jul 2013 12:00:00 EDT
Acetylsalicylic Acid Compared to Placebo in Treating High-Risk Patients With Subsolid Lung NodulesConditions: Current Smoker; Former Smoker; Multiple Pulmonary Nodules; Tobacco Use DisorderInterventions: Drug: Aspirin; Other: Laboratory Biomarker Analysis; Other: Placebo Sponsor: National Cancer Institute (NCI) Completed Mon, 23 Jun 2014 12:00:00 EDT Pharmacological Study That Measures Omeprazole Effect on Aspirins Absorption in Healthy VolunteersConditions: Aspirin Blood Level; Proton Pump Inhiditor TreatmentIntervention: Drug: aspirin and omeprazole Sponsor: Assaf-Harofeh Medical Center Completed Tue, 02 Feb 2010 12:00:00 EST Efficacy Study of Clopidogrel in High-risk Population With Acute Non-disabling Cerebrovascular Events ⅡConditions: Acute Nondisabling Ischemic Stroke; Transient Ischemic AttackInterventions: Drug: Tagrelor combined with aspirin; Drug: Clopidogrel combined with aspirin Sponsors: Peking University Third Hospital; Beijing Tiantan Hospital Recruiting Wed, 07 Jul 2021 12:00:00 EDT Prevention of Venous Obstruction After Implantation of Cardiac Pacemaker and DefibrillatorConditions: Complication of Cardiac Defibrillator; Disorder of Cardiac Pacemaker System; Venous OcclusionInterventions: Drug: placebo; Drug: Aspirin 80 mg daily; Drug: Clopidogrel 75 mg daily Sponsor: Shahid Beheshti University of Medical Sciences Unknown status Tue, 06 Jan 2015 12:00:00 EST Does Acetylsalicylic Acid Reduce the Mortality of Patients Admitted to an Intensive Care UnitCondition: Critical IllnessInterventions: Drug: Acetylsalicylic acid lysinate; Drug: 0.9% sodium-chloride solution Sponsor: Medical University of Vienna Terminated Thu, 06 Nov 2014 12:00:00 EST Benign Acute Pericarditis: Brief Versus Longer Treatment Using AspirinCondition: PericarditisInterventions: Drug: Aspirin; Drug: placebo Sponsors: University Hospital, Brest; Ministry of Health, France Terminated Mon, 27 Jul 2009 12:00:00 EDT Sarpogrelate-Aspirin Comparative Clinical Study for Efficacy and Safety in Secondary Prevention of Cerebral Infarction (S-ACCESS)Condition: Cerebral InfarctionInterventions: Drug: MCI-9042; Drug: Aspirin Sponsor: Mitsubishi Tanabe Pharma Corporation Completed Fri, 12 Aug 2005 12:00:00 EDT Clopidogrel and Aspirin Together: The Effect on C-Reactive Protein TrialCondition: Coronary Artery DiseaseInterventions: Drug: aspirin; Drug: clopidogrel Sponsors: Intermountain Health Care, Inc.; Bristol-Myers Squibb; Sanofi-Synthelabo Completed Fri, 23 Jun 2006 12:00:00 EDT Efficacy and Safety of Aspirin Therapy With CABGCondition: Coronary Heart DiseaseInterventions: Drug: acetylsalicylic acid started for 24 hours before surgery; Drug: acetylsalicylic acid stayed for 5 days before surgery Sponsor: Meshalkin Research Institute of Pathology of Circulation Unknown status Mon, 24 Oct 2016 12:00:00 EDT Antiplatelet Effect of Low Doses of Aspirin Taken Every 12 Hours in Patients Undergoing Coronary Artery Bypass Graft and/or Aortic Valve SurgeryCondition: Coronary ArteriosclerosisIntervention: Drug: Aspirin Sponsors: Centro Cardiologico Monzino; Catholic University, Italy; University of Chieti Unknown status Tue, 08 Nov 2011 12:00:00 EST
Peri-vascular Adipose Tissue Inflammation Evaluated Using Coronary CT AngiographyCondition: Cardiovascular Risk FactorIntervention: Drug: aspirin and atorvastatin Sponsors: University of Leicester; University of Oxford; British Heart Foundation; National Institute for Health Research, United Kingdom Recruiting Fri, 29 Nov 2019 12:00:00 EST Evaluation of Effectiveness of Acetylsalicylic Acid on Markers of Vascular Dysfunction in Scleroderma PatientsCondition: Systemic SclerosisInterventions: Drug: Acetylsalicylic acid; Drug: Placebo oral capsule Sponsor: Federal University of São Paulo Recruiting Fri, 15 Jun 2018 12:00:00 EDT Parnaparin vs Aspirin in the Treatment of Retinal Vein OcclusionCondition: Retinal Vein OcclusionInterventions: Drug: parnaparin; Drug: aspirin Sponsors: Università degli Studi dell'Insubria; Alfa Wassermann, Bologna, Italy Terminated Tue, 12 Aug 2008 12:00:00 EDT Antiplatelet Therapy for Silent Brain InfarctionCondition: Brain InfarctionInterventions: Drug: Aspirin; Drug: Placebo Oral Tablet Sponsor: First People's Hospital of Shenyang Not yet recruiting Tue, 24 Oct 2017 12:00:00 EDT A Proof of Concept Window Trial of the IMmunological Effects of AveLumab and Aspirin in Triple-Negative Breast CancerCondition: Breast CancerInterventions: Drug: Avelumab; Drug: Aspirin; Drug: Lansoprazole Sponsors: The Christie NHS Foundation Trust; University of Manchester Not yet recruiting Thu, 05 Dec 2019 12:00:00 EST The Effects of Aspirin and Acetaminophen on the Stomach in Healthy VolunteersCondition: HealthyInterventions: Drug: Acetaminophen - 4 grams per day + Placebo; Drug: Aspirin - 325 mg per day + Placebo; Drug: Acetaminophen 4 gram per day + Aspirin 325 mg per day Sponsor: University of Illinois at Chicago Completed Wed, 16 Jan 2008 12:00:00 EST Dual Antiplatelet Therapy Versus Oral Anticoagulation for a Short Time to Prevent Cerebral Embolism After TAVIConditions: Aortic Valve Stenosis; StrokeIntervention: Drug: aspirin+clopidogrel (Duoplavin) Sponsor: Andres Iñiguez Romo, MD, PhD Completed Tue, 17 Jul 2012 12:00:00 EDT Efficiency Study of Aspirin to Prevent the Occurrence of Prostate CancerCondition: Prostate CancerInterventions: Drug: aspirin; Drug: Levofloxacin Sponsor: West China Hospital Unknown status Mon, 02 May 2016 12:00:00 EDT Phase 4 Study of Effect of Aspirin on Flushing in Dimethyl Fumarate-Treated Participants With Relapsing-Remitting Multiple SclerosisCondition: Relapsing-Remitting Multiple SclerosisInterventions: Drug: dimethyl fumarate; Drug: acetylsalicylic acid; Drug: ASA-Placebo Sponsor: Biogen Completed Tue, 18 Mar 2014 12:00:00 EDT Walking Effect of Long Term Ticagrelor in Subjects With PAD Who Have Undergone EVRCondition: Peripheral Artery Disease (PAD)Interventions: Drug: Ticagrelor; Drug: Comparator Sponsors: AstraZeneca; CPC Clinical Research Terminated Thu, 28 Aug 2014 12:00:00 EDT
Clopidogrel and Aspirin for the Treatment of Polycythemia VeraCondition: Polycythemia VeraInterventions: Drug: Clopidogrel (Plavix); Drug: Placebo; Drug: Aspirin Sponsors: Ronald Hoffman; Myeloproliferative Disorders-Research Consortium; National Cancer Institute (NCI) Withdrawn Thu, 16 Jul 2009 12:00:00 EDT Anticoagulation for Aortic Bioprosthesis (ANTIPRO)Conditions: Aortic Valve Stenosis; Aortic Valve Disease; Aortic Valve Insufficiency; Aortic Valve RegurgitationInterventions: Drug: Warfarin; Drug: Aspirin Sponsors: Instituto Nacional de Cirugia Cardiaca, Uruguay; Universidad de la Republica Completed Thu, 17 Jan 2019 12:00:00 EST AntiPhospholipid Syndrome Low-molecular-weight Heparin Pregnancy Loss Evaluation: The Pilot StudyConditions: Antiphospholipid Syndrome in Pregnancy; Pregnancy LossInterventions: Drug: Aspirin 81 mg; Drug: Low-molecular-weight heparin Sponsor: Ottawa Hospital Research Institute Terminated Tue, 04 Apr 2017 12:00:00 EDT Acetylsalicylic Acid in the Prevention of Severe SARS-CoV2 Pneumonia in Hospitalised Patients With COVID-19Conditions: COVID-19; Thrombosis PulmonaryInterventions: Drug: Acetylsalicylic acid; Drug: Placebo Sponsor: Azienda Ospedaliera Universitaria Integrata Verona Not yet recruiting Mon, 22 Mar 2021 12:00:00 EDT Implementation of First-trimester Screening and preventiOn of pREeClAmpSia Trial (FORECAST)Condition: Pre-EclampsiaIntervention: Other: Low-dose aspirin in women with high risk of preeclampsia Sponsor: Chiu Yee Liona Poon Recruiting Wed, 08 May 2019 12:00:00 EDT ThrombElastoGraphic Haemostatic Status and Antiplatelet Therapy After Coronary Artery Bypass Graft SurgeryConditions: Graft Patency; Coronary Artery Bypass Grafting Surgery; Hypercoagulability; ThrombosisInterventions: Drug: Clopidogrel+acetylsalicylic acid; Drug: acetylsalicylic acid Sponsor: Rigshospitalet, Denmark Unknown status Tue, 12 Jan 2010 12:00:00 EST Residual Platelet Reactivity in Patients on Antiplatelet Therapy After Carotid Angioplasty With StentingCondition: Carotid Artery DiseaseIntervention: Drug: Aspirin plus clopidogrel Sponsors: Azienda Ospedaliera di Perugia; University Of Perugia Unknown status Mon, 10 Oct 2011 12:00:00 EDT Evaluation of Safety and Efficacy of Two Ticagrelor-based De-escalation Antiplatelet Strategies in Acute Coronary SyndromeConditions: STEMI; NSTEMI; Unstable AnginaInterventions: Drug: Ticagrelor 90mg; Drug: Ticagrelor 60mg; Drug: Aspirin Sponsors: Collegium Medicum w Bydgoszczy; Medical Research Agency (Poland) Not yet recruiting Fri, 22 Jan 2021 12:00:00 EST TicAgrelor Versus CLOpidogrel in Stabilized Patients With Acute Myocardial Infarction: TALOS-AMICondition: Acute Myocardial InfarctionInterventions: Drug: Aspirin+Ticagrelor; Drug: Aspirin+Clopidogrel Sponsors: The Catholic University of Korea; Chonnam National University Hospital Completed Mon, 23 Dec 2013 12:00:00 EST Aspirin and Compression Devices for VTE Prophylaxis in Orthopaedic OncologyConditions: Bone Metastases; Musculoskeletal Cancer; Soft Tissue Sarcoma; ThromboembolismInterventions: Drug: acetylsalicylic acid; Drug: enoxaparin; Device: PCD Sponsor: Ohio State University Comprehensive Cancer Center Completed Mon, 01 Oct 2012 12:00:00 EDT
A Proof of Concept, Window Trial of the IMmunological Effects of AveLumab and Aspirin in Triple-Negative Breast CancerCondition: Breast CancerInterventions: Drug: Avelumab; Drug: Aspirin; Drug: Lansoprazole (Proton Pump Inhibitor) Sponsors: The Christie NHS Foundation Trust; University of Manchester Withdrawn Mon, 07 Jan 2019 12:00:00 EST Aspirin in Preventing Colorectal Cancer in Patients at Increased Risk of Colorectal CancerConditions: Colon Cancer; Precancerous Condition; Rectal CancerInterventions: Drug: acetylsalicylic acid; Drug: placebo; Other: laboratory biomarker analysis Sponsor: National Cancer Institute (NCI) Completed Thu, 03 May 2007 12:00:00 EDT Aspirin as an Ultraviolet (UV) Protectant in Human Subjects at Risk for MelanomaCondition: Melanoma (Skin)Interventions: Drug: Aspirin 81 mg; Drug: Aspirin 325mg; Drug: Placebo oral tablet Sponsor: University of Utah Recruiting Mon, 26 Aug 2019 12:00:00 EDT ASPREE Cancer Endpoints StudyCondition: CancerInterventions: Drug: Aspirin; Drug: Placebo Sponsors: Hennepin Healthcare Research Institute; National Cancer Institute (NCI); National Institute on Aging (NIA); Monash University; Berman Center for Outcomes and Clinical Research; National Health and Medical Research Council, Australia; Bayer Active, not recruiting Thu, 24 Oct 2013 12:00:00 EDT Evaluate Onset of Action of a Fast Release AspirinCondition: Healthy SubjectsInterventions: Drug: Acetylsalicyclic acid (Fast release Aspirin, BAY1019036); Drug: Acetaminophen (Tylenol extra strength); Drug: Placebo Sponsor: Bayer Completed Fri, 19 Aug 2011 12:00:00 EDT Identification of Critical Thermal Environments for Aged AdultsCondition: AgingInterventions: Drug: Low dose ASA; Other: Control Sponsor: Penn State University Recruiting Tue, 25 Feb 2020 12:00:00 EST Evaluate the Time of Pain Relief of Fast Acting Aspirin Versus Acetaminophen in Subjects Diagnosed With Sore Throat PainCondition: PharyngitisInterventions: Drug: Acetylsalicylic Acid (Aspirin, BAY1019036) + placebo; Drug: Acetaminophen + placebo; Drug: Placebo Sponsor: Bayer Completed Mon, 17 Oct 2011 12:00:00 EDT The Effect of Celecoxib on the Antiplatelet Effect of Aspirin and Clopidogrel in Normal VolunteersCondition: HealthyInterventions: Drug: aspirin; Drug: celecoxib; Drug: aspirin + celecoxib; Drug: aspirin + clopidogrel; Drug: aspirin + clopidogrel + celecoxib Sponsor: Seoul National University Hospital Completed Thu, 16 Apr 2009 12:00:00 EDT Apixaban Versus Dual-antiplatelet Therapy (Clopidogrel and Aspirin) in Acute Non-disabling Cerebrovascular EventsConditions: Ischemic Stroke; TIAInterventions: Drug: Apixaban; Drug: Clopidogrel; Drug: Aspirin; Drug: placebo Sponsor: Xijing Hospital Unknown status Fri, 16 Aug 2013 12:00:00 EDT Assessment of Direct Biomarkers of Aspirin Action to Develop a Precision Chemoprevention Therapy of Colorectal CancerCondition: Colorectal CancerIntervention: Drug: acetylsalicylic acid Sponsors: Instituto de Investigación Sanitaria Aragón; Instituto de Salud Carlos III; G. d'Annunzio University; Hospital Clínico Universitario Lozano Blesa Unknown status Tue, 21 May 2019 12:00:00 EDT
Aspirin/Folate Prevention of Large Bowel PolypsConditions: Colorectal Cancer; Polyps; AdenomasInterventions: Drug: Aspirin; Drug: Folate Sponsors: Dartmouth-Hitchcock Medical Center; National Cancer Institute (NCI) Completed Thu, 05 Jan 2006 12:00:00 EST Multimodal DVT Protocol in Tourniquet-less Total Knee ArthroplastyCondition: Deep Vein ThrombosisInterventions: Device: extended compression; Other: Aspirin Sponsor: TriHealth Inc. Completed Thu, 03 Apr 2014 12:00:00 EDT Genetic and Dietary Predictors of Anti-platelet ResponseCondition: Platelet FunctionIntervention: Drug: Aspirin Sponsors: University of Washington; Southcentral Foundation; University of Montana; Oregon Health and Science University; National Institute of General Medical Sciences (NIGMS) Active, not recruiting Thu, 02 Jul 2020 12:00:00 EDT Study of Biochemical Markers to Determine the Acetylsalicylic Acid Chemopreventive Effect Through Antiplatelet ActionCondition: Healthy VolunteersIntervention: Drug: Acetylsalicylic acid Sponsor: Aragon Institute of Health Sciences Completed Wed, 12 Feb 2014 12:00:00 EST Maintenance of an Antiaggregation by Acetylsalicylic Acid, While a Extracorporeal Lithotripsy Session on a Kidney Stone is Perfomed: Comparative Unicentric Prospective StudyConditions: Renal Lithiasis; Antiplatelet; HematomaIntervention: Other: acetylsalicylic acid (below or equal to) 250 mg Sponsor: University Hospital, Clermont-Ferrand Recruiting Mon, 19 Feb 2018 12:00:00 EST Modified-release Dipyridamole/Aspirin (200mg/25mg bd) Versus Aspirin (75mg) in Aspirin-resistant PatientsCondition: Coronary ArteriosclerosisInterventions: Drug: modified-release dipyridamole/aspirin; Drug: aspirin Sponsor: Boehringer Ingelheim Completed Thu, 11 Aug 2005 12:00:00 EDT Induction of Gut Permeability by an Oral VaccineConditions: Intestinal Permeability; Inflammation; Vaccine; Typhoid FeverInterventions: Biological: Vivotif Typhoid Oral Vaccine; Drug: Aspirin (Positive Control) Sponsor: USDA, Western Human Nutrition Research Center Recruiting Tue, 10 Sep 2019 12:00:00 EDT Efficacy and Safety of Acetaminophen, Aspirin and Caffeine With Sumatriptan in the Acute Treatment of MigraineCondition: Pain, MigraineInterventions: Drug: Aspirin, acetaminophen and caffeine; Drug: Sumatriptan; Drug: Placebo Sponsor: Novartis Completed Thu, 25 Nov 2010 12:00:00 EST Role of Anti-platelet in Treatment of Acute Ischemic StrokeCondition: StrokeIntervention: Drug: Aspirin Sponsor: Assiut University Unknown status Wed, 30 Aug 2017 12:00:00 EDT Ticagrelor Versus Clopidogrel in Type 2 Diabetic PatientsConditions: Type-2 Diabetes Mellitus; Coronary Artery DiseaseInterventions: Drug: Ticagrelor + Aspirin; Drug: Clopidogrel + Aspirin Sponsors: Juan J Badimon; AstraZeneca Completed Thu, 04 Apr 2013 12:00:00 EDT
Preventive Application of GnRH Antagonist on Early OHSSConditions: Ovarian Hyperstimulation Syndrome; GnRH Antagonist; Aspirin; Vascular Endothelial Growth Factor; Pigment Epithelium Derived FactorInterventions: Drug: GnRH antagonist; Drug: aspirin Sponsor: First Affiliated Hospital, Sun Yat-Sen University Unknown status Thu, 15 Jun 2017 12:00:00 EDT Study Evaluating the Effect on Gastroduodenal Mucosa of PA32540, PA32540 and Celecoxib, and Aspirin With CelecoxibCondition: HealthyInterventions: Drug: PA32540; Drug: PA32540 and celecoxib; Drug: aspirin and [NSAID] Sponsor: POZEN Completed Thu, 19 Jun 2008 12:00:00 EDT Improving Aspirin Use in Diabetes: A Cluster Randomized TrialCondition: Diabetes MellitusInterventions: Behavioral: Electronic prompt plus patient-directed intervention; Behavioral: Electronic prompt to clinician to prescribe aspirin Sponsor: Northwestern University Completed Wed, 07 Dec 2005 12:00:00 EST Trial to Assess the Efficacy of Combination Formula of Aspirin Plus Clopidogrel in Patients With Coronary StentCondition: ANEURYSM CORONARY ARTERYInterventions: Drug: Clopirin 1; Drug: Clopidogrel-Aspirin(co-administration) 1; Drug: Clopirin 2; Drug: Clopidogrel-Aspirin(co-administration) 2 Sponsor: Jeil Pharmaceutical Co., Ltd. Completed Tue, 07 Apr 2015 12:00:00 EDT Evaluation of the Efficacy of Low-dose Acetylsalicylic Acid on Diarrhea Induced by Anti-cancer Targeted Therapies.Condition: CancerInterventions: Drug: Acetylsalicylic acid + loperamide; Drug: diosmectite + loperamide Sponsors: Centre Francois Baclesse; Ligue contre le cancer, France; Canceropôle Nord Ouest Withdrawn Tue, 23 Dec 2014 12:00:00 EST To Evaluate Whether Acetyl Salicylic Acid (Aspirin) and Darexaban (YM150) Interact in Their EffectsConditions: Pharmacodynamic and Pharmacokinetic Interaction; Healthy SubjectsInterventions: Drug: Darexaban; Drug: Acetyl Salicylic Acid (ASA) Sponsor: Astellas Pharma Inc Completed Mon, 29 Aug 2011 12:00:00 EDT The Clopidogrel and Aspirin After Surgery for Coronary Artery DiseaseCondition: AtherosclerosisInterventions: Drug: clopidogrel and aspirin; Drug: aspirin Sponsor: China National Center for Cardiovascular Diseases Unknown status Tue, 21 Oct 2008 12:00:00 EDT Clinical Assessment, Neuroimaging and Immunomarkers in Chagas Disease Study (CLINICS)Condition: Chagas Disease With Heart FailureIntervention: Drug: Aspirin Sponsors: Federal University of Bahia; National Institutes of Health (NIH); National Institute of Neurological Disorders and Stroke (NINDS) Recruiting Thu, 26 Jul 2012 12:00:00 EDT The Effects of Physical Training, ASA (Aspirin), and Clopidogrel on the Walking Capacity of Patients With Stage II Peripheral Arterial Disease (PAD)Condition: Peripheral Arterial DiseaseInterventions: Drug: Aspirin; Drug: Clopidogrel Sponsor: Arteriogenesis Competence Network Completed Mon, 19 Sep 2005 12:00:00 EDT Preoperative Aspirin and Postoperative Antiplatelets in Coronary Artery Bypass Grafting: The PAPA CABG StudyConditions: Coronary Artery Disease; Coronary Artery Bypass GraftingInterventions: Drug: Aspirin; Drug: Clopidogrel Sponsors: Hamilton Health Sciences Corporation; Bristol-Myers Squibb Completed Mon, 29 May 2006 12:00:00 EDT
Comparative Effects of Aspirin and NHP-544CCondition: HealthyInterventions: Drug: Bradykinin; Drug: Aspirin 81 mg; Drug: Aspirin 162 mg; Drug: NHP544-C 81 mg; Drug: NHP544C 162 mg; Drug: Placebo Sponsor: Vanderbilt University Completed Mon, 14 Jul 2014 12:00:00 EDT Patent Foramen Ovale in Cryptogenic Stroke StudyConditions: Ischemic Stroke; Patent Foramen OvaleInterventions: Drug: Warfarin; Drug: Aspirin Sponsors: Columbia University; National Institute of Neurological Disorders and Stroke (NINDS) Completed Fri, 13 Jun 2008 12:00:00 EDT The Effects of DHA on PeriodontitisConditions: Periodontitis; Gingivitis; InflammationInterventions: Drug: Aspirin; Drug: Docosahexaenoic acid; Drug: Placebo (for Docosahexaenoic acid) Sponsors: Beth Israel Deaconess Medical Center; National Center for Research Resources (NCRR); Harvard Medical School Completed Wed, 06 Nov 2013 12:00:00 EST DOACs for Stroke Prevention Post Ventricular Tachycardia AblationConditions: Ventricular Tachycardia; Premature Ventricular Contraction; StrokeInterventions: Drug: DOAC; Drug: Aspirin Sponsors: Kansas City Heart Rhythm Institute; Kansas City Heart Rhythm Research Foundation Completed Thu, 28 Jan 2016 12:00:00 EST JASAP: Japanese Aggrenox Stroke Prevention vs. Aspirin ProgrammeCondition: Cerebrovascular AccidentInterventions: Drug: Aggrenox capsule; Other: Acetylsalicylic Acid (ASA) Sponsor: Boehringer Ingelheim Completed Thu, 06 Apr 2006 12:00:00 EDT Effect of Aspirin Pretreatment or Slow Dose Titration on Flushing and Gastrointestinal Events in Healthy Volunteers Receiving Delayed-release Dimethyl FumarateCondition: HealthyInterventions: Drug: BG00012 (dimethyl fumarate); Drug: BG00012 placebo; Drug: ASA; Drug: ASA placebo Sponsor: Biogen Completed Mon, 02 Apr 2012 12:00:00 EDT Edoxaban in Patients With Coronary Artery Disease on Dual Antiplatelet Therapy With Aspirin and ClopidogrelCondition: Coronary Artery DiseaseInterventions: Drug: Edoxaban 60 mg; Drug: Edoxaban 30 mg; Drug: Clopidogrel 75 mg; Drug: Aspirin 81 mg Sponsors: University of Florida; Daiichi Sankyo, Inc. Completed Mon, 05 Oct 2015 12:00:00 EDT Dual Antiplatelet Therapy in Patients With Aspirin Resistance Following Coronary Artery Bypass GraftingConditions: Coronary Artery Disease; Aspirin ResistanceIntervention: Drug: Clopidogrel Sponsor: University of Zagreb Completed Fri, 09 Jul 2010 12:00:00 EDT Short vs Long Duration Dual Antiplatelet Therapy in Patients Undergoing Lower Extremity Endovascular RevascularizationConditions: Peripheral Arterial Disease; Endovascular ProceduresInterventions: Drug: Aspirin; Drug: Clopidogrel Sponsor: University Hospitals Cleveland Medical Center Withdrawn Tue, 05 May 2015 12:00:00 EDT Asprin Dosing Estimator in Healthy AdultsCondition: Aspirin SensitivityIntervention: Drug: Aspirin Sponsors: University of Utah; University of Colorado, Denver Recruiting Wed, 31 Jul 2019 12:00:00 EDT
COMbination of Clopidogrel and Aspirin for Prevention of Early REcurrence in Acute Atherothrombotic StrokeCondition: StrokeInterventions: Drug: Clopidogrel; Drug: Clopidogrel placebo; Drug: Aspirin Sponsors: Sanofi; Bristol-Myers Squibb Completed Wed, 24 Dec 2008 12:00:00 EST Assessing Feasibility of Thromboprophylaxis With Apixaban in JAK2-positive Myeloproliferative Neoplasm PatientsConditions: Myeloproliferative Neoplasm; Essential Thrombocythemia; JAK2 Mutation; Polycythemia Vera; Primary Myelofibrosis; Venous ThromboembolismInterventions: Drug: Apixaban 2.5 MG Oral Tablet [ELIQUIS]; Drug: Aspirin 81 mg Sponsors: Ottawa Hospital Research Institute; Canadian Venous Thromboembolism Clinical Trials and Outcomes Research (CanVECTOR) Network; the Association médicale universitaire de l'Hôpital Montfort (AMUHM); Canadian Society of Hematology Recruiting Tue, 28 Jan 2020 12:00:00 EST Efficacy and Tolerability of Clopidogrel Resinate and Clopidogrel Bisulfate in Patients With Coronary Heart Disease (CHD) or CHD EquivalentsCondition: Coronary Heart DiseaseInterventions: Drug: aspirin + pregrel (Clopidogrel resinate); Drug: aspirin + placebo; Drug: aspirin + plavix (Clopidogrel bisulfate) Sponsors: Seoul National University Hospital; CKD Pharmaceutical Limited Completed Tue, 28 Jul 2009 12:00:00 EDT Low Dose Chemotherapy With Aspirin in Patients With Breast Cancer After Neoadjuvant ChemotherapyCondition: Breast CancerIntervention: Drug: Cyclophosphamide and Methotrexate and Aspirin Sponsors: University of Vermont; Maimonides Medical Center; Dartmouth-Hitchcock Medical Center Unknown status Tue, 05 Jun 2012 12:00:00 EDT ShorT and OPtimal Duration of Dual AntiPlatelet Therapy-3 StudyCondition: Acute Coronary SyndromeInterventions: Drug: No aspirin; Drug: 1-month DAPT Sponsor: Kyoto University, Graduate School of Medicine Recruiting Fri, 30 Oct 2020 12:00:00 EDT 3-Month Discontinuation of Dual Antiplatelet Therapy After Ultimaster Sirolimus-Eluting Stent ImplantationCondition: Coronary Artery DiseaseInterventions: Drug: Aspirin; Drug: Thienopyridine Sponsor: Teikyo University Unknown status Tue, 19 Jul 2016 12:00:00 EDT Anti-Inflammatory and Anti-Platelet Effect of Clopidogrel and Aspirin vs Aspirin Alone in Symptomatic Polyvascular Disease and in Patients With Multiple Recurrent Cardiovascular EventsConditions: Polyvascular Disease; Cardiovascular DiseaseInterventions: Drug: aspirin; Drug: clopidogrel; Drug: clopidogrel plus aspirin Sponsor: Catholic University of the Sacred Heart Unknown status Mon, 20 Oct 2008 12:00:00 EDT Efficacy and Safety Clinical Trial of the Combination of Acetylsalicylic Acid, Sodium Bicarbonate and Citric Acid, Produced by Geolab Pharmaceutical Industries Ltd., Compared to Acetylsalicylic Acid (Aspirin ® - Bayer) in Patients With Episodic Tension-type Headache.Condition: Treatment of Episodic Tension HeadacheInterventions: Drug: Association: acetylsalicylic acid (500mg), sodium bicarbonate (1625) and citric acid (965); Drug: Aspirin - Bayer Sponsor: Azidus Brasil Unknown status Fri, 13 Nov 2009 12:00:00 EST Pilot Study to Examine the Use of Rivaroxaban After Angioplasty for Critical Limb IschemiaCondition: Critical Limb IschemiaInterventions: Drug: rivaroxaban plus aspirin; Drug: clopidogrel plus aspirin Sponsors: Ottawa Hospital Research Institute; The Ottawa Hospital Completed Thu, 09 Oct 2014 12:00:00 EDT Esomeprazole Magnesium With or Without Aspirin in Preventing Esophageal Cancer in Patients With Barrett EsophagusConditions: Barrett Esophagus; Esophageal CancerInterventions: Drug: acetylsalicylic acid; Drug: esomeprazole magnesium; Other: placebo Sponsor: National Cancer Institute (NCI) Completed Thu, 17 May 2007 12:00:00 EDT
Comparison of Awakening Versus Bedtime Dosing of Aspirin in Pre-Hypertension or Mild Essential HypertensionConditions: High-Normal Blood Pressure; Mild Essential HypertensionInterventions: Drug: Aspirin 100 mg; Device: Ambulatory blood pressure monitoring; Procedure: Chronotherapy, timing of medication; Drug: Placebo Sponsors: University of Vigo; Hospital Clinico Universitario de Santiago; Bayer Terminated Tue, 20 Mar 2007 12:00:00 EDT Platelet Function and Safety After IV and Oral Diclofenac, IV Ketorolac and Oral Aspirin in Adult VolunteersCondition: HealthyInterventions: Drug: intravenous diclofenac sodium (DIC075V); Drug: ketorolac; Drug: oral diclofenac (Cataflam); Drug: aspirin Sponsor: Javelin Pharmaceuticals Completed Wed, 24 Oct 2007 12:00:00 EDT Antiplatelet Therapy in HIVConditions: HIV; Cardiovascular Diseases; InflammationInterventions: Drug: Aspirin; Drug: Clopidogrel Sponsor: NYU Langone Health Completed Thu, 24 Sep 2015 12:00:00 EDT Reproducibility and Comparison of Platelet Function Assays With Aspirin and Clopidogrel (MK-0000-167)Condition: Healthy VolunteersInterventions: Drug: Placebo (to match Aspirin); Drug: Aspirin; Drug: Clopidogrel; Drug: Comparator: Placebo (to match Clopidogrel) Sponsor: Merck Sharp & Dohme Corp. Completed Thu, 22 Apr 2010 12:00:00 EDT DAILY: Vitamin D, Aspirin, ExercIse, Low Saturated Fat Foods StudY in Colorectal Cancer Patients With Minimal Residual DiseaseConditions: Colorectal Cancer; Colon CancerInterventions: Drug: Aspirin; Drug: Vitamin D; Dietary Supplement: Diet; Other: Physical Activity; Behavioral: Behavioral Support Counseling Sessions Sponsor: M.D. Anderson Cancer Center Not yet recruiting Sun, 05 Sep 2021 12:00:00 EDT A Study of the Onset and Offset of Antiplatelet Effects Comparing Ticagrelor, Clopidogrel, and Placebo With AspirinCondition: Coronary Artery DiseaseInterventions: Drug: Ticagrelor Tablets; Drug: Clopidogrel (over encapsulated) capsule; Drug: Aspirin Tablets Sponsor: AstraZeneca Completed Wed, 12 Sep 2007 12:00:00 EDT [SOCRATES -Acute Stroke Or Transient IsChaemic Attack TReated With Aspirin or Ticagrelor and Patient OutcomES]Conditions: Acute Ischaemic Stroke; Transient Ischaemic AttackInterventions: Drug: ticagrelor; Drug: Acetylsalicylic acid (ASA) Sponsor: AstraZeneca Completed Tue, 26 Nov 2013 12:00:00 EST A Safety Trial to Compare Different Analgesics in Combination With Low Dose Aspirin to Study Their Bleeding Properties and Their Effects on the StomachCondition: AnalgesicsIntervention: Drug: aspirin, acetaminophen, ibuprofen, naproxen, celecoxib, rofecoxib Sponsor: Johnson & Johnson Consumer and Personal Products Worldwide Completed Mon, 05 Dec 2005 12:00:00 EST Women's Health Study (WHS): A Randomized Trial of Low-dose Aspirin and Vitamin E in the Primary Prevention of Cardiovascular Disease and CancerConditions: Cardiovascular Diseases; Cerebrovascular Disorders; Coronary Disease; Heart Diseases; Myocardial Infarction; Myocardial Ischemia; Vascular DiseasesInterventions: Drug: Aspirin; Drug: Vitamin E; Behavioral: Placebo Sponsors: Brigham and Women's Hospital; National Cancer Institute (NCI); National Heart, Lung, and Blood Institute (NHLBI) Completed Thu, 28 Oct 1999 12:00:00 EDT Randomized Study of Beta-Blockers and Antiplatelets in Patients With Spontaneous Coronary Artery DissectionCondition: Spontaneous Coronary Artery DissectionIntervention: Drug: Beta blocker, aspirin, clopidogrel Sponsors: Spanish Society of Cardiology; Instituto de Investigación Sanitaria Hospital Universitario de la Princesa; Fundación de Investigación Biomédica - Hospital Universitario de La Princesa Not yet recruiting Tue, 20 Apr 2021 12:00:00 EDT
the Efficacy and Safety of Indobufen and Low-dose Aspirin in Different Regimens of Antiplatelet TherapyCondition: Coronary AtherosclerosisInterventions: Drug: aspirin 100mg/d therapy; Drug: aspirin 100mg/2d therapy; Drug: aspirin 100mg/3d therapy; Drug: aspirin 50mg bid therapy; Drug: aspirin 75mg/d therapy; Drug: aspirin 50mg/d therapy; Drug: indobufen 100mg bid therapy Sponsor: The First Affiliated Hospital with Nanjing Medical University Unknown status Thu, 27 Jul 2017 12:00:00 EDT Anticoagulation in ICH Survivors for Stroke Prevention and RecoveryConditions: Intracerebral Hemorrhage; Atrial FibrillationInterventions: Drug: Apixaban; Drug: Aspirin Sponsors: Yale University; National Institute of Neurological Disorders and Stroke (NINDS) Recruiting Mon, 08 Apr 2019 12:00:00 EDT Effect of Cilostazol on Carotid Atherosclerosis Estimated by 3D Ultrasound in Patients With Type 2 DiabetesConditions: Type 2 Diabetes Mellitus; Carotid AtherosclerosisInterventions: Drug: Cilostazol; Drug: Aspirin Sponsor: Seoul National University Bundang Hospital Completed Mon, 14 Aug 2017 12:00:00 EDT Comparative Bioavailability Study of Two Test Products of Fixed Dose Combination Capsule of ASA (Acetylsalicylic Acid) and Pantoprazole (Each Capsule Contains ASA 100 mg and Pantoprazole 20 mg) Under Fasting ConditionsCondition: Ulcers, Duodenal and GastricInterventions: Drug: Test 1= ASA 100 mg and pantoprazole 20 mg capsule formulation one; Drug: Test 2= ASA 100 mg and pantoprazole 20 mg capsule formulation two; Drug: ASA 100 mg tablet; Drug: Pantoprazole 20 mg gastro-resistant tablet Sponsors: GlaxoSmithKline; Piramal Clinical Research (Hyderabad, India) Completed Mon, 06 May 2013 12:00:00 EDT Study to Evaluate the EFFECTS of Acetylsalicylic Acid (ASA) on Niaspan®-Induced Flushing in Subjects With DyslipidemiaCondition: DyslipidemiaInterventions: Drug: niacin extended-release (NER); Drug: aspirin (ASA); Drug: aspirin placebo (ASA Pbo) Sponsor: Abbott Completed Fri, 29 Feb 2008 12:00:00 EST A Randomized, 2x2 Factorial Design Biomarker Prevention Trial of Low-dose Aspirin and Metformin in Stage I-III Colorectal Cancer Patients.Condition: Tertiary Prevention in Colon CancerInterventions: Drug: Aspirin (ASA) + Metformin (MET); Drug: ASA; Drug: MET; Drug: Placebos Sponsor: Ente Ospedaliero Ospedali Galliera Unknown status Thu, 09 Feb 2017 12:00:00 EST Study Comparing Esomeprazole and Acetylsalicylic Acid (ASA) Combined Together as One Capsule Versus These Medications Taken SeparatelyCondition: Peptic Ulcer DiseaseInterventions: Drug: Esomeprazole/ASA Fixed Combination; Drug: Esomeprazole - Nexium; Drug: ASA Sponsor: AstraZeneca Completed Tue, 20 Oct 2009 12:00:00 EDT Enhanced Firefighter Rehab Trial: The Role of Aspirin in Preventing Heat Stress Induced Platelet ActivationCondition: Heat Stress DisordersInterventions: Drug: Daily aspirin (ASA); Other: Active cooling; Drug: Acute aspirin (ASA); Other: Passive cooling; Drug: Daily placebo; Drug: Acute placebo Sponsors: Dave Hostler; Federal Emergency Management Administration; Eyemarker Systems, Inc Completed Wed, 10 Feb 2010 12:00:00 EST The International Polycap Study 3 (TIPS-3)Conditions: Cardiovascular Disease; Fractures; CancersInterventions: Drug: Polycap; Drug: Aspirin; Drug: Vitamin D; Drug: Matching Placebo Sponsors: Population Health Research Institute; Cadila Pharnmaceuticals; Wellcome Trust; Canadian Institutes of Health Research (CIHR); Heart and Stroke Foundation of Ontario Completed Fri, 20 Jul 2012 12:00:00 EDT Topical Analgesic Versus Saline Mouth Rinses in Post Extraction HealingCondition: Tooth Extraction Site HealingInterventions: Drug: Aspirin Powder; Drug: Normal saline Sponsor: Aga Khan University Completed Wed, 26 Apr 2017 12:00:00 EDT
Efficacy and Safety of Cilostazol in Patients of Vascular Cognitive Impairment-no Dementia (VCIND)Condition: Mild Cognitive ImpairmentInterventions: Drug: Aspirin; Drug: Cilostazol Sponsor: Huashan Hospital Unknown status Fri, 07 Jun 2013 12:00:00 EDT Primary Thrombocythaemia 1 TrialConditions: Thrombocythemia; Myeloproliferative DisorderInterventions: Drug: Hydroxyurea; Drug: Aspirin Sponsors: University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Institute of Cancer Research, United Kingdom Completed Thu, 15 Sep 2005 12:00:00 EDT Patent Foramen Ovale (PFO) Closure at the Time of Endovascular Cardiac Electronic Device ImplantationCondition: Foramen Ovale, PatentInterventions: Drug: Aspirin; Device: Cardiovascular Implantable Device (CIED); Device: Gore Cardioform Septal Occluder Sponsor: Mayo Clinic Withdrawn Fri, 28 Jul 2017 12:00:00 EDT Dipyridamole Assessment for Flare Reduction in Systemic Lupus Erythematosus (SLE)Condition: Systemic Lupus ErythematosusInterventions: Drug: extended release dipyridamole 200mg/aspirin 25mg; Drug: 81mg aspirin Sponsor: Oklahoma Medical Research Foundation Terminated Fri, 01 Feb 2013 12:00:00 EST Post-marketing Study of Cilostazol (Cilostazol Stroke Prevention Study 2)Condition: Cerebral InfarctionInterventions: Drug: Cilostazol; Drug: Aspirin Sponsor: Otsuka Pharmaceutical Co., Ltd. Completed Thu, 06 Oct 2005 12:00:00 EDT Measurement of Platelet Dense Granule Release in Healthy VolunteersCondition: Platelet AggregationIntervention: Drug: Aspirin Sponsor: Vanderbilt University Withdrawn Tue, 21 Jul 2009 12:00:00 EDT A Study of the Effects of Inhibiting Platelet Function on Circulating Cancer Cells in Breast Cancer PatientsCondition: Breast NeoplasmsInterventions: Drug: Plavix; Drug: Aspirin Sponsors: Washington University School of Medicine; Barnes-Jewish Hospital Terminated Wed, 07 Dec 2005 12:00:00 EST Efficacy of a Single Dose of Aspirin vs. Acetaminophen in Tension Type HeadacheCondition: HeadacheInterventions: Drug: Acetylsalicylic acid (Aspirin, BAY1019036); Drug: Acetaminophen; Drug: Placebo Sponsor: Bayer Terminated Tue, 13 Mar 2012 12:00:00 EDT A Different Approach to Preventing ThrombosisConditions: Venous Thromboembolism; Pulmonary EmbolismInterventions: Drug: VTE prophylaxis with Enoxaparin 30mg BID; Drug: VTE prophylaxis with Aspirin 81mg BID Sponsor: University of Maryland, Baltimore Completed Tue, 17 May 2016 12:00:00 EDT Comparison of Topical Analgesic With Saline Rinses in Post Extraction HealingConditions: Periodontitis; Dental Caries; HypertensionInterventions: Drug: analgesic mouth rinses (dissolved Aspirin); Drug: Normal saline rinses. Sponsor: Aga Khan University Completed Mon, 03 Oct 2016 12:00:00 EDT
Efficacy of Clopidogrel on Incidence of Silent Brain InfarctionCondition: Silent Brain InfarctionInterventions: Drug: Clopidogrel treatment; Drug: Aspirin treatment Sponsor: VA Office of Research and Development Not yet recruiting Wed, 06 Jan 2021 12:00:00 EST MonotherApy of Low-does TicagrElor After Percutaneous Coronary InterventionConditions: Acute Coronary Syndrome; Percutaneous Coronary Intervention; High Bleeding RiskInterventions: Drug: Standard-Does Ticagrelor plus aspirin; Drug: Low-Does Ticagrelor monotherapy Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University Not yet recruiting Thu, 24 Jun 2021 12:00:00 EDT STRATAGEM: Strategy for Managing Antiplatelet Therapy in the Perioperative Period of Non Coronary SurgeryCondition: ThrombosisIntervention: Drug: aspirin 75 mg/day Sponsors: Assistance Publique - Hôpitaux de Paris; Sanofi-Synthelabo Completed Mon, 19 Sep 2005 12:00:00 EDT Aspirin-Myocardial Infarction Study (AMIS)Conditions: Cardiovascular Diseases; Coronary Disease; Heart Diseases; Myocardial Infarction; Myocardial IschemiaIntervention: Drug: aspirin Sponsor: National Heart, Lung, and Blood Institute (NHLBI) Completed Thu, 28 Oct 1999 12:00:00 EDT Aspirin Responsiveness in Women With Coronary Artery DiseaseCondition: CADIntervention: Sponsor: Creighton University Completed Mon, 01 Aug 2011 12:00:00 EDT Study to Assess the Bioequivalence Between D961S and Esomeprazole/Buffered Acetylsalicylic Acid (ASA) in Japanese Healthy Male SubjectsCondition: Bioequivalence StudyInterventions: Drug: D961S; Drug: Esomeprazole; Drug: Buffered acetylsalicylic acid Sponsor: AstraZeneca Completed Mon, 19 Dec 2011 12:00:00 EST Comparison Between P2Y12 Antagonist Monotherapy and Dual Antiplatelet Therapy After DESCondition: Coronary Artery DiseaseInterventions: Drug: P2Y12 antagonist monotherapy; Drug: aspirin plus P2Y12 antagonist Sponsor: Samsung Medical Center Unknown status Wed, 05 Mar 2014 12:00:00 EST Triple Antiplatelets for Reducing Dependency After Ischaemic StrokeCondition: StrokeIntervention: Drug: Aspirin, Dipyradimole, Clopidogrel Sponsor: University of Nottingham Terminated Thu, 09 Aug 2012 12:00:00 EDT Pharmacodynamic and Pharmacokinetic Study of PL-ASACondition: Healthy VolunteersIntervention: Drug: PL-ASA Sponsor: PLx Pharma Active, not recruiting Tue, 23 Mar 2021 12:00:00 EDT Study of Platelet Function After Administration of Aspirin Versus Lysine AcetylsalicylateCondition: Adverse Effect of Antithrombotic DrugsInterventions: Drug: acetylsalicylic acid; Drug: prasugrel; Drug: lysine acetylsalicylate Sponsors: David Vivas; St Carlos Hospital, Madrid, Spain Completed Wed, 17 Sep 2014 12:00:00 EDT
Placebo and Active Controlled, Double Dummy Study to Prove Efficacy of Aspirin in Treatment of Acute Low Back PainCondition: Low Back PainInterventions: Drug: Acetylsalicylic Acid (Aspirin, BAYE4465); Drug: Ibuprofen; Drug: Placebo Sponsor: Bayer Completed Wed, 09 Dec 2009 12:00:00 EST Hemostasis in COVID-19: an Adaptive Clinical TrialCondition: COVID-19Interventions: Drug: acetylsalicylic acid; Drug: Unfractionated heparin nebulized Sponsor: University of Sao Paulo General Hospital Recruiting Fri, 10 Jul 2020 12:00:00 EDT TENecteplase in Central Retinal Artery Occlusion Stuy (TenCRAOS)Condition: Central Retinal Artery OcclusionInterventions: Drug: Intravenous injection of Tenecteplase and one dose of placebo tablet; Drug: One tablet of Acetylsalicylic Acid and one dose of IV placebo Sponsor: Oslo University Hospital Recruiting Wed, 26 Aug 2020 12:00:00 EDT Establishment and Evaluation to the Effects of a Clinical Pathway for Acute Ischemic StrokeCondition: Acute Ischemic StrokeIntervention: Drug: aspirin，chinese herbs； Sponsor: Guangzhou University of Traditional Chinese Medicine Completed Wed, 26 Aug 2009 12:00:00 EDT Nobori Dual Antiplatelet Therapy as Appropriate DurationCondition: Coronary Artery DiseaseInterventions: Drug: Aspirin or thienopyridine; Drug: Aspirin and thienopyridine Sponsor: Associations for Establishment of Evidence in Interventions Completed Mon, 23 Jan 2012 12:00:00 EST A Study to Examine the Effectiveness of Aspirin and/or Vitamin D3 to Prevent Prostate Cancer ProgressionCondition: Prostate CancerInterventions: Drug: High dose Aspirin & Vitamin D; Drug: High dose Aspirin, Vitamin D placebo; Drug: Low dose Aspirin , Vitamin D; Drug: Low dose Aspirin, Vitamin D placebo; Drug: Aspirin Placebo, Vitamin D; Drug: Aspirin placebo, Vitamin D placebo Sponsors: Queen Mary University of London; Barts and the London School of Medicine and Dentistry; Cancer Research UK Completed Thu, 06 Apr 2017 12:00:00 EDT The Effect and Safety of Different Intensity Anticoagulation Therapy in Elderly Patients With Non-valvular Atrial FibrillationCondition: Atrial FibrillationInterventions: Drug: Warfarin; Drug: aspirin Sponsor: Nanjing Medical University Completed Thu, 22 Sep 2011 12:00:00 EDT Randomized Trial of Aspirin and Cataracts in U.S. PhysiciansCondition: CataractIntervention: Drug: Aspirin Sponsor: National Eye Institute (NEI) Terminated Fri, 24 Sep 1999 12:00:00 EDT Apixaban for the Reduction of Thrombo-Embolism in Patients With Device-Detected Sub-Clinical Atrial FibrillationConditions: Atrial Fibrillation; StrokeInterventions: Drug: Apixaban; Drug: aspirin Sponsors: Population Health Research Institute; Bristol-Myers Squibb; Pfizer; Medtronic; Canadian Institutes of Health Research (CIHR) Active, not recruiting Tue, 10 Sep 2013 12:00:00 EDT A Phase III, Randomized, Study of Aspirin and Esomeprazole Chemoprevention in Barrett's MetaplasiaConditions: Esophageal Cancer; Precancerous ConditionInterventions: Drug: Esomeprazole; Drug: Aspirin Sponsors: University of Oxford; AstraZeneca Unknown status Thu, 27 Jul 2006 12:00:00 EDT
Prospects for the Prevention of Pregnancy-induced Hypertension and Preeclampsia TrialCondition: Pregnancy Induced HypertensionInterventions: Drug: Combined aspirin and multinutrient supplement; Other: Daily text reminder text messages Sponsors: UMC Utrecht; Ghana Health Services; University of Ghana Unknown status Wed, 11 Dec 2013 12:00:00 EST Aggrenox To Treat Acute Covid-19Condition: Covid19Interventions: Drug: Dipyridamole ER 200mg/ Aspirin 25mg orally/enterally AND Standard of care; Other: Standard of care Sponsors: Rutgers, The State University of New Jersey; Boehringer Ingelheim Recruiting Mon, 01 Jun 2020 12:00:00 EDT Apixaban, Warfarin and Aspirin Prevents Portal Vein Thrombosis in Patients After Laparoscopic Splenectomy（ESAWAAPT）Conditions: Cirrhosis; Splenectomy; Status; Venous Thrombosis; Hypertension, PortalInterventions: Drug: Apixaban; Drug: Warfarin; Drug: Aspirin; Drug: Dipyridamole; Drug: Low molecular weight heparin Sponsor: Yangzhou University Recruiting Fri, 27 Nov 2020 12:00:00 EST A Study of Aleglitazar in Combination With Aspirin in Healthy VolunteersCondition: Healthy VolunteerInterventions: Drug: aleglitazar; Drug: aspirin; Drug: placebo Sponsor: Hoffmann-La Roche Completed Wed, 25 Aug 2010 12:00:00 EDT Korean Multicenter Randomized Controlled Trial (RCT) of Pidogul for Patients With Coronary StentingCondition: Coronary Artery DiseaseInterventions: Drug: clopidogrel napadisilate + aspirin; Drug: clopidogrel bisulfate + aspirin Sponsors: Seoul National University Hospital; Hanmi Pharmaceutical co., ltd. Completed Wed, 25 Apr 2012 12:00:00 EDT Linezolid, Aspirin and Enhanced Dose Rifampicin in HIV-TBMConditions: Tuberculosis Meningitis; HIV-1-infectionInterventions: Drug: Linezolid; Drug: High dose rifampicin; Drug: Aspirin; Drug: Standard of Care anti-tuberculous therapy; Drug: Dexamethasone Sponsor: University of Cape Town Completed Thu, 25 Apr 2019 12:00:00 EDT Rivaroxaban Plus Aspirin in Patients With Chronic Coronary Syndrome and High Ischemic RiskConditions: Coronary Artery Disease (CAD); Peripheral Arterial Disease (PAD)Intervention: Drug: Rivaroxaban 2.5 MG [Xarelto] Sponsors: Maatschap Cardiologie Zwolle; Diagram B.V. Recruiting Mon, 15 Feb 2021 12:00:00 EST Aspirin and Statins for Prevention of Atherosclerosis and Arterial Thromboembolism in Systemic Lupus ErythematosusConditions: Atherosclerosis; Thromboembolism; Systemic Lupus ErythematosusInterventions: Drug: Rosuvastatin; Drug: placebo; Drug: aspirin Sponsors: Tuen Mun Hospital; AstraZeneca Completed Mon, 04 Sep 2006 12:00:00 EDT The Effect of Omega 3 on Pregnancy Complicated by Asymmetrical Intrauterine Growth RestrictionCondition: Intrauterine Growth RestrictionInterventions: Drug: Low dose aspirin; Drug: Omega 3 Sponsor: Assiut University Completed Wed, 02 Mar 2016 12:00:00 EST 3 Months Versus 12 Months Dual Antiplatelet Therapy After Drug-eluting Stent Implantation in STEMICondition: ST Elevation Myocardial InfarctionInterventions: Drug: ticagrelor monotherapy; Drug: Aspirin with P2Y12 receptor inhibitor Sponsor: Dong-A University Recruiting Wed, 30 Sep 2020 12:00:00 EDT
Edoxaban in Peripheral Arterial DiseaseCondition: Peripheral Arterial DiseaseInterventions: Drug: edoxaban; Drug: Clopidogrel; Drug: Aspirin Sponsors: Daiichi Sankyo, Inc.; UMC Utrecht Completed Fri, 01 Mar 2013 12:00:00 EST Characteristics of Patients Diagnosed With NSAID Sensitivity in ThailandConditions: Aspirin Sensitivity; Aspirin-exacerbated Respiratory Disease; Aspirin-Induced Angioedema-Urticaria; Aspirin Allergy; NSAID-Induced Asthma; NSAID-Induced Angioedema-Urticaria; NSAID-Induced Anaphylactoid Reaction; Aspirin-Induced Anaphylactoid ReactionIntervention: Drug: aspirin, NSAIDs, paracetamol Sponsor: Chulalongkorn University Unknown status Thu, 21 Feb 2019 12:00:00 EST Preventing the Inflammatory Response to Experimentally-induced Insomnia SymptomsCondition: InsomniaInterventions: Drug: Aspirin; Drug: Placebo Sponsor: Beth Israel Deaconess Medical Center Completed Mon, 20 Oct 2014 12:00:00 EDT Acetylsalicylic Acid and Eflornithine in Treating Patients at High Risk for Colorectal CancerCondition: Adenomatous PolypInterventions: Drug: Aspirin; Drug: Eflornithine; Other: Laboratory Biomarker Analysis; Other: Placebo; Other: Telephone-Based Intervention Sponsor: National Cancer Institute (NCI) Completed Thu, 24 Sep 2009 12:00:00 EDT Anti-platelet Effect of Berberine in Patients After Percutaneous Coronary InterventionConditions: Coronary Artery Disease; Percutaneous Coronary InterventionInterventions: Drug: Berberine; Drug: Standard treatment; Drug: Aspirin; Drug: Clopidogrel Sponsor: Peking Union Medical College Hospital Recruiting Wed, 20 Dec 2017 12:00:00 EST PGE2/IL-22 Pathway in Various Forms of EczemaCondition: EczemaIntervention: Drug: Aspirin 300mg Sponsor: NHS Lothian Not yet recruiting Mon, 21 Oct 2019 12:00:00 EDT Cardiovascular Risk in HIV Patients on Antiretroviral Therapy Therapy: The MHEART StudyConditions: Cardiovascular Disease Risk in HIV Patients; Endothelial FunctionInterventions: Drug: Aspirin; Drug: Placebo Sponsors: University of Pittsburgh; Fogarty International Center of the National Institute of Health; University of North Carolina Completed Fri, 27 Mar 2015 12:00:00 EDT Coronary Artery Disease After Heart TransplantationConditions: Coronary Artery Disease in Transplanted Heart (Diagnosis); Platelet DysfunctionInterventions: Drug: Aspirin 75mg; Other: Extracorporeal photopheresis Sponsor: Aarhus University Hospital Recruiting Wed, 11 Jul 2018 12:00:00 EDT A Study of Apixaban in Patients With Atrial Fibrillation, Not Caused by a Heart Valve Problem, Who Are at Risk for Thrombosis (Blood Clots) Due to Having Had a Recent Coronary Event, Such as a Heart Attack or a Procedure to Open the Vessels of the HeartCondition: Acute Coronary SyndromesInterventions: Drug: Apixaban; Drug: vitamin K antagonist; Drug: Acetylsalicylic acid; Other: Acetylsalicylic acid placebo Sponsors: Bristol-Myers Squibb; Pfizer; Duke Clinical Research Institute Completed Tue, 14 Apr 2015 12:00:00 EDT Effects of Pioglitazone on Platelet FunctionConditions: Diabetes; Platelet Function; HealthyInterventions: Drug: Aspirin; Drug: Pioglitazone Sponsor: University of Rochester Completed Fri, 13 Mar 2009 12:00:00 EDT
Antiplatelet Therapy in Acute Mild-Moderate Ischemic StrokeCondition: Ischemic StrokeInterventions: Drug: clopidogrel; Drug: Aspirin Sponsor: General Hospital of Shenyang Military Region Recruiting Tue, 16 Aug 2016 12:00:00 EDT Regorafenib in Combination With Metronomic Chemotherapies, and Low-dose Aspirin in Metastatic Colorectal CancerConditions: Colo-rectal Cancer; Metastatic CancerInterventions: Drug: Regorafenib; Drug: Cyclophosphamide; Drug: Capecitabine; Drug: Aspirin Sponsors: Centre Hospitalier Universitaire de Besancon; Bayer Active, not recruiting Tue, 01 Sep 2020 12:00:00 EDT Effects of ASA on Prostate TissueCondition: Prostate CancerInterventions: Drug: Aspirin; Drug: Placebo Sponsors: University of Washington; Fred Hutchinson Cancer Research Center Completed Thu, 06 Oct 2005 12:00:00 EDT Platelet Reactivity in PAD Undergoing Percutaneous AngioplastyConditions: Peripheral Artery Disease; Critical Limb Ischemia; Claudication, IntermittentIntervention: Drug: Aspirin 300mg and Clopidogrel 300mg Sponsor: Clinical Centre of Serbia Recruiting Mon, 18 Nov 2019 12:00:00 EST A Study to Evaluate the Bioequivalence (BE) and the Food Effect of TAK-438ASA TabletCondition: Healthy VolunteersInterventions: Drug: TAK-438ASA; Drug: TAK-438; Drug: Aspirin Sponsor: Takeda Completed Wed, 07 Mar 2018 12:00:00 EST Sildenafil Citrate for the Management of Asymmetrical Intrauterine Growth RestrictionCondition: Intrauterine Growth RestrictionInterventions: Drug: Sildenafil citrate; Drug: Aspirin Sponsor: Assiut University Unknown status Tue, 09 Feb 2016 12:00:00 EST Perioperative Antiplatelet Therapy in Patients With Drug-eluting Stent Undergoing Noncardiac SurgeryCondition: Antiplatelet DrugsInterventions: Drug: Aspirin only; Drug: No antiplatelet therapy Sponsors: Jung-min Ahn; CardioVascular Research Foundation, Korea Recruiting Mon, 13 Jun 2016 12:00:00 EDT Diagnosis of Aspirin Hypersensitivity in Aspirin Exacerbated Respiratory DiseaseCondition: Asthma, Aspirin-inducedIntervention: Sponsor: Montefiore Medical Center Active, not recruiting Tue, 22 Mar 2011 12:00:00 EDT Resistance to Antithrombotic TherapyConditions: Atherosclerosis; AngioplastyInterventions: Drug: aspirin; Drug: clopidogrel Sponsor: Medical University of Vienna Completed Tue, 10 Mar 2009 12:00:00 EDT Aspirin Responsiveness and Outcome in Coronary Artery Bypass Graft (CABG) SurgeryConditions: Coronary Artery Bypass Graft Triple Vessel; Myocardial Ischemia; Thrombosis; Antithrombotic Drugs [Platelet-aggregation Inhibitors] Causing Adverse Effects in Therapeutic UseIntervention: Sponsor: University Hospital, Basel, Switzerland Completed Wed, 04 Aug 2010 12:00:00 EDT
Biosynthesis of PGD2 in VivoCondition: HyperlipidemiaInterventions: Drug: Aspirin; Drug: Placebo; Drug: Niacin Sponsor: University of Pennsylvania Completed Wed, 12 Jan 2011 12:00:00 EST ASCEND: A Study of Cardiovascular Events iN DiabetesCondition: Diabetes MellitusInterventions: Drug: Aspirin; Drug: Omega-3 Ethyl Esters; Drug: Placebo Aspirin; Drug: Placebo Omega-3 Ethyl Esters Sponsors: University of Oxford; British Heart Foundation; Bayer; Medical Research Council; Solvay Pharmaceuticals; Abbott; Mylan Active, not recruiting Thu, 25 Aug 2005 12:00:00 EDT Optimization of Treatment in Patients With Severe Peripheral Ischemia (Fontaine Stage IIb)Condition: Peripheral Arterial DiseaseInterventions: Drug: iloprost; Drug: Standard Treatment (aspirin.....), Sponsor: Fadoi Foundation, Italy Completed Wed, 31 Oct 2012 12:00:00 EDT Evaluation of a Flushing ASsessment Tool (FAST) in Subjects Receiving Niacin Extended-release Plus AspirinCondition: DyslipidemiaInterventions: Drug: Niacin extended-release (NER); Drug: Niacin extended-release (NER) placebo; Drug: Aspirin (ASA); Drug: Aspirin (ASA) placebo Sponsor: Abbott Completed Fri, 07 Mar 2008 12:00:00 EST Impact of Combination of Clopidogrel With Aspirin on Postoperative Bleeding in Coronary Surgical PatientsConditions: Coronary Surgery; HemorrhageIntervention: Sponsor: Groupe Hospitalier Pitie-Salpetriere Completed Thu, 07 Oct 2010 12:00:00 EDT A Study on BMS-986177 for the Prevention of a Stroke in Patients Receiving Aspirin and ClopidogrelConditions: Acute Ischemic Stroke; Transient Ischemic Attack (TIA)Interventions: Drug: BMS-986177; Other: Placebo; Drug: Clopidogrel; Drug: Aspirin Sponsors: Bristol-Myers Squibb; Janssen, LP Recruiting Thu, 06 Dec 2018 12:00:00 EST The Carotid and Middle Cerebral Artery Occlusion Surgery StudyConditions: Carotid Artery Occlusion; Middle Cerebral Artery Occlusion; StrokeInterventions: Procedure: bypass surgery; Drug: Aspirin; Drug: Clopidogrel Sponsor: Xuanwu Hospital, Beijing Active, not recruiting Tue, 01 Jan 2013 12:00:00 EST Antiplatelet Strategy for Peripheral Arterial Interventions for Revascularization of Lower ExtremitiesCondition: Peripheral Arterial DiseaseInterventions: Drug: Clopidogrel; Drug: Acetylsalicylic acid (ASA) Sponsor: University of Texas Southwestern Medical Center Completed Fri, 15 Aug 2014 12:00:00 EDT Investigation of Platelet Function and Aspirin Resistance in Chronic Dialysis PatientCondition: End Stage Renal DiseaseIntervention: Sponsor: National Taiwan University Hospital Unknown status Mon, 11 Jan 2010 12:00:00 EST Optimized Antiplatelet Therapy on the Prognosis of ACS Patients With Non-predominant Coronary Artery Disease After PCIConditions: Acute Coronary Syndrome; Percutaneous Coronary InterventionInterventions: Procedure: Percutaneous coronary intervention; Drug: Ticagrelor plus aspirin Sponsor: Fujian Medical University Recruiting Wed, 08 Apr 2020 12:00:00 EDT
Strategies to Prevent Transcatheter Heart Valve Dysfunction in Low Risk Transcatheter Aortic Valve ReplacementCondition: Aortic StenosisInterventions: Device: TAVR; Other: Warfarin plus Aspirin; Other: Aspirin Only Sponsor: Medstar Health Research Institute Active, not recruiting Thu, 14 Jun 2018 12:00:00 EDT Effect of EECP on Anterior Ischemic Optic NeuropathyCondition: Anterior Ischemic Optic NeuropathyInterventions: Device: Enhanced external counterpulsation; Drug: Aspirin Sponsor: First Affiliated Hospital, Sun Yat-Sen University Unknown status Tue, 15 Jan 2013 12:00:00 EST Pharmacokinetics of Dipyridamole Administered as Aggrenox® (Dipyridamole Extended Release Plus Aspirin) Capsule Versus Dipyridamole Immediate Release Plus Aspirin Following Alteration of Stomach pHCondition: HealthyInterventions: Drug: Aggrenox; Drug: Dipyridamole; Drug: Aspirin; Drug: Lansoprazole Sponsor: Boehringer Ingelheim Completed Mon, 29 Sep 2014 12:00:00 EDT PREVENTion of Clot in Orthopaedic TraumaConditions: Blood Clot; TraumaInterventions: Drug: Acetylsalicylic acid; Drug: Low Molecular Weight Heparin (LMWH) Sponsors: Major Extremity Trauma Research Consortium; Patient-Centered Outcomes Research Institute Recruiting Tue, 06 Dec 2016 12:00:00 EST Efficacy and Safety of P1101 in Polycythemia Vera Patients for Whom the Standard of Treatment is Difficult to ApplyCondition: Polycythemia Vera (PV)Interventions: Drug: P1101; Drug: Low-dose aspirin; Procedure: Phlebotomy Sponsor: PharmaEssentia Japan K.K. Active, not recruiting Mon, 02 Dec 2019 12:00:00 EST Ticagrelor Monotherapy After 3 Months in the Patients Treated With New Generation Sirolimus Stent for Acute Coronary Syndrome (TICO Study)Condition: Acute Coronary SyndromeInterventions: Drug: Ticagrelor monotherapy; Drug: Ticagrelor with Aspirin DAPT(dual antiplatelet treatment) Sponsor: Yonsei University Recruiting Fri, 10 Jul 2015 12:00:00 EDT Effects of Acetylsalicylic Acid Compared With the Combination of Acetylsalicylic Acid + Modified-release Dipyridamole on Serum Thromboxane B2 Formation and Platelet Aggregation in Healthy VolunteersCondition: HealthyInterventions: Drug: Asasantin®; Drug: Acetylsalicylic acid low dose; Drug: Acetylsalicylic acid high dose Sponsor: Boehringer Ingelheim Completed Mon, 20 Oct 2014 12:00:00 EDT Impact of COX2 on Sera Biomarkers From Obese SubjectsCondition: Breast Cancer SurvivorsInterventions: Drug: Aspirin; Dietary Supplement: Omega 3 FFA Sponsor: The University of Texas Health Science Center at San Antonio Completed Thu, 13 Feb 2014 12:00:00 EST Type 2 Diabetes Mellitus and AtherosclerosisCondition: Type 2 Diabetes MellitusInterventions: Drug: Aspirin; Drug: Placebo Sponsors: University of Roma La Sapienza; University of Rome Tor Vergata Unknown status Tue, 30 Nov 2010 12:00:00 EST Acetylsalicylic Acid Combined With Pseudoephedrine in Common ColdCondition: Common ColdInterventions: Drug: Acetylsalicylic Acid (Aspirin, BAYE4465); Drug: Pseudoephedrine; Drug: Placebo Sponsor: Bayer Completed Fri, 21 Aug 2009 12:00:00 EDT
AntiCoagulation Versus AcetylSalicylic Acid After Transcatheter Aortic Valve ImplantationCondition: Aortic StenosisInterventions: Drug: Acetylsalicylic acid; Drug: Apixaban; Drug: Rivaroxaban; Drug: Edoxaban Sponsors: Oslo University Hospital; University of Oslo Not yet recruiting Sun, 05 Sep 2021 12:00:00 EDT Placebo and Active Controlled Study to Compare the Efficacy of Aspirin and Paracetamol in Treatment of Sore Throat Associated With a Common ColdConditions: Common Cold; Pharyngitis; TonsillitisInterventions: Drug: Acetylsalicylic acid (Aspirin, BAYE4465); Drug: Paracetamol; Drug: Placebo Sponsor: Bayer Completed Fri, 04 Nov 2011 12:00:00 EDT PTRG-DES ConsortiumConditions: Coronary Artery Disease; Clopidogrel, Poor Metabolism of; Platelet Dysfunction; Stent ThrombosisIntervention: Drug: Clopidogrel Tablets Sponsors: Gyeongsang National University Hospital; Korean Society of Interventional Cardiology Completed Tue, 02 Feb 2021 12:00:00 EST Aspirin and/or Folic Acid in Preventing Recurrent Colorectal PolypsCondition: Colorectal CancerInterventions: Dietary Supplement: folic acid; Drug: acetylsalicylic acid Sponsor: Queen's Medical Centre Unknown status Tue, 01 Jul 2003 12:00:00 EDT Improving Aspirin Use Among Adults at Risk for Cardiovascular Disease (CVD)Condition: Cardiovascular DiseaseInterventions: Behavioral: Pre-visit Summary; Behavioral: Clinical Decision Sharing Tool Sponsors: Geisinger Clinic; Agency for Healthcare Research and Quality (AHRQ) Completed Tue, 22 Sep 2009 12:00:00 EDT Clopidogrel for Acute Ischaemia of Recent OnsetCondition: Ischemic Cerebrovascular AccidentInterventions: Drug: Clopidogrel; Drug: Aspirin Sponsor: Ain Shams University Completed Wed, 18 May 2016 12:00:00 EDT Aortic Arch Related Cerebral Hazard Trial (ARCH)Conditions: Brain Infarction; Transient Ischemic Attack; EmbolismInterventions: Drug: Warfarin; Drug: Clopidogrel-aspirin Sponsors: Assistance Publique - Hôpitaux de Paris; National Health and Medical Research Council, Australia; Sanofi; Bristol-Myers Squibb Completed Mon, 10 Oct 2005 12:00:00 EDT VISSIT Intracranial Stent Study for Ischemic TherapyConditions: Ischemic Stroke; Transient Ischemic AttackInterventions: Device: Pharos Vitesse Neurovascular Stent System (Stent implantation) + Medical therapy (Aspirin and Clopidogrel); Drug: Aspirin and Clopidogrel (Medical therapy) Sponsor: Codman & Shurtleff Terminated Wed, 31 Dec 2008 12:00:00 EST Switching From DAPT to Dual Pathway Inhibition With Low-dose Rivaroxaban in Adjunct to Aspirin in Patients With Coronary Artery DiseaseCondition: Coronary Artery DiseaseInterventions: Drug: Clopidogrel; Drug: Prasugrel; Drug: ticagrelor; Drug: aspirin; Drug: rivaroxaban Sponsors: University of Florida; Janssen, LP Recruiting Fri, 05 Jul 2019 12:00:00 EDT The Safety and Efficacy of Human Umbilical Cord Mesenchymal Stem Cells in the Treatment of Acute Cerebral InfarctionCondition: Cerebral InfarctionInterventions: Biological: Allogeneic umbilical cord mesenchymal stem cells (SCLnow 19#); Drug: Aspirin Tablet Sponsor: Sclnow Biotechnology Co., Ltd. Suspended Wed, 14 Jun 2017 12:00:00 EDT
the Safety and Efficacy of Antiplatelet Therapy in Patients of CAACondition: Cerebral Amyloid AngiopathyIntervention: Drug: Aspirin/Clopidogrel Sponsor: Shenzhen Second People's Hospital Not yet recruiting Fri, 04 Dec 2020 12:00:00 EST The Comparison of Effects Between Increased Dose of Clopidogrel and Addition of CilostazolCondition: Clopidogrel Non-ResponsivenessInterventions: Drug: aspirin, clopidogrel; Drug: aspirin, clopidogrel, cilostazol Sponsor: Samsung Medical Center Completed Thu, 21 Feb 2008 12:00:00 EST Targeting Pulmonary Perfusion in Alpha-1 Antitrypsin DeficiencyConditions: Alpha-1 Antitrypsin Deficiency; Emphysema; Chronic Obstructive Pulmonary DiseaseInterventions: Drug: Aspirin; Drug: Placebo; Other: Withdrawal from alpha1 antitrypsin replacement therapy Sponsors: Columbia University; Alpha-1 Foundation; Stony Wold-Herbert Fund, Inc. Completed Wed, 04 Jan 2017 12:00:00 EST Preventive Application of Letrozole Decrease Incidence of Early Onset of OHSSCondition: Ovarian Hyperstimulation SyndromeInterventions: Drug: letrozole; Drug: Aspirin Sponsor: First Affiliated Hospital, Sun Yat-Sen University Completed Mon, 01 Feb 2016 12:00:00 EST Ticagrelor Antiplatelet Therapy to Reduce Graft Events and ThrombosisCondition: Saphenous Vein Graft DiseaseInterventions: Drug: Aspirin; Drug: Ticagrelor Sponsors: Boca Raton Regional Hospital; AstraZeneca; Ottawa Heart Institute Research Corporation Active, not recruiting Tue, 04 Feb 2014 12:00:00 EST Trial of Acetylsalicylic Acid and Atorvastatin in Patients With Castrate-resistant Prostate CancerCondition: Prostate CancerInterventions: Drug: Acetylsalicylic acid; Drug: Atorvastatin Sponsors: Gustave Roussy, Cancer Campus, Grand Paris; National Cancer Institute, France Recruiting Mon, 28 Jan 2019 12:00:00 EST Effect of Cilostazol on Coronary Artery Stenosis and Plaque Characteristics in Patients With T2DMCondition: Coronary Artery DiseaseInterventions: Drug: Cilostazol; Drug: Aspirin Sponsor: Seoul National University Bundang Hospital Completed Thu, 16 Oct 2014 12:00:00 EDT Efficacy of DLBS1033 in Patients With Acute Ischemic StrokeCondition: Acute Ischemic StrokeInterventions: Drug: DLBS1033; Drug: Aspirin; Drug: Clopidogrel Sponsor: Dexa Medica Group Completed Wed, 13 Feb 2013 12:00:00 EST Microvascular Function Assessment in Healthy SubjectsCondition: Physiology of Microvascular SkinInterventions: Drug: acetylsalicilic acids (Aspirin); Drug: Placebo Sponsor: University Hospital, Angers Completed Fri, 06 Apr 2012 12:00:00 EDT Influence of Acetylsalicylic Acid and Low Molecular Weight Heparins on the Incidence of Renal Hematoma of Shockwave LithotripsyConditions: Urolithiasis; Renal HematomaInterventions: Drug: Acetylsalicylic acid; Drug: low molecular weight heparin Sponsor: Kantonsspital Winterthur KSW Completed Tue, 23 Aug 2016 12:00:00 EDT
Dabigatran Following Transient Ischemic Attack and Minor StrokeConditions: Transient Ischemic Attack; Minor Ischemic StrokeInterventions: Drug: Dabigatran; Drug: Acetylsalicylic acid Sponsor: University of Alberta Completed Thu, 20 Nov 2014 12:00:00 EST Coronavirus Response - Active Support for Hospitalised Covid-19 PatientsCondition: Covid-19Interventions: Drug: Aspirin; Drug: Losartan; Drug: Simvastatin Sponsor: London School of Hygiene and Tropical Medicine Withdrawn Mon, 13 Apr 2020 12:00:00 EDT A sTudy of Low Dose vs Standard Dose of tIcaGrelor on Platelet Function After intErvention for Acute Coronary syndRome in Diabetes Mellitus PatientsCondition: Acute Coronary Syndrome Patients With Diabetes After PCIInterventions: Drug: Ticagrelor; Drug: Aspirin Sponsor: Shanghai Tong Ren Hospital Recruiting Fri, 13 Mar 2020 12:00:00 EDT Enterprise Stent Implantation in the Treatment of Carotid Artery Stenosis With Ischemic StrokeCondition: Carotid Artery StenosisInterventions: Device: Enterprise stent implantation; Drug: Only aspirin medication Sponsor: Beijing Chao Yang Hospital Completed Thu, 16 Jun 2016 12:00:00 EDT Active and Placebo Controlled Study to Test the Efficacy and Safety of an Aspirin-Lidocaine Lozenge in the Symptomatic Treatment of Sore Throat Associated With a Common ColdConditions: Common Cold; Pharyngitis; TonsillitisInterventions: Drug: Acetylsalicylic acid (Aspirin, BAYE4465) & Lidocain; Drug: Acetylsalicylic Acid (Aspirin, BAYE4465); Drug: Lidocain; Drug: Placebo Sponsor: Bayer Completed Thu, 26 May 2011 12:00:00 EDT Optimum Platelet Inhibition After Coronary Bypass SurgeryCondition: Ischemic Heart DiseaseIntervention: Drug: Aspirin, Clopidogrel Sponsor: Papworth Hospital NHS Foundation Trust Completed Tue, 06 Dec 2005 12:00:00 EST RACIN in Patients With Advanced TIL-negative Solid TumorsCondition: Solid Tumor, AdultIntervention: Combination Product: Low dose irradiation + Nivolumab + Ipilimumab or Cyclophosphamide + Aspirin/Celecoxib Sponsor: Centre Hospitalier Universitaire Vaudois Recruiting Thu, 01 Nov 2018 12:00:00 EDT Anti-inflmmation Treatment in Mood Disorder and Deep Learning Prediction ModelCondition: Mood DisorderInterventions: Drug: Aspirin; Drug: Atorvastatin Sponsor: Taipei Veterans General Hospital, Taiwan Recruiting Mon, 28 Dec 2020 12:00:00 EST Acetylsalicylic Acid and Colorectal Cancer Prevention: Exploring the Platelet Function of Its Mechanism of ActionCondition: Colorectal CancerInterventions: Drug: Acetylsalicylic acid; Procedure: Screening colonoscopy Sponsors: Aragon Institute of Health Sciences; G. d'Annunzio University; Catholic University, Italy Unknown status Tue, 29 Apr 2014 12:00:00 EDT The Effectiveness and Safety of Butylphthalide Soft Capsules in Secondary Prevention of Ischemic Stroke TrialConditions: Stroke; Transient Ischemic AttackInterventions: Drug: Butylphthalide Soft Capsules; Drug: Aspirin Sponsor: Peking Union Medical College Hospital Unknown status Tue, 29 Jul 2008 12:00:00 EDT
Different Antiplatelet Therapy Strategy After Coronary Artery Bypass Graft SurgeryConditions: Coronary Artery Bypass; Antiplatelet AgentsInterventions: Drug: Aspirin; Drug: Ticagrelor Sponsor: Ruijin Hospital Completed Mon, 28 Jul 2014 12:00:00 EDT Prospective Study on the Treatment of Unsuspected Pulmonary Embolism in Cancer PatientsCondition: Unsuspected Pulmonary EmbolismIntervention: Drug: Heparin, fondaparinux, vitamin-K antagonists, aspirin Sponsor: G. d'Annunzio University Completed Fri, 16 Nov 2012 12:00:00 EST Perioperative Aspirin Response in Patients Undergoing Vascular SurgeryCondition: Vascular Surgery Patient With PAD / Carotid StenosisIntervention: Drug: Whole blood aggregometry before and after vascular treatment (ASA/ Clopidogrel). Sponsor: St. Josef Hospital Bochum Completed Mon, 16 Jul 2018 12:00:00 EDT Pre-operative Withdrawal of Aspirin in Laparoscopic Inguinal Hernia RepairCondition: No Conditions. Focus of the Study is to Assess the Need to Stop Aspirin Before Laparoscopic Inguinal Hernia RepairIntervention: Procedure: Laparoscopic inguinal hernia repair Sponsor: National University Hospital, Singapore Unknown status Fri, 13 Nov 2015 12:00:00 EST ComparisoN of ticAgrelor vs. Clopidogrel in endoTHeliAl Function of COPD patieNtsConditions: Coronary Artery Disease; Chronic Obstructive Pulmonary DiseaseInterventions: Drug: Aspirin 100 mg; Drug: Ticagrelor; Drug: Clopidogrel Sponsor: University Hospital of Ferrara Completed Tue, 11 Aug 2015 12:00:00 EDT Studying the Efficacy of Aspirin & Clopidogrel in Healthy Subjects With Stable Coronary Artery Disease.Condition: Coronary Artery DiseaseInterventions: Drug: Asprin; Drug: Clopidogrel Sponsor: Neil Kleiman, MD Withdrawn Wed, 11 Nov 2009 12:00:00 EST A Study of the Efficacy and Safety of Alteplase in Participants With Mild StrokeCondition: StrokeInterventions: Drug: Alteplase; Drug: Alteplase Placebo; Drug: Aspirin; Drug: Aspirin Placebo Sponsor: Genentech, Inc. Terminated Wed, 26 Feb 2014 12:00:00 EST Triple Therapy in Patients on Oral Anticoagulation After Drug Eluting Stent ImplantationConditions: Coronary Artery Disease; Atrial FibrillationInterventions: Drug: aspirin; Drug: clopidogrel; Drug: oral anticoagulation Sponsor: Deutsches Herzzentrum Muenchen Unknown status Tue, 21 Oct 2008 12:00:00 EDT Comparison of Sulindac, Aspirin, and Ursodiol in Preventing Colorectal CancerCondition: Colorectal CancerInterventions: Drug: Acetylsalicylic acid (Aspirin); Drug: Sulindac; Drug: Ursodiol; Other: Sulindac Placebo Sponsors: M.D. Anderson Cancer Center; National Cancer Institute (NCI) Terminated Fri, 06 Jun 2003 12:00:00 EDT Arachidonic Acid-induced Platelet Aggregation Rate in Patients With Stable CAD Treated With Ticagrelor MonotherapyCondition: Coronary Heart DiseaseInterventions: Drug: ticagrelor; Drug: Aspirin Sponsor: Yong Huo Completed Mon, 18 Aug 2014 12:00:00 EDT
Pegylated Interferon Alfa-2a Salvage Therapy in High Risk Polycythemia Vera (PV) or Essential Thrombocythemia (ET)Conditions: High Risk Polycythemia Vera; High Risk Essential ThrombocythemiaInterventions: Drug: PEGASYS; Drug: Aspirin Sponsors: Ronald Hoffman; Myeloproliferative Disorders-Research Consortium; National Cancer Institute (NCI); Roche Pharma AG Completed Tue, 14 Dec 2010 12:00:00 EST Migraine Relief After Patent Foramen Ovale Closure: a Single Center AnalysisConditions: Platelet Aggregation, Spontaneous; Migraine With Aura; Patent Foramen OvaleIntervention: Device: patent foramen ovale closure Sponsor: Centro Cardiologico Monzino Unknown status Fri, 11 May 2018 12:00:00 EDT A Study to Evaluate the Effects of Laropiprant on the Antiplatelet Effects of Clopidogrel and Aspirin in Combination (MK-0524A-114)(COMPLETED)Conditions: Primary Hypercholesterolemia; Mixed HyperlipidemiaInterventions: Drug: niacin (+) laropiprant; Drug: Comparator: aspirin; Drug: Comparator: clopidogrel; Drug: Comparator: laropiprant; Drug: Comparator: placebo Sponsor: Merck Sharp & Dohme Corp. Completed Wed, 11 Nov 2009 12:00:00 EST Sleep and Inflammatory Resolution PathwayConditions: Inflammatory Response; Inflammation; Sleep; Sleep RestrictionInterventions: Drug: Aspirin; Drug: Placebo Sponsor: Beth Israel Deaconess Medical Center Recruiting Tue, 19 Dec 2017 12:00:00 EST Effects of Intensive Antiplatelet Therapy for Patients With Clopidogrel Resistance After Coronary Stent ImplantationConditions: Acute Coronary Syndromes; Percutaneous Coronary Intervention; Clopidogrel Low ResponsivenessInterventions: Drug: aspirin, clopidogrel; Drug: aspirin, clopidogrel, cilostazol Sponsor: Shenyang Northern Hospital Completed Mon, 29 Mar 2010 12:00:00 EDT Effect Of Aspirin Preoperative on Postoperative Cognitive Dysfunction In Elderly Patients Undergoing Knee ArthroplastyConditions: Elective Surgery; Postoperative Cognitive Dysfunction; Knee ArthroplastyIntervention: Sponsor: Xuzhou Medical University Not yet recruiting Mon, 13 Jan 2020 12:00:00 EST Therapeutic Control of Aspirin-Exacerbated Respiratory Disease (Aspirin)Conditions: Asthma, Aspirin-Induced; Aspirin Exacerbated AsthmaInterventions: Drug: Placebo Oral Tablet; Drug: Prasugrel Oral Tablet Sponsors: Elliot Israel, MD; Brigham and Women's Hospital Completed Mon, 14 May 2012 12:00:00 EDT Multi-center, Prospective, Cohort Study to Evaluate the Relationship of Stroke Recurrence and Anti-platelet Resistance in Ischemic Stroke PatientsCondition: Ischemic StrokeIntervention: Drug: Aspirin, Clopidogrel Sponsor: Yuhan Corporation Recruiting Wed, 30 Jan 2019 12:00:00 EST Pharmacogenomics of Antiplatelet Response - IConditions: Platelet Aggregation; Platelet Transcriptome; Coronary Artery DiseaseInterventions: Drug: Clopidogrel; Drug: Aspirin Sponsor: Johns Hopkins University Completed Wed, 20 Mar 2013 12:00:00 EDT A Trial to Assess the Safety and Efficacy of Prophylactic TicagrelOr With Acetylsalicylic Acid Versus CLopidogrel With Acetylsalicylic Acid in the Development of Cerebrovascular EMbolic Events During TAVICondition: Aortic Valve StenosisInterventions: Drug: Ticagrelor plus ASA; Drug: Clopidogrel plus ASA Sponsor: University of Athens Completed Mon, 12 Dec 2016 12:00:00 EST
AntiPlatelet theraPy stratEgy followiNg Left Atrial appenDAGe closurEConditions: Atrial Fibrillation; Atrial Appendage; Anticoagulants; Stroke; Platelet Aggregation InhibitorsInterventions: Drug: Double antiplatelet therapy; Drug: Aspirin; Device: Brain MRI; Other: Neurological tests Sponsor: University Hospital, Bordeaux Not yet recruiting Mon, 15 Mar 2021 12:00:00 EDT Outpatient Liquid Aspirin (OLA)Condition: Covid19Intervention: Drug: ASA Sponsors: Louisiana State University Health Sciences Center in New Orleans; Innovate UK Not yet recruiting Wed, 23 Jun 2021 12:00:00 EDT Early Antiplatelet Therapy After Hemorrhagic Infarction in Acute Ischemic Stroke Treated With Intravenous Thrombolysis (HITs)Conditions: Antiplatelet Therapy; Hemorrhagic InfarctionInterventions: Drug: Early aspirin Therapy; Drug: Non-Early aspirin Therapy Sponsors: Second Affiliated Hospital, School of Medicine, Zhejiang University; Shaoxing People's Hospital; First Affiliated Hospital of Jiaxing University; Huizhou Municipal Central Hospital; The Second Affiliated Hospital of Jiaxing University; Jinhua Central Hospital; Taizhou Hospital; Ningbo Medical Center Lihuili Hospital; Ningbo No.2 Hospital; Lishui Country People's Hospital; Wenzhou Central Hospital; The Fourth Affiliated Hospital of Zhejiang University School of Medicine; Shenzhen Second People's Hospital; The Affiliated Hospital of Xuzhou Medical University Recruiting Tue, 10 Nov 2020 12:00:00 EST CES1 Carriers in the PAPI StudyConditions: Heart Diseases; Coronary Disease; Coronary Artery Disease; Cardiovascular Diseases; Myocardial Ischemia; Artery Occlusion; Aspirin Sensitivity; Clopidogrel, Poor Metabolism of; Platelet Dysfunction; Platelet ThrombusInterventions: Drug: Clopidogrel; Drug: Aspirin Sponsor: University of Maryland, Baltimore Enrolling by invitation Thu, 15 Jun 2017 12:00:00 EDT Diagnosis and Treatment Strategy of Recurrent Spontaneous Abortion Associated With ThrombophillaCondition: Thrombophilia With Recurrent Pregnancy LossInterventions: Drug: Aspirin; Drug: Heparin Sponsor: Shanghai First Maternity and Infant Hospital Unknown status Thu, 08 Dec 2016 12:00:00 EST Aspirin and Thienopyridine Resistance in Peripheral Arterial DiseaseConditions: Peripheral Arterial Disease; Clopidogrel, Poor Metabolism ofIntervention: Sponsor: University of California, Davis Completed Mon, 05 Jun 2017 12:00:00 EDT Use of PRF in Treatment of Dry Socket.Condition: Alveolar OsteitisInterventions: Procedure: PRF application; Drug: Nipas application Sponsor: Medical University of Lodz Enrolling by invitation Fri, 17 Jul 2020 12:00:00 EDT A Study to Assess Disintegration of the New Aspirin Disintegrating TabletsCondition: Moderate PainInterventions: Drug: 500 mg acetylsalicylic acid (Aspirin, BAYE4465); Drug: 1000 mg acetylsalicylic acid (Aspirin, BAYE4465); Drug: 400 mg ibuprofen(Nurofen); Drug: 400 mg ibuprofen (Dolormin Extra) Sponsor: Bayer Completed Fri, 21 Jul 2017 12:00:00 EDT Aspirin and Rintatolimod With or Without Interferon-alpha 2b in Treating Patients With Prostate Cancer Before SurgeryConditions: Prostate Adenocarcinoma; Stage I Prostate Cancer AJCC v8; Stage II Prostate Cancer AJCC v8; Stage IIA Prostate Cancer AJCC v8; Stage IIB Prostate Cancer AJCC v8; Stage IIC Prostate Cancer AJCC v8; Stage III Prostate Cancer AJCC v8; Stage IIIA Prostate Cancer AJCC v8; Stage IIIB Prostate Cancer AJCC v8; Stage IIIC Prostate Cancer AJCC v8Interventions: Drug: Aspirin; Procedure: Radical Prostatectomy; Biological: Recombinant Interferon Alfa-2b; Drug: Rintatolimod Sponsors: Roswell Park Cancer Institute; National Cancer Institute (NCI); AIM ImmunoTech Inc. Recruiting Tue, 02 Apr 2019 12:00:00 EDT Intensified Tuberculosis Treatment to Reduce the Mortality of Patients With Tuberculous MeningitisCondition: Tuberculous MeningitisInterventions: Drug: Aspirin; Drug: Placebo of aspirin; Drug: WHO TBM treatment; Drug: Intensified TBM treatment Sponsors: ANRS, Emerging Infectious Diseases; European Union; European and Developing Countries Clinical Trials Partnership (EDCTP) Recruiting Wed, 30 Oct 2019 12:00:00 EDT
1-month DAPT Plus 5-month Ticagrelor Monotherapy Versus 12-month DAPT in Patients With Drug-coated BalloonConditions: Antiplatelet Drug; Acute Coronary Syndrome; Angioplasty, BalloonInterventions: Drug: Aspirin 100mg for 1-month (immediately after PCI); Drug: Ticagrelor 90mg for 6-month (immediately after PCI); Drug: Aspirin 100mg for 6-month (6-month post PCI); Drug: Aspirin 100mg for 12-month (immediately after PCI); Drug: Ticagrelor 90mg for 12-month (immediately after PCI) Sponsor: Xijing Hospital Not yet recruiting Wed, 21 Jul 2021 12:00:00 EDT Aspirin Effectiveness StudyCondition: Coronary Artery DiseaseIntervention: Sponsor: Royal College of Surgeons, Ireland Unknown status Thu, 29 Apr 2010 12:00:00 EDT NOACs for Stroke Prevention in Patients With Atrial Fibrillation and Previous ICHConditions: Atrial Fibrillation; Intracerebral HemorrhageInterventions: Drug: NOAC; Drug: Acetylsalicylic Acid Sponsor: Population Health Research Institute Completed Wed, 21 Dec 2016 12:00:00 EST Safety Study of APD-791 With Aspirin and/or ClopidogrelCondition: Acute Coronary SyndromeInterventions: Drug: Clopidogrel; Drug: Aspirin; Drug: APD791; Drug: Placebo Sponsors: IlDong Pharmaceutical Co Ltd; Asan Medical Center Terminated Mon, 13 Jan 2014 12:00:00 EST The ARIES HeartMate 3 Pump IDE StudyCondition: Heart FailureInterventions: Device: LVAD Implant; Drug: Aspirin 100mg; Drug: Placebo oral tablet Sponsor: Abbott Medical Devices Recruiting Wed, 28 Aug 2019 12:00:00 EDT Frequency of Reduced Leaflet Motion After Surgical Aortic Valve Replacement and Transcatheter Aortic Valve Replacement.Condition: Aortic Valve DisorderInterventions: Drug: SAVR Warfarin; Drug: SAVR Aspirin; Drug: TAVR Warfarin and clopidogrel; Drug: TAVR Aspirin and clopidogrel Sponsor: The Cleveland Clinic Terminated Wed, 02 Mar 2016 12:00:00 EST Effect of Platelet Inhibition and / or Lipid Lowering in Non-ACS-patients With Positive TroponinCondition: Acute Chest SyndromeInterventions: Drug: Aspirin; Drug: Atorvastatin; Drug: Placebo Aspirin; Drug: Placebo Atorvastatin Sponsor: Dr. med. Mahir Karakas Recruiting Tue, 29 Jan 2019 12:00:00 EST Chronic Kidney Disease (CKD) Platelet StudyConditions: Chronic Kidney Diseases; Heart Attack; Stroke, IschemicInterventions: Drug: Ticagrelor 90mg; Drug: Clopidogrel 75mg; Drug: Aspirin 81 mg Sponsors: University of Arkansas; American Society of Nephrology Active, not recruiting Tue, 28 Aug 2018 12:00:00 EDT The Effect of Low Dose Aspirin in Increasing the Chance of PregnancyCondition: InfertilityInterventions: Drug: Asprin; Drug: placebo Sponsor: Royan Institute Completed Wed, 04 Jul 2012 12:00:00 EDT Comparative Effectiveness of Pulmonary Embolism Prevention After Hip and Knee ReplacementConditions: Pulmonary Embolism; Venous ThrombosisInterventions: Drug: Enteric Coated Aspirin; Drug: Warfarin; Drug: Rivaroxaban Sponsors: Dartmouth-Hitchcock Medical Center; Patient-Centered Outcomes Research Institute; University of Maryland, Baltimore; Brigham and Women's Hospital; Northwestern University; Medical University of South Carolina Recruiting Thu, 23 Jun 2016 12:00:00 EDT
Effect of Naproxen, Aspirin, Celecoxib, or Clopidogrel on the Healing of Stomach and Intestinal UlcersCondition: Gastroduodenal UlcerInterventions: Drug: Naproxen; Drug: Aspirin; Drug: Celecoxib; Drug: Clopidogrel; Drug: Placebo Sponsor: Research Associates of New York, LLP Completed Thu, 23 Oct 2008 12:00:00 EDT Subclinical Cardiovascular Disease in Psoriatic DiseaseConditions: Cardiovascular Diseases; Myocardial Infarction; Atherosclerotic Cardiovascular Disease; Thrombotic Vascular DiseaseIntervention: Drug: Aspirin and/or Atorvastatin Sponsor: NYU Langone Health Completed Mon, 24 Jul 2017 12:00:00 EDT Aspirin Mouthwash in Treating Patients With Oral LeukoplakiaCondition: Precancerous ConditionInterventions: Drug: acetylsalicylic acid; Genetic: gene expression analysis; Genetic: protein expression analysis; Other: laboratory biomarker analysis; Other: questionnaire administration; Procedure: biopsy Sponsor: Institute of Head and Neck Studies and Education, United Kingdom Completed Wed, 10 Nov 2010 12:00:00 EST The Optimal Duration of Dual Antiplatelet Therapy After Implantation of Endeavor StentCondition: Coronary Artery DiseaseIntervention: Drug: Aspirin, Clopidogrel Sponsors: Samsung Medical Center; Medtronic Completed Fri, 05 Jan 2007 12:00:00 EST Use of Acetyl Salicylic Acid and Terbutalin in Assisted Reproductive Techniques (ART)Condition: Reproductive Techniques, AssistedIntervention: Drug: Acetyl Salicylic Acid and Terbutalin Sponsor: Sykehuset Telemark Completed Mon, 20 Aug 2007 12:00:00 EDT Dose-escalation, Repeated and Single Oral Dosing StudyCondition: Acute Coronary SyndromeInterventions: Drug: APD791; Drug: Clopidogrel; Drug: Aspirin; Drug: Placebo for APD791 Sponsors: IlDong Pharmaceutical Co Ltd; Asan Medical Center Terminated Fri, 17 Apr 2015 12:00:00 EDT ASA in Prevention of Ovarian Cancer (STICs and STONEs)Condition: Ovarian Cancer PreventionInterventions: Drug: Acetylsalicylic acid; Other: Placebo Sponsors: Canadian Cancer Trials Group; Apotex Inc. Recruiting Thu, 29 Mar 2018 12:00:00 EDT Optimal Anticoagulation for Higher Risk Patients Post-Catheter Ablation for Atrial Fibrillation TrialConditions: Atrial Fibrillation; StrokeInterventions: Drug: Rivaroxaban; Drug: Acetylsalicylic acid Sponsors: Ottawa Heart Institute Research Corporation; Canadian Institutes of Health Research (CIHR); Bayer; Biotronik Canada Inc Recruiting Fri, 20 Jun 2014 12:00:00 EDT A Study to Compare the Safety of Rivaroxaban Versus Acetylsalicylic Acid in Addition to Either Clopidogrel or Ticagrelor Therapy in Participants With Acute Coronary SyndromeCondition: Acute Coronary SyndromeInterventions: Drug: Acetylsalicylic acid; Drug: Rivaroxaban; Drug: Clopidogrel; Drug: Ticagrelor Sponsors: Janssen Research & Development, LLC; Bayer; Duke Clinical Research Institute; Harvard Medical School Completed Tue, 18 Nov 2014 12:00:00 EST A Comparison of microRNA Samples in Patients With Nasal Polyps and Aspirin Exacerbated Respiratory Disease and Those With Nasal Polyps OnlyConditions: Aspirin-exacerbated Respiratory Disease; Nasal PolypIntervention: Genetic: microRNA Sponsor: University of South Florida Completed Fri, 29 Jun 2012 12:00:00 EDT
Physiological Effects of Altering Cancer-related InflammationCondition: Colon CancerInterventions: Drug: Aspirin; Drug: Ibuprofen Sponsors: NHS Greater Glasgow and Clyde; Academy of Medical Sciences; Wellcome Trust Unknown status Thu, 07 Feb 2013 12:00:00 EST Warfarin After Anterior ST-Elevation Myocardial InfarctionCondition: Myocardial InfarctionInterventions: Drug: aspirin + clopidogrel; Drug: aspirin + clopidogrel + warfarin Sponsor: Hamilton Health Sciences Corporation Completed Mon, 21 Apr 2008 12:00:00 EDT A Phase III Randomized, Blind, Double Dummy, Multicenter Study Assessing the Efficacy and Safety of IV THrombolysis (Alteplase) in Patients With acutE Central retInal Artery OcclusionCondition: Central Retinal Artery OcclusionInterventions: Drug: Alteplase; Drug: acetylsalicylic acid; Drug: Placebo Oral Tablet; Drug: placebo IV Sponsor: Nantes University Hospital Recruiting Fri, 23 Jun 2017 12:00:00 EDT Pharmacodynamic Clinical Trial of Cardiovascular Polypill on LDL CholesterolCondition: Elevated LDL CholesterolInterventions: Drug: Cardiovascular fixed dose combination pill (acetylsalicylic acid, simvastatin and ramipril); Drug: Simvastatin, ramipril, acetylsalicylic acid Sponsor: Ferrer Internacional S.A. Terminated Mon, 30 May 2011 12:00:00 EDT Rivaroxaban or Aspirin in Patients With CHD & GD Undergoing PCICondition: RivaroxabanIntervention: Drug: clopidogrel combined with rivaroxaban arm Sponsor: Shenyang Northern Hospital Not yet recruiting Thu, 18 Mar 2021 12:00:00 EDT Bioresorbable Polymer-Coated EES in Patients at High Bleeding Risk Undergoing PCI Followed by 1-Month DAPTConditions: Coronary Artery Disease; Acute Coronary SyndromeInterventions: Drug: Aspirin; Drug: P2Y12 inhibitor Sponsor: Humanitas Hospital, Italy Unknown status Thu, 13 Apr 2017 12:00:00 EDT Symptomatic Treatment of Common Cold SymptomsCondition: Common ColdInterventions: Drug: Aspirin (Acetylsalicylic acid, BAYE4465); Drug: Placebo Sponsor: Bayer Completed Wed, 16 Dec 2009 12:00:00 EST To Evaluate Whether Acetyl Salicylic Acid (Aspirin), the Combination of Aspirin and Clopidogrel and Darexaban (YM150) Interact in Their EffectsConditions: Pharmacodynamic Interaction; Healthy SubjectsInterventions: Drug: darexaban; Drug: darexaban (double dose); Drug: Acetyl Salicylic Acid; Drug: clopidogrel Sponsor: Astellas Pharma Inc Completed Thu, 04 Aug 2011 12:00:00 EDT Low-molecular-weight Heparin (LMWH) Versus Unfractionated Heparin (UFH) in Pregnant Women With Recurrent Abortion Secondary to Antiphospholipid SyndromeCondition: Recurrent AbortionInterventions: Drug: enoxaparin 40mg plus low dose aspirin; Drug: Heparin calcium5,000 U twice daily plus low dose aspirin Sponsors: Cairo University; Ahmed Elgazzar Hospital Completed Wed, 20 Jan 2010 12:00:00 EST Placebo and Active Controlled, Double Dummy Study to Compare Efficacy of Aspirin and Ibuprofen in Treatment of Episodic Tension-type HeadacheConditions: Headache; Tension-Type Headache; Tension-Type Headache (Episodic)Interventions: Drug: Acetylsalicylic acid (Aspirin, BAYE4465); Drug: Ibuprofen; Drug: Placebo Sponsor: Bayer Completed Fri, 04 Nov 2011 12:00:00 EDT
Anticoagulant Plus Antiplatelet Therapy Following Iliac Vein StentingConditions: Deep Vein Thrombosis; Iliac Vein Thrombosis; Iliac Vein Obstruction; Iliac Vein Stenosis; Iliac Vein Compression SyndromeInterventions: Drug: Rivaroxaban; Drug: Aspirin Sponsors: First Affiliated Hospital of Zhejiang University; Zhejiang University; Ningbo No.2 Hospital; Taizhou Hospital of Zhejiang Province; The Central Hospital of Lishui City; Taizhou Enze Hospital; Taizhou First People's Hospital; Boston Scientific Corporation Not yet recruiting Tue, 05 Jan 2021 12:00:00 EST The Accuracy Of A Novel Platelet Activity Assay In Humans On Antiplatelet Agents: Pharmacodynamics And Comparison With Light Transmission AggregometryConditions: Platelet Activation Testing Before/After Anti-platelet Therapy; HealthyInterventions: Drug: Aspirin; Drug: Clopidogrel Sponsors: Beth Israel Deaconess Medical Center; National Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health (NIH) Recruiting Tue, 30 Mar 2021 12:00:00 EDT Effect of Upstream Treatment With High Intensity Statin on the Outcomes of STMI Patients Treated With PPCICondition: ST Elevation Myocardial InfarctionInterventions: Drug: Atorvastatin; Drug: Aspirin Sponsor: Assiut University Not yet recruiting Mon, 15 Feb 2021 12:00:00 EST Reversing Ticagrelor's Effects With Fresh PlateletsCondition: Coronary Artery DiseaseInterventions: Drug: Ticagrelor loading dose; Drug: Aspirin loading dose; Drug: Ticagrelor maintenance dose; Drug: Aspirin maintenance dose Sponsors: Icahn School of Medicine at Mount Sinai; AstraZeneca Completed Mon, 28 Jul 2014 12:00:00 EDT Double Randomized and Placebo Controlled Trail of Sanchitongshu Combined Antiplatelet Drug to Prevent Ischemic StrokeConditions: Ischemic Stroke; Antiplatelet EffectInterventions: Drug: Sanchitongshu; Drug: Aspirin; Drug: Clopidogrel; Drug: placebo of Sanchitongshu Sponsor: Xinhua Hospital, Shanghai Jiao Tong University School of Medicine Unknown status Tue, 29 Oct 2019 12:00:00 EDT Anti-Platelet and Statin Therapy to Prevent Cancer-Associated ThrombosisConditions: Solid Tumor; CancerInterventions: Drug: Aspirin; Drug: Simvastatin; Other: Observation Sponsor: Case Comprehensive Cancer Center Completed Fri, 07 Nov 2014 12:00:00 EST Study to Learn More About the Effectiveness and Safety of Rivaroxaban (Xarelto) When Given Together With Acetylsalicylic Acid to Patients Suffering From a Condition That Affects the Blood Vessels Supplying the Heart (CAD) and/or a Condition That Affects the Blood Vessel of the Lower Limbs (PAD).Conditions: Coronary Artery Disease(CAD); Peripheral Artery Disease(PAD)Interventions: Drug: Rivaroxaban (Xarelto,Bay 59-7939); Drug: Acetylsalicylic acid(ASA) Sponsor: Bayer Not yet recruiting Fri, 06 Mar 2020 12:00:00 EST Study Design of 'Influence of Sarpogrelate in Patients With Renal Impairment or Diabetes Mellitus' StudyConditions: Coronary Artery Disease; Diabetes Mellitus; Renal Insufficiency, ChronicInterventions: Drug: Sarpogrelate; Drug: Aspirin; Drug: Clopidogrel; Drug: Placebo (for Sarpogrelate) Sponsors: Seoul National University Bundang Hospital; Yuhan Corporation Completed Wed, 19 Nov 2014 12:00:00 EST Adjunctive Acetylsalicylic Acid and Ibuprofen for TuberculosisConditions: Tuberculosis, Pulmonary; Tuberculosis, MDR; Tuberculosis InfectionInterventions: Drug: Control group; Drug: ASA group; Drug: IBU group; Drug: SoC TB Sponsors: Fundació Institut Germans Trias i Pujol; National Center for Tuberculosis and Lung Disease, Tbilisi, Georgia; Perinatal HIV Research Unit of the University of the Witswatersrand Recruiting Mon, 05 Oct 2020 12:00:00 EDT Ex Vivo Human Thrombosis Chamber StudyCondition: Cardiovascular DiseaseInterventions: Drug: Clopidogrel; Drug: Aspirin Sponsor: Bristol-Myers Squibb Completed Thu, 09 Jul 2009 12:00:00 EDT
Combination Antithrombotic Treatment for Prevention of Recurrent Ischemic Stroke in Intracranial Atherosclerotic DiseaseConditions: Ischemic Stroke; Intracranial Atherosclerotic DiseaseInterventions: Drug: Rivaroxaban 2.5 Mg Oral Tablet bid; Drug: Acetylsalicyclic acid 81 mg tablet qd Sponsor: Population Health Research Institute Recruiting Tue, 29 Oct 2019 12:00:00 EDT Registry Study to Evaluate the Performance and Safety of Roxwood Medical Catheters in Arteries of Participants With a Stenotic Lesion or Chronic Total Occlusion (CTO)Conditions: Chronic Total Occlusion; Atherosclerosis; Coronary Artery Disease; Peripheral Artery DiseaseInterventions: Device: Roxwood Anchoring Catheters; Drug: Acetylsalicylic Acid; Drug: Heparin Sponsors: Boston Scientific Corporation; EKOS Corporation Withdrawn Fri, 16 Aug 2019 12:00:00 EDT Effect of Apple Flavanols on Risk of Cardiovascular DiseaseCondition: Cardiovascular DiseaseInterventions: Dietary Supplement: Low PA apple puree; Dietary Supplement: High PA apple puree; Drug: Aspirin Sponsor: Quadram Institute Bioscience Completed Wed, 05 Dec 2007 12:00:00 EST Naproxen Sodium/ASA Platelet StudyCondition: HematologyInterventions: Drug: Naproxen Sodium (Aleve, BAY117031); Drug: Acetylsalicylic Acid (Aspirin, BAYE4465) Sponsor: Bayer Completed Mon, 01 Sep 2014 12:00:00 EDT Aspirin Twice Daily in Diabetic Patients With Coronary Artery DiseaseCondition: Diabetes MellitusIntervention: Sponsor: Hopital Lariboisière Completed Tue, 12 Jun 2012 12:00:00 EDT Ticagrelor vs Clopidogrel for Platelet Inhibition in Stenting for Cerebral AneurysmCondition: Cerebral AneurysmInterventions: Drug: Clopidogrel; Drug: Ticagrelor; Drug: aspirin Sponsor: Fondation Ophtalmologique Adolphe de Rothschild Completed Fri, 05 Feb 2016 12:00:00 EST Efficacy and Safety of Alogliptin vs. Acarbose in Chinese Type 2 Diabetes Mellitus (T2DM) Patients With High CV Risk or CHD Treated With Aspirin and Inadequately Controlled With Metformin Monotherapy or Drug NaiveCondition: Type 2 Diabetes MellitusInterventions: Drug: Alogliptin; Drug: Acarbose; Drug: Metformin; Drug: Aspirin Sponsor: Sanofi Completed Mon, 07 Jan 2019 12:00:00 EST Minocycline, Acetylsalicylic Acid or Pramipexole vs Placebo in Patients With Schizophrenia or Schizoaffective DisorderConditions: Schizophrenia; Schizoaffective DisorderInterventions: Drug: minocycline; Drug: pramipexole; Drug: acetylsalicylic acid; Drug: placebo Sponsor: Sheba Medical Center Unknown status Wed, 23 Mar 2011 12:00:00 EDT The Effect of Multiple Doses of Epanova® on the Multiple-Dose Pharmacokinetics of Simvastatin in Healthy Normal SubjectsCondition: HypertriglyceridemiaInterventions: Drug: Simvastatin; Drug: acetylsalicylic acid (ASA); Drug: omefas Sponsor: AstraZeneca Completed Tue, 06 Dec 2011 12:00:00 EST Study of Combined Therapy IVIG-SN 10% and Acetylsalicylic Acid in Kawasaki DiseaseCondition: Kawasaki DiseaseInterventions: Drug: Immunoglobulin G; Drug: Acetylsalicylic acid Sponsor: Green Cross Corporation Completed Mon, 01 Jul 2019 12:00:00 EDT
A Study to Assess Administration of an Oral Anti-thrombotic With Antiplatelet Therapy in Healthy SubjectsCondition: Healthy VolunteersInterventions: Drug: BMS-986177; Other: Placebo (for BMS-986177); Drug: Clopidogrel; Drug: Aspirin Sponsor: Bristol-Myers Squibb Completed Tue, 09 Oct 2018 12:00:00 EDT Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of AZD3366 in Healthy Subjects, Japanese and Chinese SubjectsCondition: Cardiovascular DiseaseInterventions: Drug: AZD3366; Drug: Placebo; Drug: Ticagrelor; Drug: acetylsalicylic acid (ASA) Sponsor: AstraZeneca Recruiting Mon, 19 Oct 2020 12:00:00 EDT Aspirin and Neutrophils in PreeclampsiaConditions: Preeclampsia; Neutrophil; Immunology; PregnancyIntervention: Diagnostic Test: Blood test Sponsor: Queen Mary University of London Not yet recruiting Fri, 23 Jul 2021 12:00:00 EDT Apixaban for Treatment of Embolic Stroke of Undetermined SourceCondition: Embolic Stroke of Undetermined SourceInterventions: Drug: Apixaban; Drug: Aspirin Sponsors: University Hospital Tuebingen; Bristol-Myers Squibb; Medtronic; ZKS and IKEaB Tübingen Completed Mon, 27 Apr 2015 12:00:00 EDT Study to Evaluate the Long-Term Safety of PA32540 in Subjects Who Are at Risk for Developing Aspirin-Associated Gastric UlcersCondition: Aspirin-Associated Gastric UlcersIntervention: Drug: PA32540 Sponsor: POZEN Completed Thu, 15 Oct 2009 12:00:00 EDT Pharmacokinetic Assessment of Simultaneous Administration of Clopidogrel and AspirinCondition: Coronary Artery DiseaseInterventions: Drug: Cloas; Drug: Plavix/Astrix Sponsor: Ajou University School of Medicine Unknown status Thu, 07 Jul 2011 12:00:00 EDT The Effect of Triflusal on Peripheral Microcirculation DysfunctionCondition: Vasospastic SyndromeInterventions: Drug: Triflusal; Drug: Aspirin Sponsor: Yonsei University Completed Tue, 05 Jun 2012 12:00:00 EDT Residual Platelet Activity In Advanced Peripheral Artery DiseaseCondition: Peripheral Arterial DiseaseInterventions: Drug: Acetylsalicylic acid; Drug: Clopidogrel Sponsors: University of Roma La Sapienza; University of Florence Unknown status Mon, 25 Jun 2012 12:00:00 EDT Role of Prostaglandins on Niacin-Induced FlushingCondition: FlushingIntervention: Drug: Niacin and aspirin Sponsors: Eastern Virginia Medical School; Abbott Completed Thu, 02 Jul 2009 12:00:00 EDT Aspirin and Clopidogrel Resistance StudyCondition: Drug ResistanceIntervention: Sponsor: University Hospital, Basel, Switzerland Completed Fri, 25 Dec 2009 12:00:00 EST
Effect of Cilostazol in the Acute Lacunar Infarction Based on Pulsatility Index of Transcranial DopplerCondition: Cerebral InfarctionInterventions: Drug: Aspirin; Drug: cilostazol Sponsors: Inje University; Korea Otsuka Pharmaceutical Co., Ltd. Completed Tue, 26 Aug 2008 12:00:00 EDT Alternative Options to Minimize Niacin-Induced FlushingConditions: Hypercholesterolemia; FlushingInterventions: Other: Apple pectin; Drug: Aspirin 325 mg; Other: Placebo Sponsor: Patrick Moriarty, MD, FACP, FACC Completed Fri, 08 May 2009 12:00:00 EDT Study of Tirofiban Administration in Patients With Aspirin and or Clopidogrel ResistanceCondition: Angioplasty, Transluminal, Percutaneous CoronaryInterventions: Drug: Tirofiban; Drug: Placebo Sponsor: Università degli Studi di Ferrara Completed Fri, 10 Nov 2006 12:00:00 EST Safety and Efficacy Study of a Protease Activated Receptor-4 Antagonist Being Tested to Reduce the Chances of Having Additional Strokes or "Mini Strokes"Condition: ThrombosisInterventions: Drug: BMS-986141; Drug: Aspirin; Other: Placebo Sponsor: Bristol-Myers Squibb Completed Tue, 02 Feb 2016 12:00:00 EST GLP-1 and Microvascular Function in Type 2 DiabetesCondition: Type 2 DiabetesInterventions: Drug: Liraglutide; Other: diet; Drug: Aspirin Sponsors: Royal Devon and Exeter NHS Foundation Trust; University of Exeter Completed Tue, 04 Dec 2012 12:00:00 EST Ticagrelor Versus Clopidogrel in Carotid Artery StentingCondition: Carotid Artery StenosisInterventions: Drug: Ticagrelor; Drug: Clopidogrel; Drug: Aspirin Sponsor: University Hospital, Basel, Switzerland Recruiting Tue, 09 Feb 2016 12:00:00 EST Dexamethasone, Aspirin, and Diethylstilbestrol in Treating Patients With Locally Advanced or Metastatic Prostate CancerCondition: Prostate CancerInterventions: Drug: acetylsalicylic acid; Drug: dexamethasone; Drug: diethylstilbestrol Sponsor: St. Bartholomew's Hospital Completed Fri, 21 Apr 2006 12:00:00 EDT COBRA SHIELD OCT StudyCondition: Stable AnginaInterventions: Drug: Aspirin; Device: Resolute Integrity DES; Device: COBRA PzF; Drug: DAPT Sponsors: CeloNova BioSciences, Inc.; ClinLogix. LLC Terminated Mon, 25 Aug 2014 12:00:00 EDT Effectiveness of Night Administration of Low Dose Aspirin in Hypertensive PatientsCondition: HypertensionInterventions: Drug: ASA evening; Drug: Acetylsalicylic morning; Drug: Placebos morning; Drug: Placebo evening Sponsors: Basque Health Service; Preventive Services and Health Promotion Research Network; Spanish Clinical Research Network - SCReN; Public Health Service of Cataluña Completed Wed, 05 Dec 2012 12:00:00 EST Personalization of Long-Term Antiplatelet Therapy - RAPID EXTENDConditions: Coronary Artery Disease; Myocardial InfarctionInterventions: Drug: Active Comparator: Dual Antiplatelet Therapy (DAPT) - Aspirin 81 mg + Ticagrelor 60mg twice daily; Drug: Ticagrelor Monotherapy: Ticagrelor 60 mg twice daily; Drug: Personalized Therapy Arm: Aspirin 81 mg or Ticagrelor 60mg twice daily or Clopidogrel 75 mg once daily Sponsor: Ottawa Heart Institute Research Corporation Suspended Fri, 02 Nov 2018 12:00:00 EDT
Anti-programmed Cell Death-1 Ligand 1 (aPDL-1) Antibody Atezolizumab, Bevacizumab and Acetylsalicylic Acid in Recurrent Platinum Resistant Ovarian CancerCondition: Ovarian NeoplasmsInterventions: Drug: Bevacizumab; Drug: atezolizumab; Drug: acetylsalicylic acid; Drug: placebo Sponsor: European Organisation for Research and Treatment of Cancer - EORTC Active, not recruiting Wed, 20 Jan 2016 12:00:00 EST Clinical Significance of Platelet Reactivity on Clopidogrel During Off-pump Coronary Artery BypassCondition: Coronary Artery DiseaseIntervention: Drug: Dual antiplatelet therapy including aspirin and clopidogrel after off-pump coronary bypass surgery Sponsor: Yonsei University Completed Wed, 09 Oct 2013 12:00:00 EDT Smart Nitinol Stent System for the Treatment of Severe Atherosclerotic Carotid StenosisCondition: Carotid Artery StenosisInterventions: Device: Smart nitinol stent implantation; Drug: antiplatelet drug Sponsor: Beijing Jishuitan Hospital Completed Wed, 15 Jun 2016 12:00:00 EDT Safety and Efficacy of Left Atrial Appendage Closure Versus Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing Drug-Eluting Stent Implantation Due to Complex Coronary Artery DiseaseConditions: Atrial Fibrillation; Coronary Artery DiseaseInterventions: Drug: Dabigatrain plus aspirin; Drug: Dabigatrain plus clopidogrel; Device: Amplazter Cardiac Plug (ACP) Sponsor: Yonsei University Terminated Tue, 17 Nov 2015 12:00:00 EST The Middle East Dual Anti-platelet Treatment in Acute Transient Ischemic AttackConditions: Transient Ischemic Attacks; Minor StrokeIntervention: Drug: anti-thrombotic treatment using Aspirin (ASA 75-325mg) and Clopidogrel (75mg) Sponsor: University of Alberta Unknown status Thu, 22 May 2014 12:00:00 EDT Comparison of Anti-coagulation and Anti-Platelet Therapies for Intracranial Vascular AtherostenosisConditions: Intracranial Arteriosclerosis; StrokeInterventions: Drug: Ticagrelor + Aspirin; Drug: Rivaroxaban + Aspirin; Drug: Clopidogrel + Aspirin; Other: Risk Factor Management Sponsors: University of Florida; National Institute of Neurological Disorders and Stroke (NINDS); University of Cincinnati; Medical University of South Carolina; Janssen Scientific Affairs, LLC; AstraZeneca Not yet recruiting Fri, 17 Sep 2021 12:00:00 EDT Prevention of Non-Surgical Bleeding by Management of HeartMate II Patients Without Antiplatelet TherapyCondition: Heart FailureInterventions: Device: HeartMate II (HMII); Drug: Warfarin; Drug: acetylsalicylic acid (ASA) therapy Sponsor: Abbott Medical Devices Completed Tue, 19 Jul 2016 12:00:00 EDT Pulsed Radiofrequency for Frozen Shoulder Chronic Pain (PRFFSCP)Condition: Frozen ShoulderInterventions: Device: pulsed radiofrequency; Drug: NSAIDs "ibubrofen,Aspirin" Sponsor: Assiut University Unknown status Wed, 07 Mar 2018 12:00:00 EST Aggrenox Prevention of Access StenosisCondition: Kidney FailureInterventions: Drug: Aggrenox; Drug: Placebo Sponsors: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); The Cleveland Clinic; Boston University; Duke University; University of Iowa; MaineHealth; University of Texas Southwestern Medical Center; University of Alabama at Birmingham; Washington University School of Medicine; Baystate Medical Center; Vanderbilt University; CAMC Health System; Emory University; St. Louis University; Tyler Nephrology Associates; Vascular Surgery Associates LLC Completed Wed, 13 Aug 2003 12:00:00 EDT Treatment of Coronary Heart Disease With AmilorideCondition: Coronary Heart DiseaseInterventions: Drug: Amiloride; Drug: Nitrates, clopidogrel, aspirin, statins Sponsors: University of Carabobo; Clinical Research Unit at the Docent Institute of Urology; Northern Metropolitan Hospital; Venezuelan Foundation of Heart Failure Completed Mon, 01 Nov 2010 12:00:00 EDT
Patent Foramen Ovale Closure or Anticoagulants Versus Antiplatelet Therapy to Prevent Stroke RecurrenceConditions: Ischemic Stroke; Patent Foramen Ovale; Atrial Septal Aneurysm; MigraineInterventions: Drug: aspirin; Drug: Antivitamins K or rivaroxaban or dabigatran or apixaban; Device: Devices for PFO closure Sponsor: Assistance Publique - Hôpitaux de Paris Completed Thu, 22 Nov 2007 12:00:00 EST Comparative Pharmacokinetics of YH14659Condition: Acute Coronary SyndromeInterventions: Drug: YH14659; Drug: clopidogrel & aspirin Sponsor: Yuhan Corporation Completed Tue, 23 Aug 2011 12:00:00 EDT REstart or STop Antithrombotic Randomised Trial in FranceCondition: Cerebral HemorrhageIntervention: Drug: Clopidogrel or Aspirin and/or Dypyridamole Sponsors: University Hospital, Lille; Région Hauts de France, France; Ministry of Health, France Recruiting Thu, 17 Nov 2016 12:00:00 EST Risk Stratification Procedure for Thromboembolism ProphylaxisCondition: Total Knee Replacement SurgeriesIntervention: Drug: acetylsalicylic acid Sponsors: Ministry of Health, Saudi Arabia; Prince Sultan Military College of Health Sciences; Universiti Sains Malaysia Completed Wed, 24 Jul 2019 12:00:00 EDT Targeting Platelets in Chronic HIV InfectionCondition: HIV-1 InfectionInterventions: Drug: Clopidogrel; Drug: Aspirin; Drug: Placebo Sponsors: Icahn School of Medicine at Mount Sinai; National Heart, Lung, and Blood Institute (NHLBI) Completed Mon, 19 Oct 2015 12:00:00 EDT Cognitive Decline in Asymptomatic Intracranial Stenosis Patients: A 1-Year Follow-Up StudyConditions: Magnetic Resonance Imaging; Asymptomatic Intracranial Stenosis; Medical TreatmentIntervention: Drug: Aspirin Tablet, Clopidogrel Bisulfate Tablets and Atorvastatin Sponsor: Anhui Medical University Recruiting Tue, 20 Apr 2021 12:00:00 EDT On-treatment PLAtelet Reactivity-guided Therapy Modification FOR ST-segment Elevation Myocardial InfarctionCondition: Acute ST-elevation Myocardial InfarctionIntervention: Drug: Antiplatelet Regimen Modification (aspirin or ticagrelor) Sponsor: Clinical Centre of Serbia Terminated Mon, 03 Dec 2012 12:00:00 EST The Influence of Smoking Status on Prasugrel and Clopidogrel Treated Subjects Taking Aspirin and Having Stable Coronary Artery DiseaseCondition: Coronary Artery DiseaseInterventions: Drug: Prasugrel; Drug: Clopidogrel Sponsor: Daiichi Sankyo, Inc. Completed Wed, 15 Dec 2010 12:00:00 EST Management of High Bleeding Risk Patients Post Bioresorbable Polymer Coated Stent Implantation With an Abbreviated Versus Prolonged DAPT RegimenConditions: High Bleeding Risk; Coronary Artery Disease; PCIInterventions: Drug: Aspirin; Drug: P2Y12 inhibitor Sponsors: ECRI bv; Cardialysis B.V.; European Cardiovascular Research Center; University of Bern; Terumo Medical Corporation Completed Wed, 18 Jan 2017 12:00:00 EST Study Comparing Esomeprazole and ASA Combined Together as One Capsule Versus These Medications Taken SeparatelyCondition: Peptic Ulcer DiseaseInterventions: Drug: Esomeprazole/ASA Fixed Combination; Drug: Esomeprazole; Drug: ASA Sponsor: AstraZeneca Terminated Wed, 18 Nov 2009 12:00:00 EST
Clopidogrel For the Prevention of New Onset Migraine Headache Following Transcatheter Closure of Atrial Septal DefectsCondition: MigraineIntervention: Drug: Clopidogrel Sponsors: Laval University; Sanofi; Bristol-Myers Squibb Completed Thu, 27 Nov 2008 12:00:00 EST Efficacy of Immunoglobulin Plus Infliximab for the Early Regression of Coronary Artery Lesion in Kawasaki DiseaseCondition: Kawasaki DiseaseInterventions: Drug: IVIG; Drug: Aspirin; Drug: Infliximab Sponsors: Children's Hospital of Fudan University; Shanghai Children's Hospital; Shanghai Children's Medical Center; Xinhua Hospital, Shanghai Jiao Tong University School of Medicine; Shanghai 10th People's Hospital Withdrawn Wed, 02 Sep 2020 12:00:00 EDT Prevalence and Profile of Aspirin Resistance in Hemodialysis PatientsCondition: Aspirin ResistanceIntervention: Sponsors: Northwell Health; Staten Island University Hospital Completed Mon, 17 Nov 2008 12:00:00 EST To Determine the Feasibility of a Clinical Trial Comparing Anticoagulants Versus Antiplatelets in the Acute Treatment of Patients With Cervical Artery DissectionConditions: Cervical Artery Dissection; Carotid Artery Dissection; Vertebral Artery Dissection; StrokeInterventions: Drug: Antiplatelet (Aspirin, Dipyridamole, clopidogrel); Drug: Anticoagulant (Unfractionated Heparin, LMW Heparin, Warfarin) Sponsors: St George's, University of London; The Stroke Association, United Kingdom Completed Thu, 13 Oct 2005 12:00:00 EDT Vinpocetine Inhibits NF-κB-dependent Inflammation in Acute Ischemic Stroke PatientsConditions: Stroke; Immunoregulation; Inflammation; VinpocetineInterventions: Drug: vinpocetine; Drug: Aspirin Sponsor: Tianjin Medical University General Hospital Completed Thu, 25 Aug 2016 12:00:00 EDT Ticagrelor Compared to Clopidogrel in Acute Coronary SyndromesCondition: Acute Coronary SyndromeInterventions: Drug: Ticagrelor 90mg; Drug: Clopidogrel 75mg; Drug: acetylsalicylic acid (ASA) 81mg Sponsors: McGill University Health Centre/Research Institute of the McGill University Health Centre; Canadian Institutes of Health Research (CIHR) Active, not recruiting Thu, 15 Aug 2019 12:00:00 EDT Cardiovascular Disease (CVD) Risk and Prevention in Early Glucose IntoleranceConditions: Impaired Glucose Tolerance; Prediabetic StateInterventions: Drug: Aspirin; Drug: Alpha lipoic acid; Drug: Olmesartan; Drug: Placebo Sponsors: Emory University; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Daiichi Sankyo, Inc.; National Center for Research Resources (NCRR) Completed Fri, 22 Jul 2005 12:00:00 EDT Effects of Optimized Antiplatelet Treatment After Percutaneous Coronary InterventionConditions: Ischemic Heart Disease; Acute Coronary SyndromesIntervention: Drug: cilostazol in addition to aspirin and clopidogrel Sponsor: Shenyang Northern Hospital Completed Wed, 29 Nov 2006 12:00:00 EST Reversal of the Anti-platelet Effects of TicagrelorCondition: Coronary Artery DiseaseInterventions: Drug: Ticagrelor; Drug: Aspirin + Ticagrelor; Drug: Control Sponsors: The First Affiliated Hospital with Nanjing Medical University; National Natural Science Foundation of China Completed Mon, 09 Mar 2015 12:00:00 EDT Efficacy of Immunoglobulin Plus Prednisolone in Reducing Coronary Artery Lesion in Patients With Kawasaki DiseaseCondition: Kawasaki DiseaseInterventions: Drug: IVIG; Drug: Aspirin; Drug: Prednisolone Sponsors: Children's Hospital of Fudan University; Jiangxi Province Children's Hospital; First People's Hospital of Hangzhou; Shengjing Hospital; The First Hospital of Jilin University; Chengdu Women's and Children's Central Hospital; Children's Hospital of Chongqing Medical University; Inner Mongolia People's Hospital; Sichuan Provincial People's Hospital; Wuhan Union Hospital, China; Third Affiliated Hospital of Zhengzhou University; Children's Hospital Of Soochow University; Yuying Children's Hospital of Wenzhou Medical University; Beijing Children's Hospital; Qilu Hospital of Shandong University Recruiting Fri, 06 Sep 2019 12:00:00 EDT
Human Umbilical Cord Mesenchymal Stem Cell Therapy for Cerebral Infarction Patients in Convalescent Period.Condition: Cerebral InfarctionInterventions: Biological: Allogeneic umbilical cord mesenchymal stem cell; Drug: Aspirin Enteric-coated Tablets & Atorvastatin Calcium Sponsor: Sclnow Biotechnology Co., Ltd. Suspended Mon, 05 Jun 2017 12:00:00 EDT Post-operative Treatment of Diabetic Peripheral Arterial Disease Guided by Platelet Reactivity UnitCondition: Peripheral Artery DiseaseInterventions: Other: platelet (P2Y12) reaction units; Drug: ticagrelor; Drug: Comparator Sponsor: Chang Gung Memorial Hospital Unknown status Thu, 05 May 2016 12:00:00 EDT Effect of Glucose Control on the Response to Aspirin in Type 2 Diabetic PatientsCondition: Diabetes Mellitus, Type IIIntervention: Sponsor: Hadassah Medical Organization Completed Tue, 01 Apr 2008 12:00:00 EDT Anti-platelet Therapy in the Prevention of Cardiovascular Disease in Patients With COPD (APPLE-COPD: ICON 2)Condition: Chronic Obstructive Pulmonary Disease (COPD)Interventions: Drug: Ticagrelor; Drug: Aspirin; Drug: Placebo Aspirin; Drug: Placebo Ticagrelor Sponsors: Newcastle-upon-Tyne Hospitals NHS Trust; AstraZeneca; Newcastle University Completed Wed, 04 Apr 2018 12:00:00 EDT Physiopathology of Rapid Aspirin DesensitizationConditions: Hypersensitivity; Coronary Artery DiseaseIntervention: Sponsor: Assistance Publique - Hôpitaux de Paris Completed Thu, 06 May 2010 12:00:00 EDT Twelve vs 24 Months of Dual Antiplatelet Therapy in Patients With Coronary Revascularization for In-stent RestenosisCondition: Percutaneous Coronary InterventionInterventions: Drug: 12 months of P2Y12 receptor antagonist; Drug: 24 months of P2Y12 receptor antagonist; Drug: Aspirin Sponsor: Beijing Anzhen Hospital Unknown status Mon, 30 Mar 2015 12:00:00 EDT The Dual Antiplatelet Therapy Study (DAPT Study)Condition: Coronary Artery DiseaseInterventions: Drug: Placebo & Aspirin; Drug: Clopidogrel & Aspirin, Prasugrel & Aspirin Sponsors: Baim Institute for Clinical Research; Abbott; Boston Scientific Corporation; Bristol-Myers Squibb; Sanofi-Synthelabo; Cordis Corporation; Eli Lilly and Company; Daiichi Sankyo, Inc.; Medtronic Completed Wed, 16 Sep 2009 12:00:00 EDT CYPRESS - CYPHER for Evaluating Sustained SafetyCondition: Coronary Artery DiseaseInterventions: Drug: Clopidogrel & Aspirin, Prasugrel & Aspirin; Drug: Placebo & Aspirin Sponsor: Cordis Corporation Unknown status Fri, 07 Aug 2009 12:00:00 EDT Electrophilic Fatty Acid Derivatives in AsthmaConditions: Asthma; Electrophilic Fatty AcidsInterventions: Drug: Aspirin; Drug: Indomethacin Sponsor: Sally E. Wenzel MD Completed Tue, 27 Nov 2012 12:00:00 EST CARNIVAL Study: Gut Flora Dependent Metabolism of Dietary CARNItine and Phosphatidylcholine and cardioVAscuLar DiseaseCondition: Dietary ModificationInterventions: Dietary Supplement: Carnitine; Dietary Supplement: Choline; Drug: Antibiotics; Drug: Choline and Aspirin; Drug: Carnitine and Aspirin Sponsor: The Cleveland Clinic Enrolling by invitation Wed, 21 Nov 2012 12:00:00 EST
Additional Benefit of Cilostazol to Dual Antiplatelet Therapy After Biolimus-eluting Stent ImplantationCondition: Coronary Artery DiseaseInterventions: Drug: Cilostazol; Drug: Aspirin; Drug: Clopidogrel Sponsor: Yonsei University Completed Wed, 01 Sep 2010 12:00:00 EDT Aspirin Resistance and Prognosis of Patients With Critical Limb IschaemiaCondition: Aspirin ResistanceIntervention: Sponsor: University Hospital, Limoges Completed Thu, 15 Apr 2010 12:00:00 EDT The Effect of Salicylate on Platelet Function in CKD (Chronic Kidney Disease) Patients Treated With AranespCondition: Erythropoietin Adverse ReactionIntervention: Drug: Acetylsalicylic acid Sponsor: Zealand University Hospital Not yet recruiting Wed, 01 Apr 2020 12:00:00 EDT Pregnancy Outcomes in Women With Unexplained Recurrent Pregnancy Loss Treated With Low Dose Aspirin and Unfractionated HeparinCondition: Recurrent Pregnancy LossIntervention: Drug: Heparin Sponsor: Benha University Recruiting Wed, 21 May 2014 12:00:00 EDT Prevalence of Aspirin Resistance in Chronic Kidney Disease PatientsCondition: Chronic Kidney DiseaseIntervention: Sponsors: Northwell Health; Staten Island University Hospital Completed Thu, 02 Jun 2011 12:00:00 EDT Antiplatelet vs R-tPA for Acute Mild Ischemic StrokeCondition: StrokeInterventions: Drug: Aspirin; Drug: Clopidogrel 75mg; Drug: Alteplase Sponsor: General Hospital of Shenyang Military Region Recruiting Fri, 07 Sep 2018 12:00:00 EDT Study Comparing a Fixed-Dose Capsule of Esomeprazole 40mg and LDA 325mg With Free CombinationConditions: Ulcers; Upper GI SymptomsInterventions: Drug: Esomeprazole 40mg/ASA 325mg; Drug: Esomeprazole; Drug: ASA Sponsor: AstraZeneca Completed Tue, 03 Jun 2008 12:00:00 EDT Analgesic Efficacy of Orally Administered VTS-K for Pain ManagementCondition: Pain, AcuteIntervention: Drug: VTS-K Sponsor: Antonios Likourezos Recruiting Mon, 11 Jan 2021 12:00:00 EST Comparison of Effect & Safety of Clopidogrel Napadisilate With Clopidogrel Bisulfate in Coronary Artery Disease PatientsCondition: Coronary Artery Disease (CAD)Interventions: Drug: Clopidogrel; Drug: aspirin 100mg Sponsor: Hanmi Pharmaceutical Company Limited Completed Fri, 12 Apr 2013 12:00:00 EDT Effect of Aspirin Vs Omega 3 Fatty Acid After Scaling and Root Planing in Type II Diabetic Patients With Chronic PeriodontitisConditions: Periodontitis; Type2 DiabetesIntervention: Other: Scaling and root planing Sponsor: Panineeya Mahavidyalaya Institute of Dental Sciences & Research Centre Completed Thu, 26 Jul 2018 12:00:00 EDT
PGD2 Formation in Vascular InjuryConditions: Coronary Artery Disease; Acute Coronary Syndrome; Stable AnginaInterventions: Drug: No ASA; Drug: Low dose ASA; Drug: 325 mg ASA Sponsor: University of Pennsylvania Terminated Mon, 26 Oct 2009 12:00:00 EDT Prostaglandin Inhibition and Immune Checkpoint Blockade in MelanomaConditions: Stage III Cutaneous Melanoma; Stage IIIA Cutaneous Melanoma; Stage IIIB Cutaneous Melanoma; Stage IIIC Cutaneous Melanoma; Stage IV Cutaneous MelanomaInterventions: Drug: Aspirin; Biological: Ipilimumab; Other: Laboratory Biomarker Analysis; Biological: Pembrolizumab Sponsors: University of California, San Francisco; Merck Sharp & Dohme Corp. Active, not recruiting Thu, 11 Jan 2018 12:00:00 EST Efficacy of Ticagrelor vs Clopidogrel in High-risk NSTE-ACS Patients Undergoing Early PCICondition: Acute Coronary SyndromeInterventions: Drug: Ticagrelor; Drug: clopidogrel; Drug: Aspirin; Procedure: PCI Sponsor: RenJi Hospital Unknown status Mon, 28 Jul 2014 12:00:00 EDT Evaluation of a Modified Anti-Platelet Therapy Associated With Low-dose DES Firehawk in Acute Myocardial Infarction Patients Treated With Complete Revascularization StrategyConditions: Myocardial Infarction, Acute; Coronary Artery DiseaseInterventions: Drug: Shortened DAPT followed by P2Y12 inhibitor monotherapy (cessation of aspirin); Drug: Standard DAPT Sponsor: MicroPort CRM Not yet recruiting Mon, 15 Feb 2021 12:00:00 EST Determining Genetic Role in Treatment Response to Anti-Platelet Interventions (The PAPI Study)Conditions: Platelet Aggregation Inhibitors; Coronary Heart DiseaseInterventions: Drug: Clopidogrel; Drug: Aspirin Sponsors: University of Maryland, Baltimore; National Institute of General Medical Sciences (NIGMS); National Heart, Lung, and Blood Institute (NHLBI) Completed Thu, 27 Nov 2008 12:00:00 EST P2Y12 Inhibitor Monotherapy Versus Extended DAPT in Patients Treated With Bioresorbable ScaffoldConditions: Coronary Artery Disease; Stents; AtherosclerosisInterventions: Drug: Clopidogrel; Drug: Ticagrelor; Drug: Aspirin Sponsor: Samsung Medical Center Recruiting Tue, 18 Apr 2017 12:00:00 EDT PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhageConditions: Brain Ischemia; Intracranial HemorrhagesInterventions: Drug: Cilostazol; Drug: Probucol; Drug: Aspirin; Drug: placebo of cilostazol; Drug: placebo of aspirin; Device: ankle-brachial index (ABI); Device: intima-medial thickness (IMT); Device: new asymptomatic brain hemorrhage; Device: new ischemic lesions on follow-up FLAIR images Sponsors: Asan Medical Center; Korea Otsuka Pharmaceutical Co., Ltd. Unknown status Fri, 13 Nov 2009 12:00:00 EST Cilostazol Stroke Prevention Study for Antiplatelet CombinationCondition: Noncardioembolic Cerebral InfarctionInterventions: Drug: aspirin; Drug: clopidogrel; Drug: cilostazol Sponsors: Japan Cardiovascular Research Foundation; Otsuka Pharmaceutical Co., Ltd. Completed Tue, 26 Nov 2013 12:00:00 EST Prevalence and Level of Thienopyridine Resistance Seen in a Contemporary Percutaneous Coronary Intervention or Coronary Artery Bypass Graft PopulationCondition: Increased Drug ResistanceInterventions: Other: Thienopyridine resistance testing; Other: Aspirin resistance testing; Other: Genetic polymorphism assessment Sponsor: Medstar Health Research Institute Unknown status Wed, 03 Aug 2011 12:00:00 EDT Comparison of Cilostazol-based Triple Antiplatelet Therapy Versus Dual Antiplatelet Therapy for Outcomes of below-the Knee Endovascular Intervention in Patients With Critical Limb Ischemia (TAP CLI Study)Condition: Critical Limb IschemiaInterventions: Drug: Triple antiplatelet therapy (aspirin (100 mg), clopidogrel (75 mg), and cilostazol (200 mg) ); Drug: Dual antiplatelet therapy (aspirin (100 mg) and clopidogrel (75 mg)) using aspirin and clopidogrel; Drug: Dual antiplatelet therapy (aspirin (100 mg) and cilostazol (200 mg)) using aspirin and cilostazol Sponsor: Yonsei University Unknown status Tue, 12 Jul 2016 12:00:00 EDT
What is the Optimal antiplatElet and Anticoagulant Therapy in Patients With Oral Anticoagulation Undergoing revasculariSaTion 2.Conditions: Atrial Fibrillations; Heart Valve Prostheses; Acute Coronary Syndromes; Coronary Artery Diseases; Stroke; Bleeding; Myocardial InfarctionIntervention: Drug: Combination of chronic oral anticoagulation and a P2Y12 inhibitor with or without aspirin. Sponsors: R&D Cardiologie; St. Antonius Hospital Recruiting Fri, 18 Dec 2015 12:00:00 EST Cilostazol in Acute Ischemic Stroke Treatment (CAIST)Condition: Cerebral InfarctionInterventions: Drug: Cilostazol; Drug: Aspirin Sponsors: Korea Otsuka Pharmaceutical Co., Ltd.; Seoul National University Boramae Hospital; Korea Otsuka International Asia Arab Co., Ltd. Completed Fri, 06 Jan 2006 12:00:00 EST Endoscopic Mucosal Colonic Resection and Polypectomy Under AspirinCondition: PolypsIntervention: Procedure: Colonic polypectomy or endoscopic mucosal resection (EMR) Sponsor: Société Française d'Endoscopie Digestive Completed Tue, 29 Nov 2011 12:00:00 EST Aggravated Airway Inflammation: Research on Genomics and Optimal Medical Care (AirGOs-medical)Condition: Chronic Rhinosinusitis (Diagnosis)Interventions: Drug: Placebo Oral Tablet; Drug: Acetyl Salicylic Acid Sponsors: Sanna Salmi; University of Helsinki Recruiting Thu, 31 Jan 2019 12:00:00 EST Residual Platelet Activity Despite Aspirin Utilization in Coronary Heart DiseaseConditions: Coronary Heart Disease; Non ST-elevation Acute Coronary SyndromesIntervention: Sponsors: University of Sao Paulo General Hospital; Fundação de Amparo à Pesquisa do Estado de São Paulo Completed Thu, 28 Mar 2013 12:00:00 EDT Efficacy and Safety of Low Dose Ticagrelor in Patients With Unstable Angina Pectoris After Coronary Stent ImplantationConditions: Unstable Angina Pectoris; Coronary Stent ImplantationInterventions: Drug: Ticagrelor 90 mg; Drug: Ticagrelor 45 mg; Drug: Aspirin Sponsor: Xiaofan Wu Unknown status Wed, 08 Aug 2018 12:00:00 EDT Thrombolysis With rhPro-UK in 4.5-6 Hours After Acute Ischemic Stroke in a Double-blinded,Controlled TrialCondition: Acute Ischaemic StrokeInterventions: Drug: Recombinant human urokinase; Drug: Aspirin; Drug: rhPro-UK simulation agent; Drug: Aspirin simulation agent Sponsor: Tasly Biopharmaceuticals Co., Ltd. Completed Fri, 06 Jul 2018 12:00:00 EDT Duration of Platelet Inhibition by AspirinCondition: Coronary Artery DiseaseIntervention: Other: Platelet aggregation Sponsor: Hopital du Sacre-Coeur de Montreal Completed Fri, 02 May 2008 12:00:00 EDT Antiplatelet Activity of Aspirin in Infants After Aortopulmonary and Cavopulmonary ShuntsCondition: Congenital Heart DiseaseIntervention: Sponsor: University of Utah Completed Fri, 03 Aug 2012 12:00:00 EDT Antiplatelet Therapy in Heart TransplantationConditions: Cardiac Allograft Vasculopathy; Heart TransplantInterventions: Drug: Placebo; Drug: aspirin; Drug: Clopidogrel Sponsors: Ottawa Heart Institute Research Corporation; Canadian Institutes of Health Research (CIHR) Not yet recruiting Thu, 25 Feb 2021 12:00:00 EST
Application of Platelet Function Test in Prevention of Ischemic Events After Stent Placement in Intracranial AneurysmsConditions: Unruptured Intracranial Aneurysm; Stents; Antiplatelet DrugsInterventions: Drug: Aspirin and clopidogrel/Ticagrelor; Device: Light transmittance aggregometry Sponsor: Beijing Neurosurgical Institute Completed Tue, 18 Jun 2019 12:00:00 EDT CV004-007 Thrombosis Chamber StudyCondition: ThrombosisInterventions: Drug: BMS-986120; Drug: Aspirin; Drug: Clopidogrel Sponsor: Bristol-Myers Squibb Completed Fri, 08 May 2015 12:00:00 EDT Cilostazol Verse Asprin for Vascular Dementia in Poststroke Patients With White Matter LesionsConditions: Vascular Dementia; StrokeInterventions: Drug: Cilostazol; Drug: Aspirin Sponsors: Peking University First Hospital; Zhejiang Otsuka Pharmaceutical Co., Ltd. Completed Thu, 19 Feb 2009 12:00:00 EST Argatroban for Preventing Occlusion and Restenosis After Intracranial and Extracranial Artery StentingCondition: CVDInterventions: Drug: Argatroban; Drug: non-argatroban treated group Sponsor: Jinling Hospital, China Completed Fri, 16 Jul 2010 12:00:00 EDT Dabigatran Versus Conventional Treatment for Prevention of Silent Cerebral Infarct in Atrial Fibrillation Associated With Valvular DiseaseConditions: Atrial Fibrillation; Valve Heart DiseaseInterventions: Drug: Dabigatran; Drug: Acetylsalicylic acid; Drug: Warfarin Sponsors: Asan Medical Center; Boehringer Ingelheim Completed Tue, 06 Dec 2016 12:00:00 EST Clopidogrel and the Optimization of Gastrointestinal Events (COGENT-1)Conditions: Acute Coronary Syndrome; Myocardial Infarction; Coronary Artery Disease; Percutaneous Coronary InterventionInterventions: Drug: CGT-2168 (clopidogrel 75 mg/omeprazole 20 mg) and aspirin; Drug: Plavix (clopidogrel 75 mg) and aspirin Sponsor: Cogentus Pharmaceuticals Terminated Wed, 14 Nov 2007 12:00:00 EST The Impact of Factor Xa Inhibition on Thrombosis, Platelet Activation, and Endothelial Function in Peripheral Artery DiseaseCondition: Peripheral Arterial DiseaseInterventions: Drug: Rivaroxaban 2.5 Mg Oral Tablet; Drug: Placebo; Drug: Aspirin 81Mg Ec Tab Sponsors: Vanderbilt University Medical Center; National Heart, Lung, and Blood Institute (NHLBI) Not yet recruiting Wed, 18 Aug 2021 12:00:00 EDT Barrett's Esophagus - 315 - 3 Way Cross OverCondition: Barrett's EsophagusInterventions: Drug: Esomeprazole; Drug: Aspirin; Drug: Rofecoxib Sponsor: AstraZeneca Completed Tue, 18 Mar 2008 12:00:00 EDT Aspirin Resistance Reversibility in Diabetic PatientsCondition: Aspirin ResistanceIntervention: Drug: lysine acetylsalicylate Sponsor: Azienda Ospedaliera San Giovanni Battista Unknown status Thu, 05 Sep 2013 12:00:00 EDT The Study on Profile and Genetic Factors of Aspirin Resistance (ProGEAR Study)Conditions: Coronary Disease; Cerebral Infarction; Ischemic Attack, TransientIntervention: Sponsors: Ministry of Health, Labour and Welfare, Japan; The National Institute of Biomedical Innovation Completed Tue, 08 Nov 2005 12:00:00 EST
Clopidogrel Aspirin Therapy (CAT) Versus Apixiban Aspirin Therapy (AAT) After Lower Limb RevascularizationConditions: Ischemia; AnticoagulantsIntervention: Drug: Combination drug Sponsor: Mansoura University Recruiting Tue, 19 Nov 2019 12:00:00 EST XIENCE V® USA Dual Antiplatelet Therapy (DAPT) CohortConditions: Chronic Total Occlusion of Coronary Artery; Vascular Disease; Myocardial Ischemia; Coronary Artery Stenosis; Coronary Disease; Coronary Artery Disease; Coronary RestenosisInterventions: Drug: placebo + aspirin; Drug: clopidogrel + aspirin OR prasugrel + aspirin; Device: XIENCE V Everolimus Eluting Coronary Stent System (XIENCE V EECSS) Sponsors: Abbott Medical Devices; Baim Institute for Clinical Research; Bristol-Myers Squibb; Eli Lilly and Company; Daiichi Sankyo, Inc. Completed Tue, 20 Apr 2010 12:00:00 EDT Antiplatlet Effects of Standardized Tomato Extract in Hypertensive SubjectsConditions: Hypertension,Essential; ObesityInterventions: Drug: acetylsalicylic acid; Drug: Tomato Fruit Extract Sponsor: Beata Krasinska Completed Sun, 02 Jul 2017 12:00:00 EDT PeriOperative ISchemic Evaluation-2 TrialCondition: Cardiovascular DiseaseInterventions: Drug: Active Clonidine; Drug: Placebo Clonidine; Drug: Active ASA; Drug: Placebo ASA Sponsors: Hamilton Health Sciences Corporation; McMaster University Completed Tue, 09 Mar 2010 12:00:00 EST XIENCE 28 USA StudyConditions: Bleeding Disorder; Ischemic Stroke; Hemorrhagic Stroke; Hematological Diseases; Thrombocytopenia; Coagulation Disorder; Anemia; Renal Insufficiency; Coronary Artery DiseaseInterventions: Device: XIENCE; Drug: DAPT (aspirin and/or P2Y12 receptor inhibitor) Sponsor: Abbott Medical Devices Completed Thu, 24 Jan 2019 12:00:00 EST Antiplatelet Therapy for Patients Undergoing Transcatheter Aortic Valve ImplantationConditions: Aortic Valve Disease; Myocardial Infarction; Stroke; BleedingInterventions: Drug: Aspirin + clopidogrel; Drug: Aspirin monotherapy; Drug: OAC + clopicogrel; Drug: OAC monotherapy Sponsor: St. Antonius Hospital Completed Tue, 23 Sep 2014 12:00:00 EDT 1-month vs 12-month DAPT for ACS Patients Who Underwent PCI Stratified by IVUS: IVUS-ACS and ULTIMATE-DAPT TrialsCondition: Coronary Artery DiseaseInterventions: Drug: AntiPlatelet therapy; Procedure: Percutaneous coronary intervention Sponsor: Nanjing First Hospital, Nanjing Medical University Recruiting Mon, 03 Jun 2019 12:00:00 EDT Optimal Duration of Antiplatelet Therapy After Bioresorbable Vascular Scaffold Implantation to Reduce Late Coronary Arterial Thrombotic EventsConditions: Percutaneous Transluminal Coronary Angioplasty; Coronary DiseaseInterventions: Drug: aspirin and clopidogrel; Drug: Clopidogrel only Sponsors: Seung-Jung Park; CardioVascular Research Foundation, Korea Active, not recruiting Thu, 20 Oct 2016 12:00:00 EDT Enoxaparin in the Prevention of Placental Insufficiency in Pregnant WomenConditions: Placental Insufficiency; EnoxaparinInterventions: Drug: Enoxaparin 40 mg / 0.4 mL Prefilled Syringe; Drug: Aspirin 100 mg Oral Tablet, Enteric Coated Sponsor: Les Laboratoires des Médicaments Stériles Completed Fri, 18 May 2018 12:00:00 EDT Placebo and Active Controlled Study to Assess Efficacy and Tolerability of Aspirin Plus PseudoephedrineConditions: Common Cold; PharyngitisInterventions: Drug: Acetylsalicylic Acid (Aspirin Complex, BAYE4465) + Pseudoephedrine; Drug: Acetylsalicylic Acid (Aspirin, BAYE4465); Drug: Pseudoephedrine; Drug: Placebo Sponsor: Bayer Completed Thu, 04 Feb 2010 12:00:00 EST
Pharmacokinetic, Pharmacodynamic, Safety, and Efficacy Study of Rivaroxaban for Thromboprophylaxis in Pediatric Participants 2 to 8 Years of Age After the Fontan ProcedureCondition: ThrombosisInterventions: Drug: Rivaroxaban; Drug: Acetylsalicylic Acid Sponsors: Janssen Research & Development, LLC; Bayer Completed Wed, 27 Jul 2016 12:00:00 EDT Endothelial Function, Lipoproteins, and Inflammation With Low HDL Cholesterol in HIV: ER Niacin Versus FenofibrateCondition: HIV-1 InfectionInterventions: Drug: Niacin; Drug: Aspirin; Drug: Fenofibrate Sponsors: AIDS Clinical Trials Group; National Institute of Allergy and Infectious Diseases (NIAID) Completed Wed, 31 Aug 2011 12:00:00 EDT NeuroCognition After Carotid RecanalizationConditions: Cognition Disorder; Stroke; Occlusion CarotidInterventions: Procedure: Endovascular intervention; Drug: Aspirin and Clopidogrel (maximal medical Therapy) Sponsor: David Hasan Recruiting Tue, 07 Jan 2020 12:00:00 EST Association of PeriOPerative Aspirin-ResisTance and CardioVascular OutcomeCondition: Vascular SurgeryIntervention: Sponsor: University Hospital Heidelberg Unknown status Tue, 13 Aug 2019 12:00:00 EDT GLOBAL LEADERS: A Clinical Study Comparing Two Forms of Anti-platelet Therapy After Stent ImplantationCondition: Coronary Artery Disease (CAD)Interventions: Drug: Ticagrelor; Drug: Acetylsalicylic Acid; Drug: Clopidogrel Sponsors: ECRI bv; Biosensors International; AstraZeneca; The Medicines Company Completed Tue, 19 Mar 2013 12:00:00 EDT Prevention of Maternal and Perinatal Complications by Enoxaparin in Women With Previous Severe PreeclampsiaCondition: PreeclampsiaInterventions: Drug: Lovenox® (enoxaparin); Drug: Aspegic ® (Aspirin) Sponsor: Assistance Publique - Hôpitaux de Paris Completed Wed, 30 Sep 2009 12:00:00 EDT The Effects of COX-inhibiting Drugs on Skeletal Muscle Adaptations to Resistance Exercise in Healthy AdultsCondition: Skeletal Muscle Mass RegulationInterventions: Drug: Ibuprofen; Drug: Acetylsalicylic acid Sponsor: Karolinska Institutet Completed Mon, 24 Aug 2015 12:00:00 EDT A Pharmacodynamic Study to Evaluate the Effect of a Fixed Dose Combination Pill on Low Density Lipoprotein (LDL) CholesterolCondition: Elevated LDL CholesterolInterventions: Drug: Cardiovascular fixed dose combination pill (acetylsalicylic acid, simvastatin and ramipril),; Drug: Simvastatin Sponsor: Ferrer Internacional S.A. Terminated Fri, 30 Oct 2009 12:00:00 EDT Safety & Efficacy of Low Dose Aspirin / Ivermectin Combination Therapy for Treatment of Covid-19 PatientsCondition: Covid19Intervention: Drug: 3-dayIVM 200 mcg/kg/day/14-day 75mgASA/day + standard of care (intervention 1) Sponsors: Makerere University; Ministry of Health, Uganda; Mbarara University of Science and Technology; Joint Clinical Research Center Not yet recruiting Wed, 24 Feb 2021 12:00:00 EST NUTRITION: Natural Tocotrienol Against Ischemic Stroke EventConditions: Ischemic Stroke; Transient Ischemic Attack (TIA)Interventions: Other: Vitamin E tocotrienol (TCT) capsules ; Low dose Aspirin; Other: Placebo vehicle control Sponsors: Andrew Slivka; Government of Malaysia Completed Tue, 17 Apr 2012 12:00:00 EDT
L-arginine in Treatment of Intrauterine Growth RestrictionCondition: Intrauterine Growth Restriction AsymmetricalInterventions: Drug: L-arginine 1000 mg and Acetylesalicylic acid75mg; Drug: acetylsalicylic acid 75 mg Sponsor: Ain Shams University Unknown status Wed, 25 Oct 2017 12:00:00 EDT Evaluation Of HUK in Acute Stroke Patients: MRS and CTPCondition: Acute Ischemic StrokeInterventions: Drug: Human urinary kallidinogenase (HUK); Drug: aspirin® , clopidogrel® , atorvastatin® Sponsor: Xuanwu Hospital, Beijing Completed Tue, 13 Feb 2018 12:00:00 EST Platelet Reactivity After TAVI: A Multicenter Pilot StudyConditions: Severe Aortic Valve Stenosis; Transcatheter Aortic Valve Implantation; Transcatheter Aortic Valve ReplacementInterventions: Drug: Ticagrelor 90 mg twice per day during three months following TAVI; Drug: Aspirin 100 mg plus Clopidogrel 75 mg daily during three months following TAVI Sponsor: Hospital de Meixoeiro Completed Mon, 25 Aug 2014 12:00:00 EDT Comparison of Two Different Antiplatelet Preparations for an Unruptured Intracranial AneurysmConditions: Aneurysm, Cerebral; Endovascular ProceduresInterventions: Drug: Aspirin; Drug: Prasugrel; Drug: Clopidogrel; Drug: Cilostazol Sponsors: Seoul National University Hospital; Seoul National University Bundang Hospital Completed Tue, 10 Jul 2018 12:00:00 EDT Short-Term Dual Antiplatelet and Maintenance CloPidogrel Therapy After Drug-Eluting Stent ImplantationCondition: Coronary Artery DiseaseInterventions: Drug: Clopidogrel; Drug: Aspirin plus clopidogrel Sponsors: CHEOL WHAN LEE, M.D., Ph.D; CardioVascular Research Foundation, Korea; Medtronic; Chong Kun Dang Pharmaceutical Corp. Terminated Fri, 10 Jul 2015 12:00:00 EDT Vorapaxar as an Add-On Antiplatelet Therapy in Patients With and Without Diabetes MellitusConditions: Myocardial Infarction; Diabetes Mellitus; Peripheral Arterial DiseaseInterventions: Drug: Vorapaxar; Drug: Clopidogrel; Drug: Aspirin Sponsors: University of Florida; Merck Sharp & Dohme Corp. Completed Mon, 14 Sep 2015 12:00:00 EDT A Short and Long Intravenous Infusion Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of BMS-962212 in Healthy SubjectsCondition: ThrombosisInterventions: Drug: BMS-962212; Drug: Aspirin; Other: Placebo Sponsor: Bristol-Myers Squibb Completed Fri, 23 Jun 2017 12:00:00 EDT Sanchitongtshu Plus Asprine for Minor Ischemic Stroke or Transient Ischemic Attack: A Randomized Double-blind StudyConditions: Stroke, Acute; Ischemic Attack, TransientInterventions: Drug: Sanchitongshu; Drug: placebo of Sanchitongshu; Drug: Aspirin; Drug: Clopidogrel; Drug: placebo of clopidogrel Sponsor: Xinhua Hospital, Shanghai Jiao Tong University School of Medicine Unknown status Tue, 29 Nov 2016 12:00:00 EST The Vascular Biology of Dipyridamole in Peripheral Arterial Disease (PAD)Condition: Peripheral Arterial DiseaseInterventions: Drug: Dipyridamole 200mg and Aspirin 25mg bid:; Drug: Dipyridamole 200 mg bid; Drug: Aspirin 25 mg bid Sponsors: University of Pennsylvania; Boehringer Ingelheim Terminated Thu, 21 May 2009 12:00:00 EDT Pathways of Eicosanoid MetabolismCondition: Metabolism of Prostaglandin D2Interventions: Dietary Supplement: niacin; Drug: aspirin; Other: PGD2 Sponsors: Vanderbilt University; Vanderbilt University Medical Center Enrolling by invitation Thu, 09 Jul 2020 12:00:00 EDT
Aggressive Medical Treatment Evaluation for Asymptomatic Carotid Artery StenosisConditions: Carotid Artery Stenosis; Atherosclerosis; StrokeInterventions: Procedure: Carotid Endarterectomy; Drug: atorvastatin, aspirin, losartan, amlodipine Sponsor: Russian Cardiology Research and Production Center Terminated Tue, 09 Dec 2008 12:00:00 EST S.I.F.A. II: Prevention Of Thromboembolic Events In Patients With Nonrheumatic Atrial FibrillationCondition: Atrial FibrillationInterventions: Drug: indobufen; Drug: aspirin Sponsor: Pfizer Completed Wed, 26 Oct 2005 12:00:00 EDT Cardio-cerebrovascular Disease and Aspirin Ulcer Relapse EvaluationCondition: Cardio-cerebrovascular DiseaseInterventions: Drug: Low-dose PPI (Rabeprazole sodium); Drug: High-dose PPI (Rabeprazole sodium); Drug: Non-PPI (Gefarnate) Sponsors: Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan; Gastro-Intestinal Medical Care Research Center Completed Mon, 18 Jan 2010 12:00:00 EST The Clinical Utility of Thrombelastography in Guiding Prophylaxis of Venous Thromboembolism Following TraumaCondition: Venous ThromboembolismInterventions: Drug: Dalteparin sodium; Drug: Dalteparin sodium/aspirin Sponsors: Denver Health and Hospital Authority; Eisai Inc. Completed Fri, 15 Jan 2010 12:00:00 EST The Bochum Optimizing Clopidogrel-Aspirin Therapy and MORTality Study (BOCLA-Mort)Condition: Coronary Artery DiseaseIntervention: Sponsor: Ruhr University of Bochum Completed Fri, 22 Feb 2013 12:00:00 EST Optimization of Postpartum ThromboprophylaxisCondition: Venous ThromboembolismInterventions: Drug: Prophylactic low molecular weight heparin; Drug: Low molecular weight heparin and low-dose aspirin Sponsor: Mount Sinai Hospital, Canada Active, not recruiting Tue, 28 Sep 2021 12:00:00 EDT Sildenafil Citrate Added to Low Molecular Weight Heparin and Low Dose Aspirin in High-risk PregnancyCondition: High Risk PregnancyIntervention: Drug: Sildenafil Sponsor: Fayoum University Hospital Recruiting Tue, 01 Oct 2019 12:00:00 EDT The Safety and Efficacy of RIC on Adult Moyamoya DiseaseCondition: Moyamoya DiseaseInterventions: Device: RIC; Drug: Aspirin Sponsor: Capital Medical University Completed Tue, 09 Jul 2019 12:00:00 EDT Thromboxane B2 and Platelet Function Testing as Measures of Aspirin Resistance in Hong Kong Chinese PatientsCondition: Coronary DiseaseIntervention: Other: Blood samples will be taken to assess platelet function. There is no change in treatment. Sponsor: Chinese University of Hong Kong Completed Wed, 28 Apr 2021 12:00:00 EDT The Risk of Uncomplicated Peptic Ulcer in a Cohort of Secondary Prevention Aspirin UsersCondition: Uncomplicated Peptic UlcerIntervention: Sponsor: AstraZeneca Completed Wed, 20 Mar 2013 12:00:00 EDT
Comparative Pharmacokinetics of YH14659 in Healthy Male SubjectsCondition: Acute Coronary SyndromeInterventions: Drug: YH14659; Drug: clopidogrel & aspirin Sponsor: Yuhan Corporation Completed Fri, 03 Aug 2012 12:00:00 EDT Atorvastatin, Aspirin, Oxidative Stress, Coagulation and Platelet Activation IndexesConditions: Type 2 Diabetes Mellitus; HypercholesterolemiaInterventions: Drug: Atorvastatin; Drug: Placebo Sponsor: University of Roma La Sapienza Unknown status Fri, 25 Mar 2011 12:00:00 EDT Genetics and Genomics of Aspirin Exacerbated Respiratory Disease (AERD)Conditions: Aspirin Exacerbated Respiratory Disease; Aspirin-Sensitive Asthma; Nasal PolypsIntervention: Sponsors: National Jewish Health; The Scripps Research Institute Suspended Mon, 10 Feb 2020 12:00:00 EST Inducing Immune Quiescence to Prevent HIV Infection in WomenCondition: HIVInterventions: Drug: Acetylsalicylic Acid (ASA); Drug: Hydroxychloroquine (HCQ) Sponsors: University of Manitoba; University of Nairobi Completed Wed, 05 Mar 2014 12:00:00 EST Rabeprazole Specific Clinical Experience Investigation for the Long-term Combination Therapy With Low-dose AspirinConditions: Gastric Ulcer; Duodenal UlcerIntervention: Other: No Intervention Sponsor: Eisai Co., Ltd. Completed Wed, 22 Apr 2015 12:00:00 EDT The Clinical Benefit and Risk of Oral Aspirin for Unruptured Intracranial Aneurysm Combined With Cerebral IschemiaConditions: Intracranial Aneurysm; Cerebral IschemiaIntervention: Sponsors: Beijing Tiantan Hospital; Xuanwu Hospital, Beijing; Beijing Chao Yang Hospital; Beijing Friendship Hospital; The Second Hospital of Hebei Medical University; Tianjin Medical University General Hospital; Tianjin Huanhu Hospital Unknown status Wed, 27 Jul 2016 12:00:00 EDT Influence of Vorapaxar on Thrombin Generation and CoagulabilityConditions: Coronary Artery Disease; Peripheral Vascular Disease; Myocardial InfarctionInterventions: Drug: Vorapaxar; Drug: Vorapaxar and Aspirin; Drug: Vorapaxar and Clopidogrel; Drug: Vorapaxar, Aspirin, and Clopidogrel Sponsors: Inova Health Care Services; Merck Sharp & Dohme Corp. Completed Sun, 02 Jul 2017 12:00:00 EDT Optimal Duration of Clopidogrel in Second-Generation Drug-Eluting StentsCondition: Ischemic Heart DiseaseInterventions: Drug: 6-month dual anti-platelet therapy; Drug: 12-month dual anti-platelet therapy; Device: Zotarolimus eluting stent; Device: Biolimus eluting stent Sponsor: Gangnam Severance Hospital Completed Fri, 17 Feb 2017 12:00:00 EST Natural Language Processing and Quality Assessment in Primary CareCondition: DiabetesInterventions: Other: Brochure: Care of the Feet for Those at Risk; Other: Quality Survey: foot exam, tobacco and aspirin use Sponsor: Mayo Clinic Completed Wed, 02 Dec 2009 12:00:00 EST Challenge Test for Acetylsalicylic Acid HypersensitivityConditions: Asthma Aspirin-sensitive; ASA Intolerant Asthma; Asthma, Aspirin-Induced; Asthma, Nasal Polyps, and Aspirin IntoleranceInterventions: Drug: Acetylsalicylate; Drug: Isotonic NaCl Sponsors: Helse Stavanger HF; University Hospital, Akershus Unknown status Mon, 10 Sep 2012 12:00:00 EDT
Retinal Blood Flow and Microthrombi in Type 1 DiabetesConditions: Diabetes; Diabetic RetinopathyInterventions: Drug: aspirin; Drug: clopidogrel Sponsor: Schepens Eye Research Institute Completed Mon, 04 Dec 2006 12:00:00 EST Placebo and Active Controlled Study to Compare the Antipyretic Efficacy of Aspirin® in Patients With Acute Febrile Upper Respiratory Tract Infections Suspected to be of Viral OriginConditions: Respiratory Tract Infections; FeverInterventions: Drug: Acetylsalicylic acid (Aspirin, BAYE4465); Drug: Paracetamol; Drug: Placebo Sponsor: Bayer Completed Fri, 04 Nov 2011 12:00:00 EDT Prevention of Recurrent Ulcer Bleeding in High-risk Users of Low-dose AspirinCondition: Ulcer HemorrhageIntervention: Sponsor: Chinese University of Hong Kong Completed Wed, 19 Jan 2011 12:00:00 EST Effect of Berberine for Endothelial Function and Intestinal Microflora in Patients With Coronary Artery DiseaseConditions: Stable Coronary Artery Disease; Percutaneous Coronary InterventionInterventions: Drug: Berberine; Drug: Aspirin; Drug: Clopidogrel; Drug: Statin Sponsor: Peking Union Medical College Hospital Active, not recruiting Tue, 16 Jun 2020 12:00:00 EDT Trial to Assess the Safety and Effects of Vorapaxar in Japanese Subjects With Acute Coronary Syndrome (P04772; MK-5348-016)Conditions: Atherosclerosis; Myocardial Ischemia; Myocardial InfarctionInterventions: Drug: Vorapaxar; Drug: Placebo; Drug: Aspirin; Drug: Clopidogrel Sponsor: Merck Sharp & Dohme Corp. Completed Mon, 26 May 2008 12:00:00 EDT Comparison of Platelet Inhibition With Adjunctive Cilostazol Versus High Maintenance-Dose Clopidogrel According to Hepatic Cytochrome 2C19 Allele (CYP2C19) PolymorphismConditions: Coronary Artery Stenosis; Maximal Platelet Aggregation; Late Platelet Aggregation; High Post-Treatment Platelet ReactivityInterventions: Drug: cilostazol; Drug: clopidogrel; Drug: aspirin Sponsor: Gyeongsang National University Hospital Unknown status Fri, 01 May 2009 12:00:00 EDT Overcome Biochemical Aspirin Resistance Through Cilostazol CombinationCondition: Cerebral InfarctionInterventions: Drug: Cilostazol; Drug: placebo Sponsors: Asan Medical Center; Korea Otsuka Pharmaceutical Co., Ltd. Completed Tue, 13 Mar 2007 12:00:00 EDT Trial to Assess the Safety of Vorapaxar in Japanese Subjects With Cerebral Infarction (P05005; MK-5348-017)Condition: Cerebral InfarctionInterventions: Drug: Vorapaxar 2.5 mg; Drug: Vorapaxar 1 mg; Drug: Placebo; Drug: Aspirin 75-150 mg Sponsor: Merck Sharp & Dohme Corp. Completed Mon, 26 May 2008 12:00:00 EDT Therapeutic Utility of Xolair in Patients Undergoing Aspirin DesensitizationCondition: Aspirin SensitivityInterventions: Drug: Omalizumab; Drug: placebo Sponsors: David Lang; Genentech, Inc. Completed Fri, 09 Nov 2007 12:00:00 EST Assessment of the Efficacy of the First Aspirin Dose in Children Undergoing Surgery for Congenital Heart Disease (CHD) Who Require Post-operative Antiplatelet TherapyCondition: Congenital Heart DiseaseIntervention: Sponsor: University of Colorado, Denver Completed Mon, 17 Feb 2014 12:00:00 EST
Distal Venous Arterialisation of Ischemic LimbCondition: Critical Limb IschemiaInterventions: Procedure: distal venous arterialisation; Drug: Aspirin Sponsors: Clinical Centre of Serbia; University of California, Los Angeles Unknown status Thu, 30 Sep 2010 12:00:00 EDT Endovascular Stenting of Medically Refractory ICASD (Clinical and Sonographic Study)Condition: Stroke, IschemicInterventions: Device: Intracranial Stenting by Intracranial Stent Device; Drug: Optimum medical treatment Sponsor: Ain Shams University Completed Tue, 19 May 2020 12:00:00 EDT Quantitative Coronary Angiography Versus Imaging GUIDancE for Bioresorbable Vascular Scaffold ImplantationCondition: Percutaneous Transluminal Coronary AngioplastyInterventions: Procedure: QCA and Aspirin; Procedure: QCA and Clopidogrel; Procedure: Imaging guided and Aspirin; Procedure: Imaging guided and Clopidogrel Sponsors: Seung-Jung Park; CardioVascular Research Foundation, Korea Terminated Wed, 13 Jul 2016 12:00:00 EDT Prevention of Recurrent Ulcer Bleeding in High-risk Aspirin Users Who Are Not Infected With Helicobacter PyloriCondition: Ulcer BleedingIntervention: Sponsor: Chinese University of Hong Kong Completed Wed, 12 Jan 2011 12:00:00 EST Rivaroxaban for the Prevention of Major Cardiovascular Events in Coronary or Peripheral Artery DiseaseCondition: Prevention & ControlInterventions: Drug: Rivaroxaban (Xarelto, BAY59-7939); Drug: Aspirin; Drug: Aspirin placebo; Drug: Rivaroxaban placebo; Drug: Pantoprazole Sponsors: Bayer; Population Health Research Institute; Janssen Research & Development, LLC Completed Mon, 28 Jan 2013 12:00:00 EST A Study of the Antiplatelet Effects Comparing Ticagrelor (Ticag. - AZD6140) With Clopidogrel (Clop.) Responder and Non-respondersCondition: Stable Coronary Artery DiseaseInterventions: Drug: Ticagrelor; Drug: Clopidogrel; Drug: Aspirin Sponsor: AstraZeneca Completed Tue, 25 Mar 2008 12:00:00 EDT Study of the AFB and Stenting of the Iliac ArteriesCondition: Aorta-iliac Segment Lesion (C,D Type by TASC II)Interventions: Procedure: Aorta-femoral bypass; Procedure: Recanalization and stenting of aorta-iliac segment; Drug: Therapy: aspirin and clopidogrel Sponsor: Meshalkin Research Institute of Pathology of Circulation Active, not recruiting Tue, 05 Aug 2014 12:00:00 EDT Anticoagulant Therapy During Pacemaker ImplantationConditions: Hemorrhage; Thrombosis; EmbolismInterventions: Drug: Warfarin; Drug: Aspirin; Device: Permanent pacemaker; Device: Implantable Cardioverter-defibrillator Sponsors: University of Turku; Satakunta Central Hospital; Oulu University Hospital; Tampere University Hospital Completed Mon, 28 May 2007 12:00:00 EDT One Versus Twice Daily Administration of Multiple Cardiovascular Agents in Patients With Ischemic Heart DiseaseCondition: Ischemic Heart DiseaseIntervention: Drug: Aspirin, Atorvastatin, Perindopril Sponsor: University of Roma La Sapienza Not yet recruiting Mon, 04 Nov 2019 12:00:00 EST Atrial Fibrillation (AF) Patients Not Taking Vitamin-K Antagonist (VKA)Condition: Persistent or Permanent Non-valvular Atrial FibrillationInterventions: Drug: AZD0837; Drug: Aspirin Sponsor: AstraZeneca Completed Tue, 26 Feb 2008 12:00:00 EST
Gefitinib Combined With Thalidomide to Treat NSCLCCondition: NSCLCInterventions: Drug: Thalidomide; Drug: placebo; Drug: Gefitinib; Drug: Aspirin Sponsor: Bai Jun Unknown status Thu, 12 Mar 2015 12:00:00 EDT Feasibility of ExAblate MRI Guided High Intensity Focused Ultrasound Tx of Soft Tissue TumorsCondition: Soft Tissue NeoplasmsInterventions: Device: MRgHIFU; Drug: Aspirin; Drug: Enoxaparin Sponsor: Pejman Ghanouni Terminated Thu, 17 Oct 2013 12:00:00 EDT Platelet Inhibition of Ticagrelor Versus Clopidogrel in Type 2 Diabetic Patients After Elective Percutaneous Coronary InterventionConditions: Coronary Artery Disease; Diabetes Mellitus, Type 2Interventions: Drug: Ticagrelor; Drug: Clopidogrel; Drug: Aspirin Sponsor: Peking Union Medical College Hospital Completed Fri, 22 Apr 2016 12:00:00 EDT The Effect Of Antiplatelets Therapy On Saphenous Vein Coronary Artery Bypass Graft PatencyCondition: Coronary Artery DiseaseInterventions: Drug: Aspirin; Drug: Tirofiban; Drug: Clopidogrel; Drug: Prasugrel Sponsor: Prince Sultan Cardiac Center, Adult Cardiology Department. Unknown status Tue, 15 May 2012 12:00:00 EDT Efficacy of Chemopreventive Agents on Disease-free and Overall Survival in Patients With Pancreatic Ductal Adenocarcinoma: The CAOS StudyConditions: Disease Free Survival; Overall Survival; Pancreatic CancerIntervention: Behavioral: use of targeted drugs such as aspirin, B-Blockers, Metformin, ACE-inhibitors, Statins Sponsor: Massimo Falconi Recruiting Wed, 29 Jan 2020 12:00:00 EST Comparative Efficacy & Safety Study of D961H Versus Placebo for the Prevention of Gastric and Duodenal Ulcers With Low-dose AspirinCondition: PreventionInterventions: Drug: Esomeprazole; Drug: Placebo Sponsor: AstraZeneca Completed Wed, 17 Feb 2010 12:00:00 EST Alcohol Inhibits Drug Metabolism by CarboxylesterasesCondition: Drug InteractionsInterventions: Drug: Placebo; Drug: Ethanol; Drug: Oseltamivir; Drug: Aspirin Sponsor: University of Tennessee Completed Tue, 16 Oct 2012 12:00:00 EDT Low Dose Aspirin Studied With the AggreGuideCondition: Platelet AggregationIntervention: Sponsor: Edward R. Teitel, M.D. Completed Wed, 23 May 2012 12:00:00 EDT Safety of Cold Snare Polypectomy in Patients With Uninterrupted Antiplatelet AgentCondition: Post Polypectomy BleedingIntervention: Procedure: cold snare polypectomy Sponsors: Incheon St.Mary's Hospital; Seoul Hospital, Soonchunhyang University; St. Vincent's Hospital-Manhattan; Uijeongbu St. Mary's Hospital, The Catholic University of Korea; Soonchunhyang University Cheonan Hospital; Bucheon St. Mary's Hospital; Eunpyeong St. Mary's Hospital, The Catholic University of Korea; Soonchunhyang University Hospital; Gangneung Asan Hospital; Kyemyoung University Dongsan Medical Center Recruiting Wed, 01 Apr 2020 12:00:00 EDT A Phase III Study of Apixaban in Patients With Atrial FibrillationCondition: Atrial FibrillationInterventions: Drug: Apixaban; Drug: Acetylsalicylic acid Sponsors: Bristol-Myers Squibb; Pfizer Completed Wed, 04 Jul 2007 12:00:00 EDT
Chlorthalidone and HCTZ Impacts on Platelet ActivationCondition: HypertensionInterventions: Drug: Chlorthalidone 12.5 mg; Drug: Hydrochlorothiazide 25 mg; Drug: Aspirin 81 mg Sponsors: Creighton University; Dialysis Clinic, Inc. Unknown status Tue, 01 Apr 2014 12:00:00 EDT Helicobacter Eradication Aspirin TrialConditions: Gastrointestinal Ulcer Haemorrhage; Bacterial Infection Due to Helicobacter Pylori (H. Pylori)Interventions: Drug: Lansoprazole 30mg, Clarithromycin 500mg, Metronidazole 400mg; Drug: Placebo lansoprazole 30mg, clarithromycin 500mg, metronidazole 400mg Sponsors: University of Nottingham; Nottingham University Hospitals NHS Trust; University of Southampton; University of Durham; University of Birmingham; University of Oxford; Queen's University, Belfast Active, not recruiting Tue, 10 Jan 2012 12:00:00 EST Effect of Dietary Salicylate in Aspirin Exacerbated Respiratory DiseaseConditions: Chronic Rhinosinusitis; Aspirin Exacerbated Respiratory Disease; Asthma; Aspirin SensitivityInterventions: Behavioral: Low salicylate diet; Behavioral: Normal Diet Sponsor: Lawson Health Research Institute Completed Tue, 29 Jan 2013 12:00:00 EST A Healthy Female and Male Volunteers Aspirin StudyCondition: HealthyInterventions: Drug: Capsule ASA 81mg/esomeprazole 20mg; Drug: Acetylsalicylzuur Apotex Cardio Sponsor: AstraZeneca Completed Fri, 07 Oct 2011 12:00:00 EDT Alternate Dosing Regimens of BG00012 in Healthy VolunteersCondition: HealthyInterventions: Drug: Dimethyl Fumarate (BG00012); Drug: Aspirin; Drug: BG00012 matching placebo; Drug: ASA matching placebo Sponsor: Biogen Completed Fri, 21 Jan 2011 12:00:00 EST Esomeprazole or Famotidine in the Management of Aspirin Related Non-Ulcer DyspepsiaConditions: Aspirin; DyspepsiaInterventions: Drug: esomeprazole; Drug: Famotidine Sponsors: Ruttonjee Hospital; Queen Mary Hospital, Hong Kong Unknown status Wed, 16 Sep 2009 12:00:00 EDT Pilot Study Evaluating Alterations in Thrombogenicity and Platelet Reactivity Following Lower Extremity ArthroplastyCondition: Primary Total Hip and Knee ArthroplastyInterventions: Drug: Arixtra; Device: Pneumatic compression stockings; Drug: Aspirin Sponsors: LifeBridge Health; Haemonetics Corporation Completed Tue, 12 Mar 2013 12:00:00 EDT The Benefit of Add On DLBS1033 for Ischemic Stroke PatientCondition: Ischemic StrokeInterventions: Drug: DLBS1033; Drug: Aspirin; Drug: Statin; Drug: Vit B12 Sponsors: Duta Wacana Christian University; Dexa Laboratories Of Biomolecular Science Recruiting Thu, 11 Jun 2020 12:00:00 EDT Fixed Dose Combination Drug (Polypill)for Secondary Cardiovascular Prevention.Condition: Myocardial InfarctionInterventions: Drug: FDC; Drug: Separately drugs, simvastatin, aspirin and ramipril Sponsors: Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III; Mario Negri Institute for Pharmacological Research; Rusculleda Foundation Instituto DAMIC; Fundacion Clinic per a la Recerca Biomédica; ARTTIC International Management Services; Federación Argentina de Cardiología FAC; World Health Organization; Instituto de Salud Carlos III; Ferrer Internacional S.A. Completed Wed, 23 Mar 2011 12:00:00 EDT A Comparison of Prasugrel and Clopidogrel in Acute Coronary Syndrome SubjectsCondition: Acute Coronary SyndromeInterventions: Drug: Clopidogrel; Drug: Prasugrel; Drug: Commercially-available Aspirin Sponsors: Eli Lilly and Company; Daiichi Sankyo Co., Ltd.; Duke Clinical Research Institute Completed Wed, 18 Jun 2008 12:00:00 EDT
Elite Controller and ART-treated HIV+ Statin Versus ASA Treatment Intervention StudyCondition: Human Immunodeficiency VirusInterventions: Drug: Aspirin; Drug: Atorvastatin Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) Completed Fri, 07 Mar 2014 12:00:00 EST Acetylic Salicylic Acid for the Treatment of Chronic Obstructive Pulmonary DiseaseCondition: COPDIntervention: Drug: Acetylsalicylic acid Sponsor: Medical University of Vienna Unknown status Mon, 04 Apr 2011 12:00:00 EDT COX Inhibition and Biomarkers During Neoadjuvant Chemoendocrine Therapy for ER+, HER2- Stage I-III Breast CancerConditions: Breast Cancer; Estrogen Receptor-positive Breast CancerInterventions: Drug: Aspirin; Drug: Tamoxifen Pill; Drug: Doxorubicin; Drug: Cyclophosphamide; Drug: Paclitaxel Sponsor: University of Virginia Recruiting Tue, 30 Jul 2019 12:00:00 EDT Characterisation of Nasal Polyps in Patients With and Without Aspirin-exacerbated Respiratory DiseaseCondition: Polyp SinusIntervention: Other: biopsy Sponsors: Medical University of Vienna; AstraZeneca Completed Wed, 20 Feb 2019 12:00:00 EST Adjunctive Cilostazol Versus High Maintenance-dose ClopidogrEL in Acute Myocardial Infarction (AMI) Patients According to CYP2C19 PolymorphismCondition: Myocardial InfarctionInterventions: Drug: cilostazol; Drug: clopidogrel (Plavix); Genetic: CYP2C19; Drug: aspirin (Acetylsalicylic acid) Sponsor: Gyeongsang National University Hospital Completed Mon, 08 Jun 2009 12:00:00 EDT Secondary Prevention of Small Subcortical Strokes TrialConditions: Cerebrovascular Accident; HypertensionInterventions: Drug: aspirin; Drug: clopidogrel; Other: Target of Blood Pressure; Other: placebo Sponsors: University of British Columbia; National Institute of Neurological Disorders and Stroke (NINDS) Completed Thu, 24 Apr 2003 12:00:00 EDT COVID-19 Positive Outpatient Thrombosis Prevention in Adults Aged 40-80Condition: COVID-19Interventions: Drug: Apixaban 2.5 MG; Drug: Apixaban 5MG; Drug: Aspirin; Drug: Placebo Sponsors: Frank C Sciurba; National Heart, Lung, and Blood Institute (NHLBI) Active, not recruiting Tue, 04 Aug 2020 12:00:00 EDT Mechanisms of Action of AcetaminophenConditions: Myocardial Infarction; ArthritisInterventions: Drug: Aspirin First; Drug: Aspirin Last; Drug: Acetaminophen 1000 mg/d; Drug: Acetaminophen 4000 mg/d; Drug: Ibuprofen 800 mg/d Sponsor: University of Pennsylvania Completed Mon, 31 Mar 2008 12:00:00 EDT Intensive Medical Therapy for High-risk Intracranial or Extracranial Arterial StenosisConditions: Acute Stroke; Transient Ischemic AttackInterventions: Drug: Intensive antiplatelet; Drug: Standard antiplatelet; Drug: Immediate high-intensity statin; Drug: Delayed high-intensity statin Sponsors: Beijing Tiantan Hospital; Ministry of Science and Technology of the People's Republic of China Recruiting Fri, 17 Aug 2018 12:00:00 EDT Mildronate for Acute Ischemic StrokeCondition: Acute Ischemic StrokeInterventions: Drug: mildronate injection; Drug: cinepazide maleate injection; Drug: aspirin Sponsor: Xijing Hospital Completed Fri, 12 Apr 2013 12:00:00 EDT
Clopidogrel Response Evaluation and AnTi-Platelet InterVEntion in High Thrombotic Risk PCI PatientsCondition: Coronary Heart DiseaseInterventions: Drug: Clopidogrel 75mg; Drug: Clopidogrel 150mg; Drug: Aspirin 100mg; Drug: Cilostazol 100mg Sponsors: Chinese Academy of Medical Sciences, Fuwai Hospital; Beijing Municipal Health Bureau; Haemonetics Corporation; Zhejiang Otsuka Pharmaceutical Co., Ltd. Completed Wed, 30 Jan 2013 12:00:00 EST A Study on the Use of Tanakan® for Recovery of Neurological Impairment Following Ischaemic StrokeConditions: Stroke, Acute; Neurological ImpairmentInterventions: Drug: EGb761; Drug: Placebo; Drug: Acetylsalicylic acid Sponsor: Ipsen Completed Fri, 13 Jan 2006 12:00:00 EST PROMUS Element Plus US Post-Approval StudyCondition: Coronary Artery DiseaseInterventions: Device: PROMUS Element Plus Coronary Stent System; Drug: Aspirin; Drug: P2Y12 antagonist Sponsor: Boston Scientific Corporation Completed Wed, 02 May 2012 12:00:00 EDT A Project to Improve the Diagnosis and Prognosis of Myocardial Injury Associated to Non Cardiac SurgeryCondition: Myocardium; InjuryInterventions: Diagnostic Test: Troponin; Drug: Acetylsalicylic acid; Drug: Statin Sponsor: Parc de Salut Mar Active, not recruiting Fri, 28 Apr 2017 12:00:00 EDT Comparison of the VerifyNow® Aspirin Test and PRUTest® Platelet Reactivity Tests With Investigational Reagent to Reagents Registered in JapanConditions: Platelet Aggregation; Coronary Artery DiseaseIntervention: Sponsor: Accriva Diagnostics Active, not recruiting Mon, 06 Aug 2018 12:00:00 EDT A Safety and Efficacy Study of Lansoprazole in Preventing Aspirin-Induced Gastric and Duodenal UlcersConditions: Stomach Ulcer; Duodenal UlcerInterventions: Drug: Lansoprazole; Drug: Gefarnate Sponsor: Takeda Terminated Tue, 30 Sep 2008 12:00:00 EDT Efficacy of Short Term Dabigatran Etexilate Followed by Aspirin Monotherapy After LAA (Left Atrial Appendage) Device Closure (the DEA-LAA Study).Conditions: Atrial Fibrillation; Device Related Thrombus; Left Atrial Appendage Thrombosis; Watchman LAA Closure DeviceIntervention: Drug: Dabigatran Etexilate Oral Capsule Sponsors: Vanderbilt University Medical Center; Boehringer Ingelheim Active, not recruiting Tue, 29 May 2018 12:00:00 EDT A Pilot Study of Edoxaban in Patients With Non-Valvular Atrial Fibrillation and Left Atrial Appendage ClosureConditions: Non-Valvular Atrial Fibrillation; Left Atrial Appendage ClosureInterventions: Drug: Edoxaban; Device: WATCHMAN LAA Closure; Drug: Aspirin and Clopidogrel; Drug: Aspirin and Warfarin Sponsors: Scripps Health; Daiichi Sankyo, Inc. Unknown status Thu, 23 Mar 2017 12:00:00 EDT Thrombectomy In TANdem OcclusionConditions: Carotid Artery Diseases; Thrombectomy; Tandem Occlusion; StrokeInterventions: Device: Carotid Stenting; Drug: Procedural Aspirin; Drug: Dual dual antiplatelet therapy after 24-hours imaging follow-up; Procedure: Intracranial thrombectomy Sponsor: Central Hospital, Nancy, France Recruiting Fri, 07 Jun 2019 12:00:00 EDT Warfarin Prevents Portal Vein Thrombosis in Patients After Laparoscopic Splenectomy and Azygoportal DisconnectionConditions: Cirrhosis; Hypertension; Status;Splenectomy; Venous ThrombosisInterventions: Drug: Warfarin; Drug: Dipyridamole; Drug: Aspirin; Drug: Low Molecular Weight Heparin Sponsor: Yangzhou University Completed Thu, 25 Sep 2014 12:00:00 EDT
Warfarin Prevents Portal Vein Thrombosis in Liver Cirrhotic Patients With Hypersplenism After Laparoscopic SplenectomyConditions: Cirrhosis; Hypertension; Venous Thrombosis; Status; SplenectomyInterventions: Drug: Warfarin; Drug: Dipyridamole; Drug: Aspirin; Drug: Low Molecular Weight Heparin Sponsor: Yangzhou University Unknown status Fri, 12 Sep 2014 12:00:00 EDT Low-dose Acetylsalicylic Acid Before Non-cardiac SurgeryConditions: Surgery; Platelet DysfunctionIntervention: Other: preoperative questionnaires Sponsor: Universitätsklinikum Hamburg-Eppendorf Completed Fri, 10 Feb 2017 12:00:00 EST SAPT Versus DAPT in Incomplete Revascularization After CABGCondition: Coronary Artery DiseaseInterventions: Drug: Ticagrelor; Drug: acetylsalicylic acid Sponsor: Campus Bio-Medico University Recruiting Mon, 31 Dec 2018 12:00:00 EST Trial to Determine the Safety of Oral Ifetroban in Patients With a History of Aspirin Exacerbated Respiratory DiseaseCondition: Aspirin Exacerbated Respiratory Disease (AERD)Interventions: Drug: Ifetroban, Oral Capsule; Drug: Placebo, Oral Capsule Sponsor: Cumberland Pharmaceuticals Completed Wed, 13 Aug 2014 12:00:00 EDT Cross-over Study of Coronary Risk Factors With a PolypillCondition: Coronary Artery DiseaseInterventions: Drug: Polypill of acetylsalicylic acid, ramipril and atorvastatin; Drug: Drugs taken separately: acetylsalicylic acid, ramipril and atorvastatin Sponsor: Fundación para la Investigación Biosanitaria del Principado de Asturias Not yet recruiting Wed, 01 Sep 2021 12:00:00 EDT Aspirin Response in High Risk Patients With Coronary Artery DiseaseConditions: Coronary Artery Disease; Myocardial Infarction; Diabetes Mellitus; Renal Insufficiency, ChronicIntervention: Sponsors: University of Aarhus; Aarhus University Hospital Skejby; Danish Heart Foundation Unknown status Tue, 28 Jun 2011 12:00:00 EDT Paediatric Arteriopathy Steroid Aspirin ProjectCondition: Arterial Ischemic StrokeIntervention: Drug: Methylprednisolone + prednisolone Sponsors: Centre Hospitalier Universitaire de Saint Etienne; Ministry of Health, France Not yet recruiting Tue, 15 Aug 2017 12:00:00 EDT Efficacy of Ticagrelor Plus Aspirin in Minor Non-cardioembolic Ischemic StrokeConditions: Ischemic Stroke; Transient Ischemic AttackInterventions: Drug: Ticagrelor 90mg; Drug: Clopidogrel 75 mg Sponsor: Mazandaran University of Medical Sciences Recruiting Thu, 04 Feb 2021 12:00:00 EST Thrombolysis of Urokinase for Minor StrokeCondition: Minor StrokeInterventions: Drug: Urokinase thrombolysis; Drug: Aspirin;Clopidogrel Sponsors: The First Affiliated Hospital of Zhengzhou University; Beijing Tiantan Hospital; Shanghai 10th People's Hospital; General Hospital of Shenyang Military Region Not yet recruiting Tue, 09 Jun 2020 12:00:00 EDT Comparative Bioavailability Study of Two Test Products of Fixed Dose Combination Capsule of Acetylsalicylic Acid (ASA) and Pantoprazole (Each Capsule Contains ASA 100 mg and Pantoprazole 20 mg) Under Fed ConditionsCondition: Ulcers, Duodenal and GastricInterventions: Drug: Test 1= ASA 100 mg and pantoprazole 20 mg capsule formulation one; Drug: Test 2= ASA 100 mg and pantoprazole 20 mg capsule formulation two; Drug: ASA 100 mg tablet; Drug: Pantoprazole 20 mg gastro-resistant tablet Sponsors: GlaxoSmithKline; Piramal Clinical Research (Hyderabad, India) Completed Mon, 06 May 2013 12:00:00 EDT
Vorapaxar in Patients With Prior Myocardial Infarction Treated With Prasugrel and TicagrelorCondition: Myocardial InfarctionInterventions: Drug: Prasugrel; Drug: Vorapaxar; Drug: Aspirin; Drug: Ticagrelor Sponsors: University of Florida; Merck Sharp & Dohme Corp. Completed Thu, 10 Sep 2015 12:00:00 EDT Effect of Herbal Products on Platelet Function and ClottingCondition: Platelet Function TestInterventions: Drug: Curcuma longa; Drug: Angelica sinensis; Drug: Siwu Tang; Drug: Aspirin Sponsors: Singapore General Hospital; Singhealth Foundation Completed Wed, 11 Dec 2013 12:00:00 EST Ticagrelor in Human Endotoxemia Response to Human EndotoxemiaCondition: EndotoxemiaInterventions: Drug: ticagrelor; Drug: Clopidogrel; Drug: Acetylsalicylic acid lysinate; Drug: Placebo Sponsor: Radboud University Completed Mon, 23 Nov 2015 12:00:00 EST Recurrent Carotid StenosisConditions: Cardiovascular Diseases; Carotid Stenosis; Cerebrovascular Disorders; Heart Diseases; Vascular DiseasesInterventions: Drug: aspirin; Drug: dipyridamole Sponsors: Emory University; National Heart, Lung, and Blood Institute (NHLBI) Completed Thu, 28 Oct 1999 12:00:00 EDT Physicians' Health StudyConditions: Cardiovascular Diseases; Coronary Disease; Heart Diseases; Myocardial IschemiaInterventions: Drug: aspirin; Drug: carotene Sponsors: Brigham and Women's Hospital; National Heart, Lung, and Blood Institute (NHLBI) Completed Thu, 28 Oct 1999 12:00:00 EDT Platelet Drug Trial in Coronary Disease ProgressionConditions: Cardiovascular Diseases; Coronary Disease; Heart Diseases; Myocardial IschemiaInterventions: Drug: aspirin; Drug: dipyridamole Sponsor: National Heart, Lung, and Blood Institute (NHLBI) Completed Thu, 28 Oct 1999 12:00:00 EDT ASP (PPI_H2RA) Study-H2RA Versus PPI for the Prevention of Recurrent UGIB in High-risk Users of Low-dose ASACondition: Upper Gastrointestinal BleedingInterventions: Drug: Rabeprazole; Drug: Famotidine Sponsor: Chinese University of Hong Kong Completed Wed, 03 Aug 2011 12:00:00 EDT High Omega-3/Low Omega-6 Treatment Diet for Aspirin-exacerbated Respiratory Disease (AERD)Conditions: ASA Triad; Asthma, Nasal Polyps, And Aspirin IntoleranceIntervention: Behavioral: Restricting daily intake of omega-6 fatty acids to less than 4 grams and increasing omega-3 fatty acids to 3 grams Sponsor: Brigham and Women's Hospital Completed Mon, 17 Feb 2014 12:00:00 EST Standard Medical Management in Secondary Prevention of Ischemic Stroke in ChinaCondition: StrokeInterventions: Drug: Aspirin / Clopidogrel, Atorvastatin / Simvastatin; Drug: Asprin / Clopidogrel, Atorvastatin / Simvastatin Sponsor: Peking Union Medical College Hospital Completed Wed, 23 Apr 2008 12:00:00 EDT Peptic Ulcer Disease in Ischemic Heart Patients Taking Aspirin and Clopidogrel With or Without Proton Pump InhibitorConditions: Peptic Ulcer; Ulcer ComplicationsInterventions: Drug: lansoprazole; Drug: aluminum hydroxide 334 mg and Mg hydroxide 166 mg Sponsor: Taipei Veterans General Hospital, Taiwan Unknown status Tue, 03 Mar 2009 12:00:00 EST
Acute Coronary Syndrome Sri Lanka Audit ProjectConditions: Acute Coronary Syndrome; Unstable Angina; Non ST Elevation Myocardial Infarction; ST Elevation Myocardial InfarctionIntervention: Drug: aspirin, clopidogrel, statin, enoxaparin, streptokinase Sponsors: University of Colombo; Ministry of Health, Sri Lanka Withdrawn Thu, 08 Sep 2016 12:00:00 EDT Prevention of Recurrent Gastric or Duodenal Ulcers Caused by Low-dose Aspirin With Rabeprazole (E3810) Treatment (Planetarium Study)Condition: Gastric or Duodenal Ulcers Caused by Low-dose AspirinInterventions: Drug: E3810; Drug: Teprenone Sponsor: Eisai Co., Ltd. Completed Tue, 19 Jul 2011 12:00:00 EDT Long-term Prevention of Recurrent Gastric or Duodenal Ulcers Caused by Low-dose Aspirin With Rabeprazole (E3810) Treatment (Planetarium Study)Condition: Gastric Ulcers Duodenal Ulcers Caused by Low-dose AspirinIntervention: Drug: Rabeprazole Sponsor: Eisai Co., Ltd. Completed Wed, 20 Jul 2011 12:00:00 EDT Perioperative Aspirin Usage SurveyConditions: Surgery; Cardiovascular DiseaseIntervention: Behavioral: Survey Sponsor: University of New Mexico Completed Mon, 28 Sep 2015 12:00:00 EDT Study to Evaluate the Reinduction and Second Stop of TKI With Ponatinib in CML in Molecular Response (ResToP)Condition: Chronic Myeloid Leukemia, Chronic PhaseInterventions: Drug: Ponatinib 15 MG; Drug: Acetylsalicylic acid 100 MG Sponsors: Fundacion CRIS de Investigación para Vencer el Cáncer; Incyte Biosciences UK; Apices Soluciones S.L. Recruiting Wed, 13 Nov 2019 12:00:00 EST Misoprostol for Small Bowel Ulcers and Obscure Bleeding Due to Aspirin or Nonsteroidal Antiinflammatory DrugsConditions: Chronic Arthritis; Ischemic Heart Disease; Atrial Fibrillation; Anemia; BleedingInterventions: Drug: Misoprostol; Drug: Placebo Sponsor: NHS Greater Glasgow and Clyde Completed Tue, 29 Jul 2014 12:00:00 EDT Famotidine Compared With Pantoprazole to Prevent Recurrent Aspirin-Induced Peptic Ulcer/ErosionCondition: Peptic Ulcer/ErosionsIntervention: Drug: pantoprazole vs famotidine Sponsor: Ruttonjee Hospital Completed Fri, 13 Feb 2009 12:00:00 EST High-Shear Microfluidic Thrombosis AssayCondition: Coagulation Defects, Other and UnspecifiedIntervention: Sponsor: Emory University Completed Tue, 21 Apr 2015 12:00:00 EDT Effect of Sodium Glucose co Transporter 2 Inhibitor ( SGLT2) on Proteinuria in Diabetic PatientsCondition: Diabetic NephropathiesInterventions: Drug: SGLT2 inhibitor; Drug: ACE inhibitor Sponsor: Nahla H Tohami Recruiting Fri, 29 Jun 2018 12:00:00 EDT Study to Assess Safety and Efficacy of Ticagrelor (AZD6140) Versus Clopidogrel in Asian/Japanese Patients With Non-ST or ST Elevation Acute Coronary Syndromes (ACS)Conditions: Acute Coronary Syndrome; Percutaneous Coronary InterventionInterventions: Drug: Ticagrelor; Drug: Clopidogrel; Drug: Acetylsalicylic acid ASA Sponsor: AstraZeneca Completed Fri, 11 Feb 2011 12:00:00 EST
Influence of Esomeprazole on Antiplatelet Action of Clopidogrel Associated With AspirinConditions: Acute Coronary Syndrome; Acute Myocardial InfarctionInterventions: Drug: esomeprazole 20 mg daily; Drug: famotidine 40 mg daily Sponsor: Ruttonjee Hospital Completed Thu, 04 Feb 2010 12:00:00 EST Anticoagulation in Stent InterventionConditions: Atrial Fibrillation; StrokeInterventions: Drug: Acetylsalicylic Acid + clopidogrel + acenocoumarol; Drug: Acetylsalicylic Acid + clopidogrel Sponsor: Hospital Universitari Vall d'Hebron Research Institute Unknown status Thu, 10 Jun 2010 12:00:00 EDT "Normal Coronary Artery" With Slow Flow Improved by Adenosine Injection, Dipyridamole Treatment and Clinical Follow-upCondition: Coronary AngiographyInterventions: Drug: Statin, aspirin; Drug: Dipyridamole Sponsor: Hillel Yaffe Medical Center Unknown status Tue, 18 Aug 2009 12:00:00 EDT Prophylactic Anticoagulation for Catheter-related ThrombosisConditions: Venous Thrombosis Due to Central Venous Access Device (Disorder); Prophylactic Anticoagulation; Patients With TumorInterventions: Drug: Rivaroxaban 10mg; Drug: Aspirin 100mg; Drug: low molecule heparin Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University Recruiting Wed, 05 Feb 2020 12:00:00 EST Efficacy and Safety of Mildronate for Acute Ischemic StrokeCondition: Acute Ischemic StrokeInterventions: Drug: infusion of mildronate; Drug: placebo; Drug: aspirin Sponsor: Xijing Hospital Unknown status Wed, 27 Feb 2013 12:00:00 EST The Standardized Management of Hypertension in Rural ShaanxiCondition: HypertensionIntervention: Drug: Hydrochlorothiazide, Captopril, Nitrendipine, Aspirin Sponsor: First Affiliated Hospital Xi'an Jiaotong University Completed Fri, 01 May 2020 12:00:00 EDT Polypectomy in Patients Taking Dual Antiplatelet AgentsCondition: Colonic PolypsInterventions: Drug: Continue thienopyridine; Drug: Discontinue thienopyridine Sponsor: Incheon St.Mary's Hospital Unknown status Mon, 15 Aug 2016 12:00:00 EDT Mechanism of Dipyridamole Action in Platelets: in Vivo Study With Healthy VolunteersCondition: HealthyInterventions: Drug: Aggrenox; Drug: Persantin Retard; Drug: Acetylsalicylic acid Sponsor: Boehringer Ingelheim Completed Wed, 27 Aug 2014 12:00:00 EDT Effectivity and Safety of PFO Closure vs Medicine in Alleviating MigraineConditions: PFO - Patent Foramen Ovale; MigraineInterventions: Device: PFO closure device; Drug: Aspirin and clopidogrel; Drug: Triptans Sponsor: Guangdong Provincial People's Hospital Not yet recruiting Thu, 01 Jul 2021 12:00:00 EDT Combination Anti-Platelet and Anti-Coagulation Treatment After Lysis of Ischemic Stroke Trial (CATALIST)Condition: Ischemic StrokeInterventions: Drug: Aspirin; Drug: tinzaparin sodium; Drug: eptifibatide Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) Completed Mon, 26 May 2003 12:00:00 EDT
Appropriateness of Aspirin Use in Medical OutpatientsCondition: Primary Prevention of Cardiovascular DiseasesIntervention: Other: Non-interventional study Sponsor: Muğla Sıtkı Koçman University Unknown status Tue, 02 Jan 2018 12:00:00 EST Pharmacodynamic Study of Cilostazol in Healthy VolunteersCondition: HealthyInterventions: Drug: Cilostazol; Drug: Acetylsalicylic acid; Drug: Clopidogrel Sponsor: Otsuka Pharmaceutical Co., Ltd. Completed Fri, 18 Sep 2015 12:00:00 EDT Dupilumab for Aspirin-exacerbated Respiratory DiseaseCondition: Aspirin-exacerbated Respiratory DiseaseIntervention: Drug: Dupilumab Sponsor: Rochester General Hospital Completed Mon, 23 Jul 2018 12:00:00 EDT A Novel Strategy For Personalized Long-Term Dual Antiplatelet Therapy (RAPID EXTEND PILOT STUDY)Conditions: Stable Coronary Syndrome; Percutaneous Coronary Intervention; Antiplatelet Therapy; TicagrelorInterventions: Drug: Ticagrelor 60mg; Drug: Clopidogrel 75mg; Drug: Aspirin 81 mg Sponsor: Ottawa Heart Institute Research Corporation Terminated Fri, 21 Jul 2017 12:00:00 EDT PreventIon of IMT Progression in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage-IMT StudyConditions: Brain Ischemia; Intracranial HemorrhagesInterventions: Drug: cilostazol; Drug: Probucol; Drug: Aspirin; Drug: placebo of cilostazol; Drug: Placebo of aspirin; Device: Intima-medial thickness Sponsors: Asan Medical Center; Korea Otsuka Pharmaceutical Co., Ltd. Unknown status Fri, 26 Jun 2015 12:00:00 EDT Double Randomization of a Monitoring Adjusted Antiplatelet Treatment Versus a Common Antiplatelet Treatment for DES Implantation, and Interruption Versus Continuation of Double Antiplatelet TherapyConditions: Coronary Artery Disease; Acute Coronary SyndromeInterventions: Drug: Aspirin and clopidogrel / Prasugrel; Device: VerifyNow; Drug: Aspirin Sponsors: Assistance Publique - Hôpitaux de Paris; Allies in Cardiovascular Trials Initiatives and Organized; Institut National de la Santé Et de la Recherche Médicale, France; Sanofi; Bristol-Myers Squibb; Medtronic; Cordis Corporation; Fondation de France; Diagnostica Stago; Boston Scientific Corporation Completed Thu, 22 Jan 2009 12:00:00 EST Effect of Dupilumab on Aspirin IntoleranceCondition: AERD - Aspirin Exacerbated Respiratory DiseaseIntervention: Drug: Dupilumab Sponsor: Medical University of Vienna Recruiting Mon, 22 Jun 2020 12:00:00 EDT Therapeutic Control of Aspirin-Exacerbated Respiratory Disease With IfetrobanConditions: Nasal Polyps; Asthma, Aspirin-Induced; Aspirin-exacerbated Respiratory Disease; Aspirin-Sensitive Asthma With Nasal PolypsInterventions: Drug: Ifetroban; Drug: Placebo Sponsor: Brigham and Women's Hospital Recruiting Mon, 30 Oct 2017 12:00:00 EDT Aspirin Resistance and Sleep Apnea in Type-2 Diabetic PatientsConditions: Atherothrombosis; Type 2 Diabetes; Obstructive Sleep Apnea SyndromeIntervention: Device: CPAP Sponsor: University Hospital, Grenoble Terminated Mon, 11 Feb 2013 12:00:00 EST Warfarin and Antiplatelet Therapy in Chronic Heart FailureCondition: Heart FailureInterventions: Drug: Warfarin titrated to an INR of 2.5-3.0; Drug: Aspirin; Drug: Clopidogrel 75 Sponsors: US Department of Veterans Affairs; Sanofi-Synthelabo; Bristol-Myers Squibb Completed Mon, 01 Jan 2001 12:00:00 EST
ISAR-DAPT (A Comparative Evaluation of Efficacy and Safety in the 3-Months DAPT Group vs. the 6-Months DAPT Group of Patients Treated With the Coroflex ISAR Stent; A Prospective, Multicenter, Randomized, Open-Label Clinical Trial)Condition: Stable Angina, Unstable Angina, Silent Coronary Ischemia, Coronary Artery DiseaseInterventions: Device: Coroflex ISAR; Drug: 3 months DAPT; Drug: 6 months DAPT Sponsors: Ajou University School of Medicine; B. Braun Korea Co., Ltd. Unknown status Fri, 20 Nov 2015 12:00:00 EST Novel Treatment for Coronary Artery DiseaseCondition: Coronary Artery DiseaseInterventions: Drug: Placebo; Drug: amiloride Sponsors: University of Carabobo; Clinical Research Unit at the Instituto Docente de Urologia; Northern Metropolitan Hospital; Venezuelan Foundation of Heart Failure Unknown status Tue, 26 Oct 2010 12:00:00 EDT Biomarkers and Antithrombotic Treatment in Cervical Artery Dissection - TREAT-CADCondition: Cervical Artery DissectionInterventions: Drug: Acetylsalicylic acid; Drug: Vitamin K antagonist Sponsor: Stefan Engelter Completed Mon, 27 Jan 2014 12:00:00 EST Mechanisms of Alcohol Sensitivity in AERDConditions: Aspirin-Sensitive Asthma With Nasal Polyps; Samter's SyndromeInterventions: Dietary Supplement: Water; Dietary Supplement: Red wine; Dietary Supplement: Polyphenolic Compounds Sponsor: University of Virginia Unknown status Thu, 22 Feb 2018 12:00:00 EST Dual Antithrombotic Therapy With Dabigatran and Ticagrelor in Patients With ACS and Non-valvular AF Undergoing PCIConditions: Atrial Fibrillation; Antithrombotic Therapy; Acute Coronary Syndrome; Percutaneous Coronary InterventionsInterventions: Drug: Ticagrelor; Drug: Dabigatran Etexilate; Drug: Aspirin; Drug: Clopidogrel Sponsors: Medical University of Gdansk; Medical University of Warsaw; Nicolaus Copernicus University; Institute of Cardiology, Warsaw, Poland; Military Institute of Medicine, Poland; Bielanski Hospital; Medical University of Silesia; Poznan University of Medical Sciences; University of Opole, Poland; Medical University of Łódź; Voivodeship Hospital, Kielce, Poland; Voivode Specialist Hospital in Olsztyn, Poland; Medical University of Lublin; Pomeranian Medical University Szczecin; Central Clinical Hospital of the Ministry of Internal Affairs and Administration, Warsaw, Poland Not yet recruiting Tue, 05 Jan 2021 12:00:00 EST Aspirin and Clopidogrel Reactivity in Patients With Critical Limb Ischemia (CLI)Condition: Critical Limb IschemiaIntervention: Other: Blood draw only Sponsor: University of Southern California Completed Mon, 24 Mar 2014 12:00:00 EDT Nitric Oxide-Releasing Acetylsalicyclic Acid in Preventing Colorectal Cancer in Patients at High Risk of Colorectal CancerCondition: Colorectal CancerInterventions: Drug: nitric oxide-releasing acetylsalicylic acid derivative; Other: laboratory biomarker analysis; Procedure: biopsy Sponsors: Stony Brook University; National Cancer Institute (NCI) Completed Wed, 31 May 2006 12:00:00 EDT Rivaroxaban in Combination With Aspirin Alone or With Aspirin and a Thienopyridine in Patients With Acute Coronary Syndromes (The ATLAS ACS TIMI 46 Trial)Condition: Acute Coronary SyndromeInterventions: Drug: Rivaroxaban/Placebo; Drug: Placebo; Drug: Rivaroxaban Sponsors: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.; Bayer Completed Wed, 22 Nov 2006 12:00:00 EST Tailored Antiplatelet Therapy During Percutaneous Coronary Intervention in Patients With Diabetes MellitusCondition: Diabetes MellitusInterventions: Drug: Abciximab; Drug: control Sponsor: Seoul National University Bundang Hospital Completed Mon, 21 Nov 2011 12:00:00 EST New Topical Treatment for Continued Pain After ShinglesCondition: Postherpetic NeuralgiaInterventions: Drug: Epikeia coatings with aspirin; Drug: Epikeia coatings with lidocaine; Other: Epikeia coatings alone Sponsors: Biomedical Development Corporation; National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS); The University of Texas Health Science Center, Houston Completed Tue, 04 Dec 2007 12:00:00 EST
Testing a Community Intervention to Increase Aspirin UseConditions: Myocardial Infarction; StrokeInterventions: Other: Mass Media plus clinic intervention.; Other: Media Sponsor: University of Minnesota Completed Wed, 18 Nov 2015 12:00:00 EST Aspirin Mono Therapy 12-months After Drug-eluting Stents ImplantationCondition: Drug-eluting Stent (DES)Interventions: Drug: Atorvastatin (High dose statin treatment); Drug: Pravastatin (High dose statin treatment) Sponsor: Yonsei University Unknown status Mon, 19 Mar 2012 12:00:00 EDT Stroke Imaging Package Study of Intracranial Atherosclerosis ( SIPS-ICAS )Conditions: Acute Ischemic Stroke AIS; Intracranial Atherosclerosis ICASIntervention: Drug: aggressive medical management Sponsors: Wei-Hai Xu; Peking Union Medical College Hospital; General Hospital of Chinese Armed Police Forces; General Hospital of Shenyang Military Region; Subei People's Hospital of Jiangsu Province; Fujian Medical University Union Hospital; Tangshan Gongren Hospital; Third Affiliated Hospital, Sun Yat-Sen University; Qingdao Municipal Hospital; West China Hospital; Shanghai Tong Ren Hospital; Shanghai Ruijin Hospital, Shanghai Jiaotong University School of Medicine; The First Affiliated Hospital of University of South China; JiNing NO.1 People Hospital; Tongji Hospital; The University of HongKong-Shenzhen Hospital; Beijing Anzhen Hospital; Beijing Hospital; Peking University International Hospital; Beijing Tongren Hospital; China-Japan Friendship Hospital; Peking University First Hospital; Beijing Friendship Hospital; Beijing Chao Yang Hospital; Qilu Hospital of Shandong University (Qingdao); Shandong Provincial Hospital; The Second Hospital of Hebei Medical University; Hebei General Hospital; First Affiliated Hospital of Zhejiang University; China-Japan Union Hospital, Jilin University; Zhejiang Provincial Tongde Hospital; People's Hospital of Ningxia Hui Autonomous Region; Taiyuan Central Hospital of Shanxi Medical University; Hong Xinglong Central Hospital; Changzhi People's Hospital; Weihai Municipal Hospital; The first hospital affiliated to AMU (Southwest Hospital); Affiliated Taihe Hospital of Hubei University of Medicine; Nanshi Hospital of Nanyang Recruiting Thu, 25 Oct 2018 12:00:00 EDT Cilostazol-Aspirin Therapy Against Recurrent Stroke With Intracranial Artery StenosisCondition: Cerebrovascular DiseaseIntervention: Drug: Asprin, Cilostazol Sponsors: Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan; Foundation for Biomedical Research and Innovation; Neurology, Tokyo Women's Medical University, School of Medicine; Kobe City General Hospital; Tohoku University; Kyushu University; Department of Neurology, Saiseikai Central Hospital; China National Center for Cardiovascular Diseases Completed Fri, 02 Jun 2006 12:00:00 EDT Ticagrelor and Aspirin for the Prevention of Cardiovascular Events After Coronary Artery Bypass SurgeryCondition: Coronary Artery DiseaseInterventions: Drug: ticagrelor; Drug: Placebo Sponsors: Cardiology Research UBC; University of British Columbia Completed Wed, 15 Jun 2011 12:00:00 EDT Oral Ifetroban to Treat Aspirin Exacerbated Respiratory Disease (AERD)Condition: Asthma, Aspirin-InducedInterventions: Drug: Ifetroban Oral Capsule; Drug: Placebo Oral Capsule Sponsor: Cumberland Pharmaceuticals Recruiting Mon, 23 Jan 2017 12:00:00 EST Rifaximin and Misoprostol Combination Therapy for Healing of Small Bowel Ulcers in Aspirin UsersConditions: Small Bowel Disease; RifaximinInterventions: Drug: Rifaximin; Drug: Placebo oral tablet Sponsors: Chinese University of Hong Kong; Beijing Friendship Hospital Recruiting Fri, 24 May 2019 12:00:00 EDT Transcranial Doppler (TCD) Assessment During Early Anti-thrombotic Therapy After Bioprosthetic Aortic Valve ReplacementCondition: Aortic Valve DiseaseIntervention: Procedure: Prophylaxis of Thrombosis after aortic valve replacement Sponsors: Ottawa Heart Institute Research Corporation; Edwards Lifesciences Completed Tue, 24 Apr 2007 12:00:00 EDT Antithrombotic Effects of Ticagrelor Versus ClopidogrelCondition: Acute Coronary SyndromeInterventions: Drug: Ticagrelor + ASA + Bivalirudin; Drug: Clopidogrel + ASA + Bivalirudin Sponsors: Juan J Badimon; AstraZeneca Completed Tue, 17 Jul 2012 12:00:00 EDT The Effect of a Probiotic Strain on Aspirin-induced GI Damage.Condition: Side Effects of Acetylsalicylic Acid UseInterventions: Dietary Supplement: probiotic strain; Dietary Supplement: Placebo Sponsors: Chr Hansen; Atlantia Food Clinical Trials Completed Tue, 25 Jul 2017 12:00:00 EDT
Aspirin Resistance and Percutaneous Coronary Intervention (PCI)Condition: Stable AnginaInterventions: Drug: Intravenous Glycoprotein inhibitor + ASA, Clopidogrel; Drug: Antiplatelet Therapy (ASA, Clopidogrel) Sponsor: Icahn School of Medicine at Mount Sinai Completed Wed, 14 Apr 2010 12:00:00 EDT INVestIgation of rheumatiC AF Treatment Using Vitamin K Antagonists, Rivaroxaban or Aspirin Studies, Non-InferiorityCondition: Rheumatic Heart DiseaseInterventions: Drug: Rivaroxaban (20 mg); Drug: Vitamin K antagonists (VKA) Sponsors: Population Health Research Institute; University of Cape Town; Bayer Active, not recruiting Thu, 14 Jul 2016 12:00:00 EDT Safety And Efficacy of Low Dose Oral Anticoagulants And Aspirin TherapyCondition: Anticoagulation in PregnancyInterventions: Drug: Warfarin; Drug: phenindione Sponsor: Yasser Elnahas Completed Tue, 01 Jan 2013 12:00:00 EST Pharmacodynamic-pharmacokinetic Trial, of Slow Release ASA, in the Platelet Functionalism.Condition: Cardiovascular DiseaseInterventions: Drug: slow release acetyl salicylic acid; Drug: ASA; Drug: SR-ASA Sponsor: Rottapharm Spain Completed Mon, 22 Jan 2007 12:00:00 EST Simplified Anti-Thrombotic Therapy for FFRCondition: Coronary Artery DiseaseInterventions: Procedure: FFR; Drug: Aspirin; Drug: Clopidogrel; Drug: Bivalirudin Sponsor: Odessa Heart Institute Completed Tue, 10 Mar 2015 12:00:00 EDT Effect of Allopurinol on Mono and Co-administration With Statins on Platelets Reactivity on Diabetic Patiets Treated With Aspirin and InsulinCondition: Diabetes Mellitus Type 2 Platelets Reactivity StatinInterventions: Drug: Atorvastatin 80mg; Drug: ALLOPURINOL 300 MG; Drug: Atorvastatin 80mg AND allopurinol 300 mg Sponsor: University of Roma La Sapienza Unknown status Thu, 22 Jun 2017 12:00:00 EDT ASA vs. Rivaroxaban in Newly Diagnosed or Relapsed and Refractory Multiple Myeloma Patients Treated With Len-Dex Combination Therapy.Conditions: Multiple Myeloma in Relapse; Multiple Myeloma Progression; Multiple Myeloma Stage II; Multiple Myeloma Stage I; Multiple Myeloma With Failed Remission; Multiple Myeloma Stage IIIInterventions: Drug: Rivaroxaban; Drug: ASA Sponsors: Lawson Health Research Institute; The Ottawa Hospital; Dalhousie University; St. Boniface Hospital; Hamilton Health Sciences Corporation Unknown status Fri, 09 Feb 2018 12:00:00 EST Study of Combined Therapy of Aspirin and "IVIG-SN" in Kawasaki DiseaseCondition: Kawasaki DiseaseIntervention: Drug: immunoglobulin G Sponsor: Green Cross Corporation Completed Thu, 02 Feb 2012 12:00:00 EST Platelet Administration To Patients With Traumatic Brain Injury Who Were Treated With AspirinConditions: Aspirin Treatment; Traumatic Intracranial Bleed; Hemorrhage Growth; Neurological OutcomeIntervention: Drug: platelets Sponsor: Tel-Aviv Sourasky Medical Center Unknown status Thu, 03 Jun 2010 12:00:00 EDT Special Drug Use Surveillance of Vonoprazan for "Prevention of Recurrence of Gastric/Duodenal Ulcer in Patients Receiving Low-dose Aspirin: Long-term Use"Condition: Gastric or Duodenal UlcersIntervention: Drug: Vonoprazan Sponsor: Takeda Completed Tue, 11 Jul 2017 12:00:00 EDT
Comparison of the Efficacy and Safety of Closone and Clopidogrel With AspirinCondition: Coronary Artery DiseaseInterventions: Drug: Closone; Drug: Plavix with Astrix Sponsor: Seoul St. Mary's Hospital Completed Wed, 09 Jan 2013 12:00:00 EST Extended Venous Thromboembolism Prophylaxis Comparing Rivaroxaban to Aspirin Following Total Hip and Knee ArthroplastyCondition: Venous ThromboembolismIntervention: Drug: rivaroxaban and ASA Sponsors: David Anderson; Canadian Institutes of Health Research (CIHR) Completed Fri, 02 Nov 2012 12:00:00 EDT Atrial Fibrillation and Ischemic Events With Rivaroxaban in Patients With Stable Coronary Artery Disease StudyCondition: Atrial FibrillationInterventions: Drug: Rivaroxaban and single antiplatelet drug (aspirin, clopidogrel or prasugrel); Drug: Rivaroxaban Sponsor: Japan Cardiovascular Research Foundation Unknown status Wed, 30 Dec 2015 12:00:00 EST Gastroprotective Agent Utilization and Compliance in Patients > 60 Years Taking Low-dose Aspirin in FranceCondition: Self-administered Questionnaire to PatientsIntervention: Sponsor: AstraZeneca Withdrawn Thu, 11 Nov 2010 12:00:00 EST Efficacy and Safety of PMK-S005 in the Prevention of Recurrent Peptic Ulcer in Low-dose Aspirin UsersCondition: Peptic UlcerInterventions: Drug: Placebo; Drug: PMK-S005 1; Drug: PMK-S005 2; Drug: PMK-S005 3 Sponsor: PharmaKing Completed Wed, 21 Jan 2015 12:00:00 EST An Observational Study of Burden of Upper GI-Symptoms in CV Risk PatientsCondition: Cardiovascular DiseaseIntervention: Sponsor: AstraZeneca Completed Wed, 21 May 2008 12:00:00 EDT Evaluate Misoprostol for the Healing of Small Bowel Ulcers in Low-dose Aspirin Users Complicated by Small Bowel BleedingCondition: Ulcer HemorrhageInterventions: Drug: Misoprostol; Drug: Placebo Sponsor: Chinese University of Hong Kong Completed Mon, 02 Dec 2013 12:00:00 EST The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of Long De Novo Coronary Artery Lesions (PLATINUM LL)Condition: Coronary Artery DiseaseInterventions: Device: PROMUS Element Coronary Stent System; Drug: Aspirin; Drug: Thienopyridine Sponsor: Boston Scientific Corporation Completed Wed, 28 Dec 2011 12:00:00 EST Pilot Study of VVD-101 for the Treatment of Delayed Alcohol-Induced HeadachesCondition: Delayed Alcohol Induced HeadacheInterventions: Drug: VVD-101; Drug: Placebo Sponsors: Cady, Roger, M.D.; Vivid Pharma Inc. Completed Fri, 27 Jun 2014 12:00:00 EDT The Safety and Efficacy of Albis®: The Prevention of Aspirin-induced Gastrointestinal Ulcers in PatientsCondition: Patients Taking Low-dose AspirinInterventions: Drug: Albis Tab; Drug: Placebo Sponsor: Daewoong Pharmaceutical Co. LTD. Unknown status Tue, 19 Jul 2011 12:00:00 EDT
App Reminder on ASA AdherenceCondition: Thromboembolic EventInterventions: Behavioral: Standard Education; Behavioral: Medication Reminder App Sponsors: Emory University; National Association of Orthopaedic Nurses Completed Wed, 09 Aug 2017 12:00:00 EDT A Study Assessing Inhibition of Serum Thromboxane B2 Levels With PN400 and Low Dose AspirinCondition: Platelet InhibitionInterventions: Drug: PN400; Drug: ASA; Drug: Placebo Sponsors: AstraZeneca; POZEN Completed Mon, 29 Mar 2010 12:00:00 EDT Study to Compare the Effect of a Combination of Dipyridamole With Sustained Release and Acetyl Salicylic Acid (Aggrenox®) on the Performance Relevant to Safety and on the General Condition of Healthy VolunteersCondition: HealthyInterventions: Drug: Aggrenox®; Drug: Placebo; Other: Ethanol Sponsor: Boehringer Ingelheim Completed Thu, 30 Oct 2014 12:00:00 EDT Long-term Use of Takepron Capsules on the Prevention of Recurrence of Gastric/Duodenal Ulcer in Patients Receiving Low-dose AspirinCondition: Gastric or Duodenal UlcersIntervention: Drug: Lansoprazole Sponsor: Takeda Completed Mon, 31 Mar 2014 12:00:00 EDT Pembrolizumab in Combination With Anti-platelet Therapy for Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and NeckCondition: Head and Neck CancerInterventions: Drug: Pembrolizumab; Drug: Clopidogrel; Drug: acetylsalicylic acid Sponsor: Medical University of South Carolina Recruiting Thu, 10 Aug 2017 12:00:00 EDT The Success of Opening Concurrent CTO leSion to Improve Cardiac Function Trial in Patients With Multi-vessel DiseaseConditions: Chronic Total Occlusion of Coronary Artery; Percutaneous Coronary Intervention; Coronary Artery Disease; Viable MyocardiumInterventions: Drug: aspirin, betaloc, atorvastatin, rosuvastatin, clopidogrel, ticagrelor; Device: coronary wires. stents or coronary balloons Sponsors: Beijing Anzhen Hospital; The First Affiliated Hospital of Dalian Medical University; Beijing Friendship Hospital Enrolling by invitation Thu, 14 Dec 2017 12:00:00 EST Statin and Dual Antiplatelet Therapy to Prevent Early Neurological Deterioration in Branch Atheromatous DiseaseConditions: Acute Stroke; Dual Antiplatelet Therapy; StatinInterventions: Drug: Clopidogrel; Drug: Aspirin; Drug: Atorvastatin; Drug: Rosuvastatin Sponsor: Chang Gung Memorial Hospital Recruiting Thu, 01 Apr 2021 12:00:00 EDT Impact of Hybrid Coronary Revascularization on Antiplatelet TherapyCondition: Coronary Artery DiseaseIntervention: Procedure: Hybrid coronary revascularization Sponsors: Aarhus University Hospital Skejby; Danish Heart Foundation; Aase and Ejnar Danielsens Foundation Completed Wed, 19 Nov 2014 12:00:00 EST International PFO ConsortiumConditions: Stroke; Transient Ischemic AttackInterventions: Drug: Antithrombotic treatment; Device: percutaneous device closure of PFO Sponsors: University Hospital Inselspital, Berne; University Hospital, Basel, Switzerland; University of Lausanne Hospitals; University Hospital, Geneva; University Hospital, Zürich; Triemli Hospital; Cantonal Hospital of Aarau, Switzerland; Alfried-Krupp Krankenhaus of Essen, Germany; University Hospital, Essen; Klinikum Worms; Tufts Medical Center; Baystate Medical Center; East Medical Center Tyler, Texas; Universitaire Ziekenhuizen Leuven; Ammerland Klinik GmbH, Westerstede, Germany; University Hospital, Ghent; Arcispedale Santa Maria Nuova-IRCCS Recruiting Wed, 11 Mar 2009 12:00:00 EDT Anticoagulation in Blunt Cerebrovascular InjuriesConditions: Carotid Artery Injury; Vertebral Artery InjuryInterventions: Drug: heparin; Drug: aspirin and clopidogrel Sponsor: C. Clay Cothren, MD Withdrawn Fri, 29 Jun 2007 12:00:00 EDT
Efficacy and Safety of TAK-438 for the Prevention of Recurrent Gastric or Duodenal Ulcers During Therapy of Low-dose AspirinConditions: Gastric Ulcers; Duodenal UlcersInterventions: Drug: TAK-438; Drug: Placebo; Drug: Lansoprazole Sponsor: Takeda Completed Mon, 17 Oct 2011 12:00:00 EDT Long-term Extension Study of TAK-438 for the Prevention of Recurrent Gastric or Duodenal Ulcers During Therapy of Low-dose AspirinConditions: Gastric Ulcers; Duodenal UlcersInterventions: Drug: TAK-438; Drug: Placebo; Drug: Lansoprazole Sponsor: Takeda Completed Thu, 20 Oct 2011 12:00:00 EDT Heredity and Phenotype Intervention (HAPI) Heart StudyCondition: Cardiovascular DiseasesInterventions: Other: Aspirin; Other: Cold Pressor Test; Other: High Fat Meal; Other: Dietary Salt Sponsors: University of Maryland, Baltimore; National Heart, Lung, and Blood Institute (NHLBI) Completed Tue, 22 Apr 2008 12:00:00 EDT The Success of Opening Single CTO Lesions to Improve Myocardial Viability Study (SOS-comedy)Conditions: Hibernation, Myocardial; Complete Occlusion of Coronary ArteryInterventions: Device: stenting or balloon expansion; Drug: aspirin, clopidogrel, ticagrelor, atorvastatin, rosuvastatin, betaloc Sponsors: The First Affiliated Hospital of Dalian Medical University; Beijing Anzhen Hospital; First Hospital of China Medical University; Nanfang Hospital of Southern Medical University Completed Tue, 10 May 2016 12:00:00 EDT TIMES: Ticagrelor vs. Placebo/ Clopidogrel With Aspirin in Anterior STEMI Patients Treated With Primary PCICondition: ST Elevation Myocardial InfarctionInterventions: Drug: Ticagrelor; Other: Placebo Sponsors: Papworth Hospital NHS Foundation Trust; AstraZeneca Unknown status Tue, 09 May 2017 12:00:00 EDT Asymptomatic Carotid Artery Plaque Study (ACAPS)Conditions: Cardiovascular Diseases; Carotid Stenosis; Cerebral Arteriosclerosis; Cerebrovascular Disorders; Heart Diseases; Vascular DiseasesInterventions: Drug: aspirin; Drug: lovastatin Sponsor: National Heart, Lung, and Blood Institute (NHLBI) Completed Thu, 28 Oct 1999 12:00:00 EDT First Approach for Aspirin Misuse Objective ScreeningCondition: Peripheral Arterial DiseaseIntervention: Device: Laser speckle flowmetry Sponsor: University Hospital, Angers Completed Tue, 20 Dec 2016 12:00:00 EST Study of Esomeprazole 20 mg or 40 mg vs Placebo Effectiveness on the Occurrence of Peptic Ulcers in Subjects on Low Dose Acetylsalicylic Acid (LDA)Conditions: Gastric Ulcer; Duodenal UlcerInterventions: Drug: Esomeprazole 40 mg; Drug: Esomeprazole 20 mg; Drug: Placebo Sponsor: AstraZeneca Completed Thu, 01 Mar 2007 12:00:00 EST AggreGuide 325 mg. Aspirin Study for Aspirin Induced Platelet DysfunctionCondition: Platelet Dysfunction Due to Aspirin IngestionIntervention: Sponsor: Aggredyne, Inc. Completed Fri, 02 Aug 2013 12:00:00 EDT Comparison of a Rivaroxaban-based Strategy With an Antiplatelet-based Strategy Following Successful TAVR for the Prevention of Leaflet Thickening and Reduced Leaflet Motion as Evaluated by Four-dimensional, Volume-rendered Computed Tomography (4DCT)Conditions: Aortic Valve Stenosis; Cardiovascular Diseases; Heart Valve Diseases; Ventricular Outflow Obstruction; ThrombosisInterventions: Drug: Acetylsalicylic acid; Drug: Clopidogrel; Drug: Rivaroxaban Sponsors: ECRI bv; Rigshospitalet, Denmark; Bayer; Cardialysis BV Completed Thu, 14 Jul 2016 12:00:00 EDT
Perfusion Computer Tomography: Imaging and Clinical Validation Following Reperfusion Therapy in Acute Ischaemic StrokeCondition: Ischemic StrokeInterventions: Drug: acetylsalicylic acid, clopidogrel bisulfate and/or warfarin, Apixaban, Rivaroxaban, Dabigatran; Drug: alteplase; Procedure: endovascular Sponsor: Rabin Medical Center Unknown status Fri, 05 Dec 2014 12:00:00 EST Safety and Effectiveness of Ticagrelor in Patients Undergoing Carotid StentingCondition: Carotid StenosisInterventions: Drug: Ticagrelor; Drug: Clopidogrel; Procedure: Carotid stenting Sponsor: Assiut University Not yet recruiting Mon, 16 Sep 2019 12:00:00 EDT Optical Coherence Tomography Guided Antithrombotic Treatment After Endovascular Thrombectomy of the Posterior CirculationConditions: Stroke of Basilar Artery; Optical Coherence Tomography; Antithrombotics; Endovascular ThrombectomyInterventions: Drug: Unfractionated heparin; Drug: Acetylsalicylic Acid (ASA) Sponsor: Sunnybrook Health Sciences Centre Recruiting Thu, 10 Oct 2019 12:00:00 EDT Randomized Trial of Pegylated Interferon Alfa-2a Versus Hydroxyurea in Polycythemia Vera (PV) and Essential Thrombocythemia (ET)Conditions: High Risk Polycythemia Vera; High Risk Essential ThrombocythemiaInterventions: Drug: PEGASYS; Drug: Hydroxyurea; Drug: Aspirin Sponsors: Ronald Hoffman; Myeloproliferative Disorders-Research Consortium; National Cancer Institute (NCI); Roche Pharma AG Completed Tue, 14 Dec 2010 12:00:00 EST Cilostazol and Endothelial Progenitor CellCondition: Myocardial Infarction, AcuteInterventions: Drug: Cilostazol Tablets; Drug: placebo; Drug: Aspirin; Drug: Clopidogrel Sponsors: Gyeongsang National University Hospital; Korea Otsuka Pharmaceutical Co., Ltd. Active, not recruiting Fri, 29 May 2020 12:00:00 EDT The Effect of Early Administration of Dapagliflozin in STEMI Patients With LV Systolic DysfunctionConditions: STEMI - ST Elevation Myocardial Infarction; Left Ventricular Systolic DysfunctionInterventions: Drug: Dapagliflozin 10Mg Tab; Drug: Placebo Sponsor: Assiut University Not yet recruiting Thu, 16 Sep 2021 12:00:00 EDT Hydroxychloroquine in Prevention of PreeclampsiaCondition: HydroxychloroquineInterventions: Drug: Hydroxychloroquine; Drug: Folic acid; Drug: Low-dose aspirin; Drug: Placebo Sponsor: Assiut University Recruiting Tue, 16 Feb 2021 12:00:00 EST PLATINUM Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions-Pharmacokinetics (PLATINUM PK)Condition: Coronary Artery DiseaseInterventions: Device: PROMUS Element Everolimus-Eluting Coronary Stent System; Drug: Aspirin; Drug: Thienopyridine Sponsor: Boston Scientific Corporation Completed Mon, 16 Jan 2012 12:00:00 EST Efficacy and Safety of Qizhitongluo Capsule in the Recovery Phase of Ischemic StrokeCondition: Ischemic StrokeInterventions: Drug: Qizhitongluo Capsule; Drug: Naoxintong Capsule; Drug: Aspirin Enteric-coated Tablets; Behavioral: the routine recovery training; Drug: placebo Sponsor: China Academy of Chinese Medical Sciences Completed Mon, 07 Jan 2013 12:00:00 EST Aspirin Resistance Following Coronary Bypass SurgeryCondition: Ischemic Heart DiseaseIntervention: Procedure: Coronary artery bypass surgery Sponsor: Sheba Medical Center Terminated Thu, 01 Dec 2005 12:00:00 EST
|